Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,ligand-gated ion channel activity (GO:0015276),0.8348685973344342,2.7069980112696257,0.0,0.0,0.0,14/30,3.60%,GRID2;GRIA4;GRIK5;GRIK2;GRIN2A;GRIK1;GABRB1;GRIN2B;GRIA3;GRIN3A;GRID1;GRIA2;GRIK4;GRIA1
prerank,ligand-gated channel activity (GO:0022834),0.8348708089579245,2.678979658595147,0.0,0.0,0.0,14/29,3.60%,GRID2;GRIA4;GRIK5;GRIK2;GRIN2A;GRIK1;GABRB1;GRIN2B;GRIA3;GRIN3A;GRID1;GRIA2;GRIK4;GRIA1
prerank,transmitter-gated ion channel activity (GO:0022824),0.829560578847187,2.5962880389907323,0.0,0.0,0.0,17/29,8.91%,GRID2;GRIA4;GRIK5;GRIK2;GABRB3;GRIK1;GABRG3;GABRB1;GABRA2;GRID1;GRIA2;GRIK4;GABRA3;GABRA5;GABRB2;GABRG2;GLRA2
prerank,glutamate receptor activity (GO:0008066),0.8957825088171766,2.487506432617877,0.0,0.0,0.0,13/19,3.60%,GRM7;GRID2;GRIA4;GRIK5;GRIK2;GRM5;GRIK1;GRM8;GRM1;GRID1;GRIA2;GRIK4;GRIA1
prerank,ionotropic glutamate receptor activity (GO:0004970),0.8660315512136355,2.425972489309182,0.0,0.0,0.0,11/17,3.60%,GRIA4;GRIK5;GRIK2;GRIN2A;GRIK1;GRIN2B;GRIA3;GRIN3A;GRIA2;GRIK4;GRIA1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.7810363974478045,2.420751110592379,0.0,0.0,0.0,12/28,7.68%,GRID2;GRIK5;GRIK2;GRIK1;GABRG3;GABRA2;GRID1;GRIK4;GABRA3;GABRA5;GABRG2;CHRNA5
prerank,potassium channel activity (GO:0005267),0.6186531306630363,2.4117460134144952,0.0,0.0,0.0,34/89,15.93%,KCND2;GRIK5;GRIK2;KCNB2;GRIK1;KCNQ3;KCNN2;KCNQ5;KCNC2;KCNK10;KCND3;KCNT2;KCNMB2;KCNMB3;KCNH7;KCNH5;KCNH1;GRIK4;KCNK2;HCN2;KCNA1;KCNH4;TMEM175;HCN1;KCNF1;KCNG1;KCNMA1;KCNV1;KCNH8;KCNA2;KCNS3;TMEM38A;GRIK3;KCNK12
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.8464444048128497,2.3914340498937805,0.0,0.0,0.0,11/19,7.35%,GRID2;GRIK5;GRIK2;GRIK1;GABRG3;GABRA2;GRID1;GRIK4;GABRA3;GABRA5;GABRG2
prerank,voltage-gated cation channel activity (GO:0022843),0.6054661091699868,2.385218368966611,0.0,0.0,0.0,34/97,14.00%,KCND2;KCNB2;GRIN2A;CACNA2D3;KCNQ3;CACNA1C;CACNA1E;KCNQ5;GRIN2B;KCNC2;CACNA2D1;KCND3;GRIN3A;KCNH7;KCNH5;CACNB2;KCNH1;NCS1;TMC1;CACHD1;HCN2;KCNA1;CACNG4;CACNG2;KCNH4;HCN1;RYR1;KCNF1;KCNG1;KCNMA1;KCNV1;KCNH8;KCNA2;KCNS3
prerank,voltage-gated potassium channel activity (GO:0005249),0.6213508241921701,2.358136212658904,0.0,0.0,0.0,30/80,14.00%,KCND2;KCNB2;KCNQ3;KCNN2;KCNQ5;KCNC2;KCND3;KCNT2;KCNH7;KCNH5;KCNH1;KCNJ6;KCNJ3;KCNJ10;KCNK2;KCNJ9;HCN2;KCNIP2;KCNA1;KCNH4;KCNJ16;HCN1;KCNF1;KCNG1;KCNMA1;KCNJ12;KCNV1;KCNH8;KCNA2;KCNS3
prerank,ion channel activity (GO:0005216),0.5995549398757112,2.3483975681912828,0.0,0.0,0.0,22/80,8.42%,GRID2;GRIA4;GRIK5;GRIK2;GRIN2A;GRIK1;UNC80;TRPM3;GABRB1;GRIN2B;GRIA3;GRIN3A;NALCN;TRPC1;GRID1;GRIA2;GRIK4;GRIA1;TMC1;CHRNA5;PKD1L3;TRPM1
prerank,ligand-gated cation channel activity (GO:0099094),0.6009220252376481,2.278958201269837,0.0,0.0,0.0,19/75,7.75%,ASIC2;GRIA4;GRIK5;GRIK2;GRIN2A;GRIK1;KCNN2;GRIN2B;GRIA3;GRIN3A;GRIA2;GRIK4;GRIA1;KCNJ6;KCNJ3;KCNJ10;KCNJ9;CHRNA5;KCNJ16
prerank,neuropeptide receptor activity (GO:0008188),0.6916268203965708,2.1911769123685745,0.0,6.682965228988181e-05,0.001,12/29,15.93%,SORCS1;HCRTR2;SORCS3;GPR37;NPY2R;NTSR1;GPR143;NPSR1;GALR1;NPY1R;TACR3;OPRM1
prerank,GABA receptor activity (GO:0016917),0.7332328906494491,2.146474641725278,0.0,0.00024822442279098957,0.004,10/21,8.61%,GABRB3;GABRG3;GABRB1;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2;GABBR1;GPR156
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.8033343009858076,2.1370661910577278,0.0,0.00028959515992282116,0.005,8/15,3.84%,HS3ST6;HS3ST5;HS6ST3;HS3ST4;HS6ST2;NDST4;NDST3;HS3ST1
prerank,sodium channel activity (GO:0005272),0.6448730927294255,2.128652727959166,0.0,0.0003257945549131738,0.006,12/37,10.11%,ASIC2;GRIK5;GRIK2;GRIK1;SCN2A;SCN1A;GRIK4;SCN3A;SCN9A;HCN2;HCN1;SLC4A11
prerank,ligand-gated anion channel activity (GO:0099095),0.7818370448120319,2.0863477364709695,0.0,0.0009198905079901377,0.015,10/17,8.91%,GABRB3;GABRG3;GABRB1;GLRA1;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2;GLRA2
prerank,GABA-A receptor activity (GO:0004890),0.7472132436920964,2.0832575591817655,0.0,0.0009653171997427373,0.017,8/18,7.35%,GABRB3;GABRG3;GABRB1;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.8282717898378492,2.0374848407569486,0.0,0.002377728681471584,0.043,8/12,7.35%,GABRB3;GABRG3;GABRB1;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2
prerank,phosphatidylinositol binding (GO:0035091),-0.5309674670061756,-2.0292428505325435,0.0,0.010929961695677224,0.01,38/91,20.46%,DENND1A;SNX10;PITPNC1;SNX2;SNX9;PITPNA;ITPR1;SNX27;SNX8;MTM1;FES;SNX24;WDFY3;PITPNM1;ANKFY1;SNX5;FCHO2;ESYT1;PICALM;HIP1;EEA1;ESYT2;MYO1E;SESTD1;NCF1;SNX13;CCDC88A;AIDA;ITPR3;RNF34;SNX16;APPL2;SNX4;SNX1;WDFY1;DENND1B;APPL1;MPPE1
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.7365049785991247,-1.9825087316907262,0.0,0.016941440628299696,0.029,6/17,5.29%,ABCA1;ABCG1;PLTP;PITPNC1;PITPNA;PITPNM1
prerank,acetylcholine receptor activity (GO:0015464),0.6661303938153946,1.9810206657614475,0.0,0.005733984166471859,0.109,6/22,14.99%,CHRM2;CHRM3;HRH3;CHRNA5;CHRNA7;CHRFAM7A
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.6669005897972197,1.9249036321863287,0.002242152466367713,0.010839133128539877,0.208,6/21,14.99%,GRM5;GRM1;GRIA1;CHRNA5;CHRNA7;CHRFAM7A
prerank,voltage-gated calcium channel activity (GO:0005245),0.5789459995296722,1.9215289056010658,0.0,0.01066236725170387,0.216,14/37,15.93%,CACNA2D3;CACNA1C;CACNA1E;CACNA2D1;CACNB2;NCS1;TMC1;CACHD1;CACNG4;CACNG2;RYR1;TMC2;CACNA1G;OPRM1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.6181579505172384,-1.9138478511070345,0.0,0.039712194160960584,0.092,17/35,19.64%,LYN;FGR;SYK;PEAK1;FES;ABL2;TEC;PTK2B;PKDCC;LCK;DYRK1A;ITK;FRK;TXK;ZAP70;HCK;SLA
prerank,outward rectifier potassium channel activity (GO:0015271),0.795386430484804,1.8976593503975354,0.0044943820224719105,0.014542713465689498,0.294,5/11,6.79%,KCND2;KCND3;KCNT2;KCNK2;KCNIP2
prerank,cholesterol transfer activity (GO:0120020),-0.7191286211495715,-1.8916157065197134,0.0,0.04262685061314117,0.125,6/16,11.17%,ABCA1;ABCG1;PLTP;GRAMD1B;NPC2;STARD5
prerank,sterol transfer activity (GO:0120015),-0.7062369503473089,-1.8812665305241885,0.001694915254237288,0.04044085827400574,0.149,6/17,11.17%,ABCA1;ABCG1;PLTP;GRAMD1B;NPC2;STARD5
prerank,cyclic nucleotide binding (GO:0030551),0.6536516478298565,1.8763563893383437,0.0,0.017882501125234204,0.357,8/21,10.31%,PDE4B;PDE10A;KCNH1;PDE4D;PDE11A;RAPGEF4;HCN1;POPDC2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.6426303372884405,1.8728797142196645,0.0,0.017723223787276653,0.365,7/21,3.88%,PDE4B;PDE10A;PDE1A;PDE1C;PDE4D;PDE11A;PDE9A
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.7386365639006106,-1.8532749458079711,0.0,0.05319248025229582,0.222,7/14,12.05%,CYBB;CYBA;KMO;NCF1;NCF4;MICAL1;NCF2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.6273140576057357,1.8506667547583102,0.0,0.021652807341921706,0.43,7/23,3.88%,PDE4B;PDE10A;PDE1A;PDE1C;PDE4D;PDE11A;PDE9A
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.7166997899875991,1.829057904702274,0.0022471910112359553,0.026610577472908122,0.509,7/13,8.91%,GABRG3;GLRA1;GABRA2;GABRA3;GABRA5;GABRG2;GLRA2
prerank,calcium channel activity (GO:0005262),0.4606449198997969,1.820080974047875,0.00234192037470726,0.028266556145323935,0.542,19/84,9.81%,CACNA2D3;CACNA1C;CACNA1E;TRPC5;RYR2;CACNA2D1;SLC24A4;SLC24A2;TRPC1;CACNB2;NCS1;SLC24A3;TMC1;CACHD1;CACNG4;CACNG2;PKD1L3;TRPM1;RYR1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.7930781951254592,-1.8156653220711845,0.0035587188612099642,0.0755728780101111,0.341,5/10,12.05%,CYBB;CYBA;NCF1;NCF4;NCF2
prerank,chemorepellent activity (GO:0045499),0.5996260861591081,1.8016386823145618,0.005141388174807198,0.0333733456711058,0.622,7/25,3.42%,NRG3;NRG1;SEMA6D;EPHA7;SEMA6A;SEMA3E;SEMA5A
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.7036038654422346,1.7924092439431647,0.007125890736342043,0.03544644757455331,0.666,5/12,9.82%,OPN3;OPN1MW;OPN1MW3;OPN5;OPN4
prerank,neuropeptide binding (GO:0042923),0.6529614573687661,1.789046035798363,0.00966183574879227,0.035788356698849284,0.684,8/18,23.35%,GPR37;OPRD1;GPR149;OPRK1;OPRL1;OPRM1;SORL1;MC4R
prerank,calcium ion binding (GO:0005509),0.37846736253597235,1.779985321909238,0.0,0.037493523361257754,0.71,91/323,14.77%,KCNIP4;NRXN1;ADGRL3;ASTN2;CDH18;SPOCK1;CDH8;RYR3;CDH10;RYR2;SYT1;EML1;CDH2;SLIT3;SLIT2;CDH20;CDH11;PCLO;KCNIP1;SYT10;ENPP2;NCS1;CDH13;SCUBE1;TUBB4A;PAM;TESC;MMP12;SYT2;CDH12;PITPNM3;CDH22;SLIT1;CDH19;CDH7;PDCD6;SPARCL1;SLC25A23;CASQ2;DCHS1;PRNP;SYT5;ENPP3;PLA2G4E;KCNIP2;GLCE;ADGRV1;CDH6;LETM1;PCDHB6;CALR3;CCDC47;SYT11;SYT12;DNER;CDH17;PLA2G10;CRP;RYR1;PCDHA4;MMP13;DSC2;DSC3;CABCOCO1;CETN3;CDHR3;SMOC2;GSN;TTN;CDH9;CDK5R1;CAPN3;AMY1A;AMY1B;AMY1C;DYSF;NDUFAB1;RET;CALM1;F9;CALM3;SYT7;CALM2;MICU3;CDH1;NOL3;CDH5;CLEC3B;ATP2A1;BRAF;MCTP2
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5652435813336533,1.7750719665694543,0.0,0.038226561109812394,0.726,14/32,21.56%,KCNB2;KCNQ3;KCNQ5;KCNC2;KCNH1;KCNA1;KCNG1;KCNA2;KCNS3;KCNE4;KCNA6;KCNQ2;KCNG3;KCNA5
prerank,phosphotyrosine residue binding (GO:0001784),-0.563209593872254,-1.7734300414907398,0.0,0.11654071658015841,0.514,19/37,18.46%,BCAR3;FGR;GRB2;PLCG2;SYK;VAV1;ABL2;SH3BP2;STAP1;PTPN6;VAV2;LCK;CRK;SAMSN1;RASA1;CRKL;ZAP70;HCK;PTPN11
prerank,GTPase regulator activity (GO:0030695),-0.41561102925338844,-1.7615660615827933,0.0,0.12107968678433549,0.585,70/212,16.72%,ARHGAP15;IQGAP2;IQGAP1;NRP1;VAV3;ABR;ARHGAP10;ARHGAP25;ASAP1;STARD8;ARHGAP22;MYO9B;JUN;ARHGAP24;ARHGAP30;ARHGAP19;ARHGAP17;IPO5;SIPA1;TBC1D15;SGSM2;RGS1;HTR2B;TBC1D2B;TBC1D9;RIN2;ARAP1;ARFGEF1;RGS3;ARHGAP18;RAB3GAP1;TBC1D5;TBC1D1;SIPA1L2;PREB;WASL;RIC8B;TBC1D22A;ARRB1;TBC1D16;EIF5;GPS1;ALS2;SIRPA;TBC1D22B;SIPA1L3;RGS11;SH3BP1;TBC1D8B;TBC1D8;ITGB1BP1;NCKAP1L;ADAP1;CDC42EP2;TBC1D17;FLCN;CCDC88A;RGS12;TBC1D10B;RASA1;RACGAP1;RALGAPA2;RP2;RGS14;TBC1D30;ACAP2;BNIP2;TBC1D7;ARHGAP31;TBC1D9B
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.7508407522216843,1.7596291765168424,0.0069767441860465115,0.04262159353687638,0.774,5/10,7.35%,GABRG3;GABRA2;GABRA3;GABRA5;GABRG2
prerank,G protein-coupled receptor activity (GO:0004930),0.3893702483503415,1.7569708838159201,0.0,0.0426946007200502,0.782,72/239,19.88%,ADGRB3;ADGRL3;GRM5;GRM8;HCRTR2;LGR5;RORB;GRM1;GPR37;P2RY12;PAX8;GPR173;GPR45;OPRD1;GPR149;ADRA1B;GRM3;NTSR1;ADGRV1;GABBR1;GPR101;GPR85;TRHR;PTH1R;GPR22;CX3CR1;GPR156;GPR183;ADGRL2;OPN3;OXTR;OPN1MW;OPN1MW3;OPN5;OPN4;GPR143;LGR6;GPR3;AGTR1;ADRA2C;TAS1R1;LPAR2;GALR1;TAPT1;LGR4;FFAR1;F2RL2;ADRA1A;ADRA1D;ADRB1;ADGRG1;GPR26;OPRK1;ADGRB2;ADGRA1;OPRL1;OPRM1;ADGRL4;GPR157;CRHR1;LANCL1;GRM4;GPR61;ADGRB1;TM2D1;CELSR2;GPR34;NMBR;RXFP1;ADGRG2;GABBR2;GPR35
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.5384787089097818,-1.7561905570445098,0.0,0.1154203955063515,0.603,21/42,18.46%,BCAR3;FGR;GRB2;PLCG2;SYK;VAV1;ABL2;SH3BP2;STAP1;PTPN6;VAV2;YWHAE;PIN1;LCK;CRK;SAMSN1;RASA1;CRKL;ZAP70;HCK;PTPN11
prerank,GTPase activator activity (GO:0005096),-0.39431816303839007,-1.7455060603838293,0.0,0.11794422302517152,0.637,80/313,11.72%,ARHGAP15;IQGAP2;DOCK2;IQGAP1;NRP1;VAV3;DENND1A;AKAP13;ABR;ARHGAP10;ARHGAP25;ASAP1;STARD8;ITSN1;RIN3;DENND4C;ARHGAP22;MYO9B;FGD6;JUN;ARHGAP24;ARHGAP30;ARHGAP19;ARHGAP17;DOCK10;SIPA1;ARHGEF2;CYTH1;DOCK11;VAV1;TBC1D15;SGSM2;RGS1;HTR2B;TBC1D2B;RASGRP4;TBC1D9;RAP1A;FGD4;RIN2;RGL2;DOCK8;ARAP1;ARFGEF1;RGS3;ARHGAP18;RAB3GAP1;TBC1D5;TBC1D1;SIPA1L2;FGD3;DOCK5;ARHGEF10;PREB;RIC8B;EIF2B3;TBC1D22A;ARRB1;ARHGEF18;DENND2D;TBC1D16;EEF1B2;ALS2;TBC1D22B;SIPA1L3;RGS11;SH3BP1;TBC1D8B;FNIP1;VAV2;TBC1D8;NCKAP1L;ADAP1;CDC42EP2;TBC1D17;FLCN;ARHGEF11;ARFGEF2;CCDC88A;DNMBP
prerank,RNA binding (GO:0003723),-0.3536343170251941,-1.7435954074490791,0.0,0.11048369614047061,0.646,464/1321,25.12%,APOBEC1;RBM47;DIAPH1;MYO5A;RFTN1;FNDC3B;AHNAK;MBNL1;PTBP3;RBM39;MSN;GRB2;RBMS1;VIM;ZC3HAV1;TLR8;LRP1;SAMHD1;MYH9;CNOT4;JUN;IREB2;YTHDF3;DEK;ANXA11;IPO5;AGO2;DCP1A;CANX;RPS18;MAP3K20;MBNL2;ANXA2;FLNA;ERI3;TRA2B;SON;DDX46;FARS2;NFX1;CDK13;RPL7;RPS12;SRRM1;TLR7;RNASEL;XPOT;ADAT1;MKRN2;RPS21;UCHL5;HNRNPA3;ZCCHC9;RPS8;RPS24;BRCA1;GSPT1;STAT3;TUT7;DHX58;CNOT1;SEC63;ANP32A;DHX9;ESF1;AKAP8;RBPMS;CHD3;HSPA9;MPHOSPH10;RC3H1;DYNC1H1;TEP1;TOP2A;NUP42;NOC3L;NOA1;CCDC59;SARS1;FAM120A;RPL36;SF3B6;TCF20;ELP5;DHX40;RPS6;MACF1;RPS20;EIF4G3;DDX50;PUS7;RPL11;RPL10A;EIF4A2;ZC3H7B;BICC1;RPL12;SNRNP35;DDX60;CRNKL1;RRBP1;PUM3;ERAL1;CHTOP;DDX49;SRRT;SNTB2;YTHDC2;PATL1;EIF3A;SECISBP2;MRPL42;SRP14;SNRPG;FUS;GRN;MBNL3;RPS14;HNRNPH1;USP36;TUFM;RBM18;REXO4;HNRNPDL;ISG20L2;RAE1;EIF5;NUFIP2;EDF1;NOP14;SNRPF;ALKBH1;NME1;DALRD3;RPL32;HNRNPL;CDC40;WDR36;DIMT1;DCP2;CNBP;RPS28;BST2;RPS13;PUM2;HELZ2;ELP1;NOL6;PRMT1;ACIN1;EIF2AK2;CAST;NVL;CWC22;LARP4B;KHNYN;RBM19;AGFG1;RPS15A;KMT2C;EXD1;SPEN;KNOP1;LARP4;RALY;DDX5;DARS1;UBE2L3;UBC;RPS27A;FNDC3A;YWHAE;RPL28;PRPF8;RPS4X;NUCKS1;ZC3H14;FASTKD2;PUS1;DHX37;TPT1;TENT5A;XPO5;KRR1;APTX;DUSP11;CHCHD1;SF3B5;IBA57;MOV10;EEF2;SART1;GTPBP1;PCBP2;EIF4A1;HSPE1;SSBP1;HNRNPUL1;TPR;XRCC6;LRPPRC;MTPAP;ZYX;PRDX1;ALYREF;KCTD12;NUDT21;CSDE1;HSP90B1;IFIT1;RPS23;SNRPA;LLPH;EIF3E;CELF1;ZNF106;CCDC86;RPL22;OASL;GPATCH4;HNRNPLL;RPL14;RBM14;EEF1A1;CPNE3;PKM;HSP90AB1;HMGB2;IFIT2;ZBED4;CWC15;NYNRIN;WDR33;LGALS1;RBM10;METTL14;RPL34;OAS3;MKI67;MAP4;RADX;YTHDC1;RPS11;MRPS11;ZNF326;DHX36;UNK;RPL6;NIFK;CFAP20;PSMA1;NGDN;MANF;NOLC1;DUT;GTF2E2;RBMS2;NCBP1;MARK2;GAR1;FAU;VIRMA;NGRN;SAMSN1;SART3;PPIL4;PSPC1;TFAM;RAD51AP1;POLR2A;NUSAP1;DDX31;TRMT6;YY1;EIF4G1;SNUPN;PNISR;FASTKD3;TMSB4X;RPS10;CRKL;EMG1;PPIG;HLTF;AATF;DAZAP1;RPL18A;OTUD4;DDX1;SF3A1;THOC2;NCL;KARS1;SRSF10;DNAJC2;NUFIP1;EIF2A;RPL37A;ASS1;POLR2G;MCAT;DAP3;HDLBP;RPS9;RBM4B;ZCCHC3;MRPS15;SELENOH;UTP6;TDRD7;UBE2I;MRPL21;G3BP1;LSM6;DNA2;RPS27;HSPA1A;EIF3L;TENT4B;WBP11;GTPBP10;ABCF1;REPIN1;ERH;ACAA2;SURF6;ZRANB2;RPS3;HUWE1;CCT4;MRPL45;HTATSF1;MRPL22;TWF2;PPARGC1B;ANG;RNPS1;SNRNP70;NSRP1;HNRNPA1;RPL23A;WRAP53;EXOSC10;PDIA4;TYW5;HSPB1;PPIB;RPS16;API5;MAGOH;EIF5B;RPL9;DDX3X;ZNFX1;HMGB3;RBM42;RBPMS2;PSMD4;BUD13;DDX6;C1QBP;SMC1A;OAS2;HMGB1;MRPL15;UBAP2;SF3B1;RTF1;THUMPD1;AARS1;GRSF1;MAZ;S100A4;RBM11;CPSF3;DARS2;CPEB4;LSM5;TSNAX;ZC3H12A;TPD52L2;LRRFIP1;HNRNPH2;RACK1;DDX54;RBM3;PCDHGA9;KDM1A;PNLDC1;TRIM25;SRPK1;PTPN1;ELAC2;NIP7;RBM38;LSM14A;EWSR1;DNTTIP2;HNRNPK;ANXA7;GDI2;BRIX1;EIF3H;SNU13;XRN2;NONO;PPP1CC;SYF2;MEX3A;RPL7A;RPL19;ANKHD1;P4HB;ATXN2L;RRP8;MDH2;SUCLG1;RPS15;SMG1;RBM22;RPL39;PABPC1L;TES;MTREX;SRSF11;RPLP0;GPATCH8;DHX35;C1D;EIF1;PDIA3;NQO1;EIF2S2;PCBP4;UNC50;DDX39B;MTDH;PRRC2C;PRKDC;DCN;PUM1;ARCN1;RPP40;PTCD2;RPL41;CTNNA1;PRR3;ASCC3;TSN;SND1;ACTN1;DUSP14;TRIM28;TARDBP;DSP;ESRP1;PRPF6;MRPS7;GTF2F1;AKAP8L;BUD23;UBE2N;NHP2;RBM15B
prerank,cAMP binding (GO:0030552),0.712480961772688,1.7428189746130098,0.02188183807439825,0.04650415609760636,0.815,6/11,10.31%,PDE4B;PDE10A;PDE4D;RAPGEF4;HCN1;POPDC2
prerank,androgen receptor binding (GO:0050681),-0.589612805538366,-1.7292401660745709,0.0,0.12241557099158491,0.708,12/25,24.92%,FOXP1;PRKCB;KDM3A;PRMT2;TGFB1I1;DDX5;TRIM68;NSD1;ARID5A;KDM1A;ZBTB7A;PRPF6
prerank,ATP binding (GO:0005524),-0.3948112936173051,-1.7273566789635657,0.0,0.11632602090399333,0.717,93/266,21.84%,ABCA1;MAP3K5;ABCG1;P2RX7;DAPK1;CDK6;MYH9;MYO9B;MTHFS;MAP4K3;PI4K2A;MYO1F;RUNX3;ERN1;MAP3K20;INSR;P2RX4;PEAK1;PRKAG2;ABCD2;SMARCA5;TLK1;MINK1;ERCC6;DYRK2;DHX9;NLRC4;HSPA9;PIM1;ATP7A;MTHFD1L;DAPK3;SMC4;STK3;BLM;ABCE1;RTEL1;CARS2;IRAK3;ABCF3;GUK1;STK38;MCM6;NME1;NVL;TRIB1;TGFBR1;NEK6;RAD51;SIK1;KIFC1;KIF14;TAOK1;TAP2;MTPAP;STK17B;HSP90AB1;STK11;CHD8;KSR1;OAS3;MKNK1;DHX36;MARK2;ABCB8;MAST2;HSPA4;EIF4G1;MKNK2;LATS2;PDXK;UBA2;ABCD3;HSPA1A;PGK1;ZAP70;MLKL;ABCF1;TWF2;ENPP1;PAPOLA;HSPA2;OAS2;CDC42BPG;WNK1;AARS1;DARS2;NOL9;HSPA13;PRKAG1;SRPK1;PYGL;VPS4A
prerank,histone methyltransferase activity (GO:0042054),-0.5646237963112357,-1.72348051099888,0.0,0.11381733445765217,0.728,14/32,16.15%,NSD3;PRMT2;SMYD2;SMYD3;EZH2;KMT5B;EED;PRMT1;KMT2C;SMYD1;SETDB1;DOT1L;PRMT6;KMT5A
prerank,thioesterase binding (GO:0031996),-0.7329117078609886,-1.7207019605337686,0.0,0.1105975499081339,0.742,7/11,13.44%,RAC1;TRAF5;CDC42;TRAF3;TRAF1;HAUS7;TRAF2
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5854628745189037,1.719631065281974,0.002288329519450801,0.052862254961296505,0.881,7/22,15.14%,HTR2C;CHRM2;CHRM3;HRH3;HTR1B;HRH2;HTR7
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5854628745189037,1.719631065281974,0.002288329519450801,0.052862254961296505,0.881,7/22,15.14%,HTR2C;CHRM2;CHRM3;HRH3;HTR1B;HRH2;HTR7
prerank,serotonin receptor activity (GO:0099589),0.5854628745189037,1.719631065281974,0.002288329519450801,0.052862254961296505,0.881,7/22,15.14%,HTR2C;CHRM2;CHRM3;HRH3;HTR1B;HRH2;HTR7
prerank,WW domain binding (GO:0050699),-0.5685322203727791,-1.7181668890766444,0.006896551724137931,0.10737080018694685,0.751,13/26,26.82%,LITAF;PMEPA1;KIF20B;NFE2;WBP11;NDFIP2;TCEAL5;CDC25C;SCNN1A;WBP1;TCEAL6;TCEAL3;RAPGEF2
prerank,ephrin receptor activity (GO:0005003),0.6210453080005687,1.7155766187130066,0.0070921985815602835,0.05221188834510961,0.886,8/17,16.33%,EPHA6;EPHA7;EPHA5;EPHB1;EPHA10;EPHB4;EPHB3;EPHA3
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.6210453080005687,1.7155766187130066,0.0070921985815602835,0.05221188834510961,0.886,8/17,16.33%,EPHA6;EPHA7;EPHA5;EPHB1;EPHA10;EPHB4;EPHB3;EPHA3
prerank,cation channel activity (GO:0005261),0.43293287033135597,1.7140032210428067,0.0,0.05154793846626216,0.888,22/94,11.52%,UNC80;TRPM3;CACNA1E;TRPC5;RYR2;KCNK10;SLC24A4;SLC24A2;NALCN;TRPC1;CACNB2;SLC24A3;KCNA1;PKD1L3;TRPM1;TMEM175;HCN1;RYR1;SLC4A11;KCNF1;KCNG1;PKD1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.5511780046060112,-1.7057127873146807,0.003355704697986577,0.11719347818142802,0.803,8/34,5.81%,IQGAP2;IQGAP1;GAB2;OGT;DAPP1;KIF16B;ARAP1;MYO1G
prerank,calcium-activated potassium channel activity (GO:0015269),0.7135421899748273,1.7051922031777134,0.006993006993006993,0.054592055031032274,0.906,3/11,2.05%,KCNN2;KCNMB2;KCNMB3
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.44013729992731165,-1.7008504688884742,0.0,0.1158575939741786,0.815,33/100,19.23%,IQGAP2;IQGAP1;OSBPL8;DENND1A;SH3PXD2B;ZFYVE26;GAB2;SNX3;SNX27;OGT;DAPP1;TECPR1;SNX24;KIF16B;ARAP1;ANKFY1;MYO1G;GOLPH3L;HIP1;OSBPL5;SESTD1;SNX13;NCF4;CYTH3;RACGAP1;MYO10;PLA2G4A;RNF34;ARFIP1;LAPTM4B;ARFIP2;PLEKHA4;DENND1B
prerank,cell adhesion mediator activity (GO:0098631),0.5841336090408953,1.696716640232859,0.007957559681697613,0.057379331913798966,0.922,8/24,13.12%,LRRC4C;CNTN6;CNTN4;DSCAM;NTNG1;DSCAML1;ROBO3;VSTM2L
prerank,single-stranded DNA binding (GO:0003697),-0.44464102333891825,-1.6924845543206193,0.0,0.1213225748220172,0.846,40/93,22.87%,FAM111A;RBMS1;SAMHD1;TOP3A;RAD51B;DHX9;NABP1;BLM;WDR48;REXO4;POLR2H;MCM6;NEIL3;RAD51;NUCKS1;MCM9;APTX;MCM3;PCBP2;SSBP1;HMGB2;RADX;RPA3;DHX36;RAD51AP1;RAD52;ERCC4;MCM2;POLR2G;WBP11;HNRNPA1;NUP35;RBBP8;HMGB1;RTF1;DMC1;SMC6;CDC45;TWNK;MLH1
prerank,retinoic acid receptor binding (GO:0042974),-0.6295830627590197,-1.6874992052003868,0.008849557522123894,0.12215533380835451,0.86,9/17,18.22%,PPARG;CNOT1;RARG;PRMT2;ASXL1;NSD1;NRIP1;ARID5A;NCOA6
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.3687660405112444,-1.6834540176510924,0.0,0.12236588934751368,0.875,159/431,24.71%,ABCA1;MAP3K5;ABCG1;MFHAS1;P2RX7;DAPK1;CDK6;MYH9;MYO9B;RAC1;MTHFS;ARL8B;RAB7A;DNM2;MAP4K3;RAP1B;PI4K2A;MYO1F;RHOA;RUNX3;ERN1;RAP2B;ARL8A;MAP3K20;INSR;P2RX4;PEAK1;RAP2A;PRKAG2;RAB31;ABCD2;SMARCA5;TLK1;MINK1;ERCC6;RAP1A;DYRK2;CDC42;DHX9;NLRC4;HSPA9;PIM1;ATP7A;NOA1;MTHFD1L;DAPK3;SMC4;ARL11;STK3;BLM;ABCE1;RTEL1;RHOQ;RAB32;CARS2;IRAK3;ABCF3;GUK1;STK38;MCM6;NME1;GBP5;RAB5A;NVL;TRIB1;TGFBR1;NEK6;RAD51;RAB21;ADSS1;SIK1;GBP2;TGM2;KIFC1;KIF14;TAOK1;TAP2;RRAGD;MTPAP;RAB11B;SEPHS1;RAB29;STK17B;EEF1A1;RAB10;HSP90AB1;STK11;CHD8;KSR1;OAS3;MKNK1;DHX36;ARL3;TUBD1;GCH1;MARK2;ANXA6;ABCB8;MAST2;ARL5A;HSPA4;EIF4G1;MKNK2;LATS2;RAB13;PDXK;RND2;ARHGEF5;RAB39A;UBA2;RALB;ABCD3;HSPA1A;PGK1;ZAP70;GTPBP10;MLKL;ABCF1;ARL1;TWF2;KRAS;NRAS;ARFIP2;RHEB;GBP3;ENPP1;PAPOLA;RHOBTB1;GBP7;HSPA2;GBP6;OAS2;CDC42BPG;WNK1;AARS1;DARS2;NOL9;HSPA13;PRKAG1;SRPK1;PYGL;VPS4A;TUBA4A;RHOF;MAP4K4;RPS6KA5;TUBB1;TUBA8;RABL3;MTREX;RND1;RAB26;RAB4A;SIK3;PNPLA8;RAB35;GBP4;ABCA2;RAB1B
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.612760643132788,1.6831021704609463,0.022222222222222223,0.06191040875393528,0.939,8/16,8.86%,PTPRD;PTPRG;PTPRN2;PTPRR;PTPRT;PTPRK;PTPRB;PTPRZ1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.612760643132788,1.6831021704609463,0.022222222222222223,0.06191040875393528,0.939,8/16,8.86%,PTPRD;PTPRG;PTPRN2;PTPRR;PTPRT;PTPRK;PTPRB;PTPRZ1
prerank,manganese ion binding (GO:0030145),-0.5019895210846809,-1.67594096009194,0.003395585738539898,0.1269776419602154,0.9,24/48,20.46%,FAM20C;MGAT5;ABL2;GYG1;DYRK2;PIM1;PRIMPOL;GALNT3;IMPA1;XXYLT1;GALNT1;B4GALT7;MTPAP;WRN;XYLT2;FEN1;POMGNT1;LARGE1;ARG2;XPNPEP3;MGAT2;PAPOLA;B4GALT1;MPPE1
prerank,phosphatidate phosphatase activity (GO:0008195),0.6383538411443658,1.675915629391937,0.02534562211981567,0.06441951908495948,0.949,3/13,2.70%,PLPP4;PLPPR1;PLPPR4
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.6189966823131374,-1.6712060928281487,0.01694915254237288,0.12747067827583564,0.907,6/18,10.12%,BIRC3;TNFAIP8;GAS6;SERPINB9;PRDX5;CD27
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.5809844516547318,-1.6694872656913247,0.01054481546572935,0.12468900302428579,0.91,10/25,18.44%,GAB2;PLEK;DAPP1;KIF16B;MYO1G;HIP1;SESTD1;NCF1;PLEKHA2;PLEKHA4
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.5618701133483072,-1.6651722752669331,0.009328358208955223,0.12565252118607395,0.916,11/25,20.16%,ZC3HAV1;PARP11;PARP14;TIPARP;PARP4;SIRT3;PARP8;PARP9;TNKS2;PARP10;SIRT2
prerank,double-stranded RNA binding (GO:0003725),-0.45913748853044184,-1.6628088401287113,0.005,0.1242777126138114,0.922,18/70,13.49%,RFTN1;MBNL1;MSN;VIM;TLR8;AGO2;TLR7;DHX58;DHX9;RC3H1;DDX60;EIF2AK2;APTX;EIF4A1;OASL;HSP90AB1;OAS3;DHX36
prerank,potassium channel regulator activity (GO:0015459),0.48195635314210533,1.662778106793122,0.004830917874396135,0.070009629911342,0.968,6/49,2.05%,DPP10;KCNIP4;DPP6;KCNIP1;KCNMB2;KCNMB3
prerank,low-density lipoprotein particle binding (GO:0030169),-0.6413386301722566,-1.6549684259291164,0.0017889087656529517,0.1289345124315067,0.946,4/16,1.67%,MSR1;STAB1;PLTP;CD36
prerank,adenylate cyclase binding (GO:0008179),0.6947903596959927,1.6505940586242431,0.03117505995203837,0.07554887610802903,0.978,6/10,13.42%,AKAP6;ADCY2;ADCY5;CALM1;CALM3;CALM2
prerank,carboxylic acid binding (GO:0031406),0.5022501641943301,1.6491703441173151,0.004618937644341801,0.07494143548482765,0.978,10/38,9.13%,GRM7;GRIN2B;GRIN3A;GLRA1;EPDR1;GLDC;SESN3;UBR1;GLRA2;CASTOR2
prerank,glycine binding (GO:0016594),0.6808250163440429,1.6253211689202538,0.02830188679245283,0.08752587833432088,0.991,6/11,14.09%,GRIN2B;GRIN3A;GLRA1;GLDC;GLRA2;GLRA3
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.6052525362147889,-1.6246140489205578,0.014035087719298246,0.1693390272368199,0.981,9/18,22.81%,ANXA2;S100A11;ANXA1;BAIAP2;PPP1CA;RAB10;TRIM29;PDLIM5;PDLIM1
prerank,semaphorin receptor activity (GO:0017154),-0.7005121372000678,-1.6209744582322627,0.023172905525846704,0.170689568480826,0.985,5/11,7.24%,NRP1;PLXNC1;PLXNA1;PLXND1;NRP2
prerank,syntaxin-1 binding (GO:0017075),0.5521087636842421,1.6199869842198182,0.01904761904761905,0.08930112287235457,0.992,8/22,12.46%,SYT1;UNC13C;SNPH;SNAP25;CPLX1;PRRT2;STXBP2;UNC13B
prerank,phosphoric diester hydrolase activity (GO:0008081),0.4948948964717117,1.6183848577121571,0.027160493827160494,0.08892757033479083,0.993,10/35,7.65%,PLCL1;MPPED2;APEX2;ENPP2;PDE11A;GDPD1;PLCE1;ENPP3;FAM83B;PLCXD3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.6763448484644329,1.6111921734046974,0.015873015873015872,0.09230041291540138,0.997,6/10,17.24%,DPYS;DPYSL5;DPYSL4;DPYSL3;DPYSL2;CAD
prerank,mannosyltransferase activity (GO:0000030),0.5588817382763523,1.6092405133339593,0.028368794326241134,0.09221762965251436,0.997,6/21,5.26%,TMTC2;TMTC1;DPY19L1;TMTC3;POMT2;DPY19L2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.6497186669241067,-1.6080592040161608,0.017035775127768313,0.18760750381515648,0.991,7/13,21.25%,GEN1;DNASE1L1;EXO1;FEN1;SLX4;DNA2;FAN1
prerank,Tat protein binding (GO:0030957),-0.7109105643589011,-1.6066821673734353,0.01415929203539823,0.18420401070246023,0.992,3/10,8.28%,MDFIC;ACTB;DNAJA1
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.43513805855293664,1.5990655783346577,0.004962779156327543,0.09750565607758559,0.998,22/60,17.26%,ERBB4;NTRK3;EPHA6;NTRK2;EPHA7;EPHA5;BMPR1B;CSF1R;ACVR1;TIE1;EPHB1;ALK;EPHA10;ROS1;LTK;TYRO3;RET;EPHB4;EPHB3;ERBB3;EPHA3;ROR1
prerank,cysteine-type peptidase activity (GO:0008234),-0.43380822827370985,-1.5984501774623254,0.006633499170812604,0.19336095872534437,0.994,28/73,20.99%,CTSB;USP12;CTSZ;USP50;USP18;MALT1;USP8;USP9X;USP36;ATG4C;CASP4;CTSC;CTSH;OTULIN;CTSS;USP42;CASP7;CASP1;USP35;GGH;USP40;USP30;USP7;CASP8;USP11;CASP2;SFRP1;USP9Y
prerank,amino acid binding (GO:0016597),0.5097528628913229,1.5961446839392899,0.0171990171990172,0.09774598739921327,0.998,7/31,9.13%,GRM7;GRIN2B;GRIN3A;GLRA1;GLDC;GLRA2;CASTOR2
prerank,small GTPase binding (GO:0031267),-0.38440121512927505,-1.5961374068609495,0.0,0.19162794608215275,0.994,50/169,18.51%,IQGAP2;IQGAP1;MYO5A;ABCA1;AKAP13;RIN3;PAK2;MYO9B;FGD6;GOLGA5;EPS8;OPTN;FLNA;ARHGEF2;GOLGA4;SGSM2;KIF3B;IFT20;RNF41;GGA3;FGD4;TNFAIP1;DAPK3;ANKFY1;RAB3GAP1;FGD3;TRIOBP;AP1G1;CYRIB;PICALM;EXOC4;ALS2;XPO5;CDC42EP2;AP3M1;RAB29;CIB1;GCC1;BRK1;EHD1;TBC1D30;RABGGTA;TBC1D7;SPHK2;EXOC2;RAB34;RILP;PDE6D;ARFIP2;RCC1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.39041991441838714,-1.588313709622897,0.0,0.1996747859490291,0.995,38/147,11.72%,DOCK2;VAV3;DENND1A;AKAP13;ABR;ITSN1;RIN3;DENND4C;FGD6;DOCK10;ARHGEF2;CYTH1;DOCK11;VAV1;RASGRP4;RAP1A;FGD4;RIN2;RGL2;DOCK8;ARFGEF1;RAB3GAP1;FGD3;DOCK5;ARHGEF10;PREB;RIC8B;EIF2B3;ARHGEF18;DENND2D;EEF1B2;ALS2;FNIP1;VAV2;ARHGEF11;ARFGEF2;CCDC88A;DNMBP
prerank,DNA binding (GO:0003677),-0.3345916868635494,-1.5866477975350408,0.0,0.19631425645624703,0.995,234/694,24.81%,RBPJ;ZEB2;FLI1;FAM111A;TCF4;RBMS1;TLR8;SAMHD1;BCL6;JUN;TOP3A;DDB2;CREBBP;CGAS;MEF2A;NUPR1;PPARD;BPTF;ARID5B;NFE2L2;DNMT3A;RAD51B;IRF2;ZNF148;NFYA;RPL7;SMARCA5;PPARG;GTF2A1;ZNF3;BRCA1;ERCC6;STAT3;FOXO3;E2F2;LYL1;RFC1;DHX9;IKZF1;USF2;DCLRE1C;CHD3;RYBP;HHEX;ZBTB21;TOP2A;RARG;IRF5;BCL2;CRLF3;AIM2;NABP1;PARP4;NR1H2;CIITA;BATF;BLM;CUX1;RAD1;TSG101;DDX60;SRRT;TAF6;WDR48;AHR;REXO4;NR2F1;ATF6;POLR2H;MCM6;E2F1;RNF4;CNBP;ARID1A;CEBPG;CBFB;THAP1;E2F3;NEIL3;RAD51;HIF1A;SIRT3;NUCKS1;EGR1;MCM9;ARNT;APTX;MCM3;APP;IKZF3;HP1BP3;PCBP2;XBP1;TIMELESS;SSBP1;XRCC6;DNASE1L1;CUL4B;RELA;PCNA;KMT2D;MAU2;DCLRE1A;NFE2;PRDM2;WRN;EXO1;ARID3B;OASL;FOXJ1;FEN1;HMGB2;CHD8;WDR76;FOXJ3;RADX;RPA3;CALCOCO1;DHX36;SPTY2D1;RPL6;RXRA;XRCC4;KLF2;TCF3;MAP1S;TFAM;RAD51AP1;POLR2A;TFAP4;YY1;INO80;RAD52;ERCC4;TAF4B;ZMYM6;HMGN1;APLP2;NUFIP1;TFCP2;QRICH1;MCM2;NR4A1;BRIP1;POLR2G;SOX10;TAF9;ZCCHC3;DNA2;RPS27;CHTF18;WBP11;JRK;ATF5;CSRNP1;REPIN1;SURF6;GATA3;RPS3;ARID5A;HUWE1;DNTTIP1;SNAPC3;ANG;HNRNPA1;TRIM16;NUP35;RBBP8;MEIS3;DDX3X;TAF4;MBD6;HMGB3;ZDHHC1;SMC1A;HMGB1;EHF;GTF3C5;RFC3;RTF1;RLF;PDS5B;KDM5B;TIPIN;TSNAX;ZC3H12A;ZFPL1;DMC1;STAT1;LRRFIP1;LIN9;MAX;POU3F1;NLRP3;FAN1;SMC6;CCDC25;HOXB2;CEBPB;TBX2;NBN;SNAI2;EGR2;MTF1;TOPORS;BARX2;MYRFL;PALB2;NR1H4;CDC45;TWNK;HES7;ESR2;MLH1;RPS15;ZBTB7A;POLG2;RFX5;C1D;MAFF;ZNF395;PAX6;PRKDC;DNASE2;MCM5;DRAP1;DDB1;MYC;RAD51C;GZF1;POGK;TSN;TRIM28;TARDBP
prerank,amino acid:sodium symporter activity (GO:0005283),0.6441523436783184,1.5811501241207053,0.042105263157894736,0.10699542555148507,1.0,7/11,18.06%,SLC1A2;SLC6A15;SLC1A1;SLC6A1;SLC6A13;SLC6A11;SLC38A1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.5559723406248155,-1.5809312530363964,0.017064846416382253,0.20090451214135352,0.995,11/22,27.18%,ATP6V0D2;ATP6V1E1;ATP6V1A;TCIRG1;ATP2A3;ATP6V0B;ATP6V0E1;ATP6V0D1;ATP5F1B;ATP6V0A1;ATP2C1
prerank,glutamate receptor binding (GO:0035254),0.5912454472558373,1.5787789039176603,0.018518518518518517,0.10706676649824573,1.0,11/17,24.13%,SHISA6;SYNDIG1;SHANK3;HOMER1;CAMK2A;HOMER3;SHANK2;NSF;HOMER2;SHANK1;SHISA7
prerank,inward rectifier potassium channel activity (GO:0005242),0.5363802700215323,1.576195729868027,0.03153153153153153,0.10722260796142453,1.0,6/24,7.75%,KCNN2;KCNJ6;KCNJ3;KCNJ10;KCNJ9;KCNJ16
prerank,adrenergic receptor binding (GO:0031690),0.5892389088784424,1.5713415031251268,0.02391304347826087,0.10919636513745588,1.0,5/16,13.22%,MAGI2;PDE4D;NEDD4;ADRA2C;ADRB1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.6722029039162949,1.5680197223510373,0.03740648379052369,0.11043384461379453,1.0,2/10,2.55%,CACNA1C;CACNB2
prerank,lipoprotein particle binding (GO:0071813),-0.5717647156918256,-1.5670923855582302,0.012544802867383513,0.22095780459524325,0.995,4/20,1.67%,MSR1;STAB1;PLTP;CD36
prerank,monocarboxylic acid binding (GO:0033293),-0.589486375527256,-1.5668613991106441,0.03466204506065858,0.2157966796326016,0.995,11/18,31.38%,PSAP;RXRA;RARA;CYP26C1;PYGL;NR1H4;UGT1A7;UGT1A4;UGT1A6;UGT1A8;UGT1A1
prerank,MAP-kinase scaffold activity (GO:0005078),-0.6538920264419054,-1.564530910241351,0.03389830508474576,0.2150743212666886,0.996,5/11,17.17%,IQGAP1;AKAP13;MAP2K1;KSR1;SPAG9
prerank,5'-3' exonuclease activity (GO:0008409),-0.6130475261780164,-1.5591196786581358,0.025179856115107913,0.219665571639952,0.996,10/14,26.81%,DCLRE1C;DCP2;DCLRE1A;EXO1;FEN1;CPSF3;FAN1;XRN2;DCLRE1B;MRE11
prerank,death domain binding (GO:0070513),-0.6538350276308095,-1.5580112027470707,0.019230769230769232,0.21662143132099337,0.996,4/11,5.13%,MCL1;CRADD;RIPK1;BCL2
prerank,voltage-gated sodium channel activity (GO:0005248),0.531838384235394,1.5567155760918654,0.024390243902439025,0.11761700566579722,1.0,9/22,15.92%,SCN2A;SCN2B;SCN1A;SCN3A;SCN9A;HCN2;HCN1;CACNA1G;SCN10A
prerank,translation initiation factor activity (GO:0003743),-0.4849193687077573,-1.553451047854487,0.023809523809523808,0.2195143004741128,0.996,20/36,28.13%,AGO2;EIF4G3;EIF4A2;EIF2B3;EIF3A;EIF5;EIF4A1;EIF3E;EIF4G1;EIF2A;EIF3L;EIF5B;COPS5;EIF2B1;EIF3H;EIF1;EIF2S2;EIF1B;EIF2B2;EIF2B4
prerank,cytokine receptor activity (GO:0004896),-0.4135808387155003,-1.550875705760683,0.0032733224222585926,0.21897184624407895,0.996,26/83,18.69%,CD44;CD74;CCR2;CSF2RA;IL6R;IL10RB;CCR1;IFNAR2;IL17RA;IL18RAP;IFNGR2;IL7R;IL2RG;IL4R;IFNAR1;CSF2RB;IL20RA;CCRL2;CNTFR;IL31RA;IL27RA;IL2RB;IL18R1;IL17RD;CMKLR1;IL1R2
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.6601648295106745,-1.5451692446518126,0.03442340791738382,0.22435568040660117,0.998,5/11,18.39%,MAP3K5;MAP3K1;MAP3K20;MAP3K15;TAOK2
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.6442558577759178,-1.5422739237371412,0.033216783216783216,0.22461071284616696,0.998,6/12,21.38%,KDM3A;JMJD1C;KDM7A;KDM3B;HR;KDM1A
prerank,protein tyrosine kinase activator activity (GO:0030296),0.5461531528882644,1.540526810580903,0.044226044226044224,0.12936758784677277,1.0,5/19,3.33%,NRG3;NRG1;GRM5;EFNA5;EGF
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.5842583978897189,-1.534451177315673,0.03951890034364261,0.22991629841927697,0.998,8/16,25.72%,ATP6V0D2;ATP6V1A;TCIRG1;ATP6V0B;ATP6V0E1;ATP6V0D1;ATP5F1B;ATP6V0A1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.5842583978897189,-1.534451177315673,0.03951890034364261,0.22991629841927697,0.998,8/16,25.72%,ATP6V0D2;ATP6V1A;TCIRG1;ATP6V0B;ATP6V0E1;ATP6V0D1;ATP5F1B;ATP6V0A1
prerank,GTPase binding (GO:0051020),-0.362551646817468,-1.5343348045984906,0.0,0.22540257741799666,0.998,54/194,18.51%,IQGAP2;IQGAP1;MYO5A;ABCA1;AKAP13;RIN3;GNB1;PAK2;MYO9B;FGD6;GOLGA5;EPS8;OPTN;FLNA;ARHGEF2;GOLGA4;SGSM2;KIF3B;IFT20;RNF41;GGA3;FGD4;TNFAIP1;DAPK3;ANKFY1;RAB3GAP1;FGD3;TRIOBP;AP1G1;CYRIB;PICALM;EXOC4;ALS2;LCP1;XPO5;CDC42EP2;AP3M1;RRAGD;RAB29;CIB1;GCC1;RASA1;BRK1;EHD1;TBC1D30;RABGGTA;TBC1D7;SPHK2;EXOC2;RAB34;RILP;PDE6D;ARFIP2;RCC1
prerank,ribonuclease activity (GO:0004540),-0.4381947576459685,-1.5316036953697871,0.01903114186851211,0.22592230824964823,1.0,29/56,28.71%,SAMHD1;ERN1;AGO2;RNASEL;RNASE12;RNASE4;INTS11;RNASE7;EXOSC5;KHNYN;NYNRIN;RNASE6;ENDOG;ANG;EXOSC10;CPSF3;TSNAX;ZC3H12A;EXOSC4;ELAC2;YBEY;RPP40;SND1;RCL1;LACTB2;ERN2;EXOSC8;ZC3H12D;ZC3H12C
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.3437903500522262,-1.5314499388386371,0.0,0.22174963463759262,1.0,124/346,25.91%,BIRC3;RNF213;WWP1;ZNRF3;CBL;CNOT4;RNF150;HECTD1;BFAR;DDB2;BIRC6;RNF19A;RNF149;FBXW8;NEURL3;RNF111;NFX1;MALT1;MKRN2;TRAF5;WWP2;MYLIP;RNF41;BRCA1;AMFR;AREL1;RNF166;CDC42;TNFAIP1;PELI1;RC3H1;RNF20;FBXW11;UBE2R2;RNF31;RBCK1;TRAF3;UHRF2;UBE3B;MGRN1;UBR2;KCTD10;RNF4;CBLL1;TRIM47;RNF123;UBA7;RNF38;ANKRD39;UBE2L3;RFWD3;RNF8;TRAF1;NEDD4L;SEL1L;CUL4B;MAEA;TSPAN17;RNF180;TRIM24;RNF128;FBXO10;UBE3A;TRIM68;UHRF1;UBE2H;TRAF2;FBXW2;CUL2;RNF185;TRIM11;ARIH1;RNF25;CBLB;KCMF1;RNF43;RNF34;UBE2T;UBE2G1;HLTF;CDC34;BRAP;RNF216;TRIM14;RNFT2;UBE2C;ASB4;KLHL42;MIB1;FBXO7;RNF121;HUWE1;DTX1;TRIM39;UBE2M;FBXL6;VPS18;FBXO22;TRIP12;DTX3;DTX3L;UBE3C;SMURF2;RNF125;TRIM25;TOPORS;HECTD3;RNF135;RSPRY1;MEFV;TRIM72;RNF115;ZNRF1;TRIM69;RNF187;TRIM28;RNF19B;UBE2N;RNF40;LRSAM1;NEURL1B;VPS11;SIAH2;SMURF1
prerank,GTPase inhibitor activity (GO:0005095),-0.616539787433274,-1.5281975738477942,0.03951890034364261,0.2236228124621346,1.0,4/13,7.67%,IQGAP2;IQGAP1;IPO5;GPS1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.626950349855203,-1.52459758659221,0.03677758318739054,0.22622958453128142,1.0,5/12,12.94%,APAF1;NOD1;ATP2A3;CTSH;CASP1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.35114576416655835,-1.5217439211461568,0.0,0.22744440661912033,1.0,72/254,22.34%,RBPJ;MITF;ELF4;RUNX1;TCF4;RREB1;REL;LITAF;JUN;MEF2A;IRF2;NFIC;ATF3;ELF1;UBP1;ELK3;ETV1;STAT3;FOXO3;E2F2;STAT6;NFKB1;HHEX;SMARCD3;IRF5;MLXIP;MEF2B;KLF6;NR1H2;NRF1;NFATC3;ATF6;ATMIN;CEBPG;E2F3;HIF1A;TFEC;MEF2C;EGR1;ZNF319;RELA;KLF10;PRDM2;FOXJ1;FOSL2;FOXJ3;TCF3;TFAP4;YY1;TFCP2;NR4A1;FOXJ2;SOX10;ATF5;GATA3;MYB;PLAG1;NFATC1;TCF12;NR3C1;MDM4;MEIS3;HOXD8;EHF;CASZ1;RLF;ZSCAN21;HOXB2;EGR2;MTF1;BARX2;NR1H4
prerank,cholesterol binding (GO:0015485),-0.44823062074211817,-1.5207770892483363,0.02030456852791878,0.2250578476428083,1.0,12/47,14.81%,OSBPL8;ABCA1;ABCG1;OSBPL3;GRAMD1B;VDAC2;OSBPL5;ERLIN1;NPC2;STARD5;ANXA6;NPC1
prerank,adenyl ribonucleotide binding (GO:0032559),-0.3422673456585304,-1.515164914070783,0.0,0.23114917207483104,1.0,95/291,21.84%,ABCA1;MAP3K5;ABCG1;P2RX7;DAPK1;CDK6;MYH9;MYO9B;MTHFS;MAP4K3;PI4K2A;MYO1F;RUNX3;ERN1;MAP3K20;INSR;P2RX4;PEAK1;PRKAG2;ABCD2;SMARCA5;TLK1;MINK1;ERCC6;DYRK2;DHX9;NLRC4;HSPA9;PIM1;ATP7A;MTHFD1L;DAPK3;SMC4;STK3;BLM;ABCE1;RTEL1;CARS2;IRAK3;ABCF3;GUK1;STK38;MCM6;NME1;COQ8A;NVL;TRIB1;TGFBR1;NEK6;RAD51;SIK1;KIFC1;CNBD2;KIF14;TAOK1;TAP2;MTPAP;STK17B;HSP90AB1;STK11;CHD8;KSR1;OAS3;MKNK1;DHX36;MARK2;ABCB8;MAST2;HSPA4;EIF4G1;MKNK2;LATS2;PDXK;UBA2;ABCD3;HSPA1A;PGK1;ZAP70;MLKL;ABCF1;TWF2;ENPP1;PAPOLA;HSPA2;OAS2;CDC42BPG;WNK1;AARS1;DARS2;NOL9;HSPA13;PRKAG1;SRPK1;PYGL;VPS4A
prerank,rRNA binding (GO:0019843),-0.46012483003082666,-1.514855317919843,0.025817555938037865,0.22757330772683734,1.0,18/42,25.39%,RPL11;RPL12;ERAL1;RPS14;RPS13;FASTKD2;MRPS6;MRPS11;NGRN;EMG1;RPS9;RPS3;ANG;GTF3A;RPLP0;MRPL18;MRPS7;RPL5
prerank,SH3 domain binding (GO:0017124),-0.43144203486677357,-1.513764642176009,0.017482517482517484,0.22540219283102636,1.0,20/62,14.41%,ABI1;GRB2;WIPF1;CYBA;CBL;DNM2;WASF2;SH3BP2;SYNJ1;PTPN12;PTPN22;ADAM9;AFAP1L2;NCF1;CRK;MICAL1;ZNF106;AFAP1L1;ADAM15;CBLB
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.4563749690209831,-1.5112994640991098,0.015100671140939598,0.22595380135961884,1.0,18/44,18.40%,NSD3;ASH1L;SMYD2;SMYD3;EZH2;KMT5B;EED;WDR5;KMT2C;KMT5C;KMT2D;SMYD1;SETDB1;DOT1L;NSD1;KMT5A;KMT2A;CXXC1
prerank,calcium:sodium antiporter activity (GO:0005432),0.6427554149552313,1.5077698804616115,0.04899777282850779,0.15703631695076425,1.0,5/10,8.87%,SLC24A4;SLC24A2;SLC8A3;SLC24A3;SLC8A2
prerank,ligand-gated calcium channel activity (GO:0099604),0.5284512678900554,1.5031326175069064,0.058823529411764705,0.15900090621398894,1.0,4/19,1.34%,GRIN2A;RYR3;RYR2;GRIN2B
prerank,chloride channel activity (GO:0005254),0.4163129917159058,1.493223001649128,0.023148148148148147,0.16641780369176803,1.0,13/59,8.91%,GABRB3;GABRG3;GABRB1;GLRA1;GABRA2;ANO4;GABRA3;GABRA5;GABRB2;ANO3;GABRG2;ANO5;GLRA2
prerank,neurexin family protein binding (GO:0042043),0.6328356984764931,1.4897564358032833,0.07568807339449542,0.16773947888059054,1.0,4/10,14.26%,NLGN1;CPE;SYTL2;NLGN2
prerank,histone acetyltransferase binding (GO:0035035),-0.5298530500784552,-1.4887746488161604,0.05344827586206897,0.265233737148434,1.0,10/21,23.75%,MEF2A;HIF1A;EGR1;PCNA;TRIM68;SIRT2;STAT1;KANSL1;ZBTB7A;PAX6
prerank,phospholipase inhibitor activity (GO:0004859),-0.6405562297125761,-1.4885306809460532,0.058287795992714025,0.26136942828662896,1.0,4/10,5.38%,ANXA4;ANXA2;ANXA5;ANXA1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.5136734657913993,-1.4853013115191178,0.04886561954624782,0.2638175431867898,1.0,10/24,17.04%,MAPKAPK3;DAPK1;CAMK1D;MAPKAPK2;PTK2B;PHKG2;MKNK1;CAMKK1;MKNK2;PNCK
prerank,retinoic acid binding (GO:0001972),-0.6200880963102968,-1.4794696592988599,0.0657439446366782,0.2715661752737073,1.0,8/12,31.38%,RXRA;RARA;CYP26C1;UGT1A7;UGT1A4;UGT1A6;UGT1A8;UGT1A1
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.4813387269479815,1.4791712054752733,0.035545023696682464,0.17657750098946276,1.0,12/31,15.54%,KCNK10;SLC12A2;SLC12A8;SLC12A1;KCNA1;TMEM175;HCN1;KCNF1;KCNG1;SLC12A5;KCNA2;TMEM38A
prerank,four-way junction DNA binding (GO:0000400),-0.5558733513844869,-1.4791583398287578,0.07026143790849673,0.26798899832588596,1.0,10/17,24.46%,RAD51B;BLM;GEN1;WRN;HMGB2;YY1;XRCC3;HMGB3;HMGB1;RAD51C
prerank,P-type ion transporter activity (GO:0015662),-0.61916497807916,-1.4756830852497447,0.05067567567567568,0.27072674353908205,1.0,4/12,9.50%,ATP2B1;ATP6V1E1;ATP7A;ATP2A3
prerank,CARD domain binding (GO:0050700),-0.600901357071057,-1.4750791350769963,0.04974271012006861,0.2678337431881633,1.0,10/14,30.78%,CARD11;CASP4;NOD1;CASP1;MAVS;NOD2;CARD10;CARD16;RIPK2;BCL10
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.5615654826553154,-1.4742808102917258,0.0636042402826855,0.26538599532130913,1.0,6/16,9.28%,MTM1;MTMR10;SYNJ1;MTMR3;MTMR14;MTMR6
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.5839085980164709,-1.4737154531078405,0.05169340463458111,0.2626726971040547,1.0,6/14,9.28%,MTM1;MTMR10;SYNJ1;MTMR3;MTMR14;MTMR6
prerank,RNA polymerase II complex binding (GO:0000993),-0.4813785946280177,-1.4723668856808847,0.03146853146853147,0.2615270544864217,1.0,11/32,16.47%,AGO2;BRD4;CTR9;DHX9;SMYD2;PCIF1;RPRD2;WAC;ZNF326;ELOF1;ELP4
prerank,damaged DNA binding (GO:0003684),-0.4516530268892497,-1.4701791205380048,0.02264808362369338,0.26171012568749424,1.0,21/44,25.95%,DDB2;CREBBP;DCLRE1C;RAD1;NEIL3;APTX;CUL4B;PCNA;DCLRE1A;FEN1;HMGB2;RPA3;ERCC4;RPS3;RBBP8;HMGB1;SMC6;NBN;DDB1;XRCC1;DCLRE1B
prerank,lysine-acetylated histone binding (GO:0070577),-0.5382813204704014,-1.4691519819796737,0.05008635578583765,0.2560798942283043,1.0,10/20,19.72%,BRD7;BRD4;PSME4;DPF2;ATAD2B;TRIM24;KMT2A;BRD2;ZMYND8;BRD9
prerank,acetylation-dependent protein binding (GO:0140033),-0.5382813204704014,-1.4691519819796737,0.05008635578583765,0.2560798942283043,1.0,10/20,19.72%,BRD7;BRD4;PSME4;DPF2;ATAD2B;TRIM24;KMT2A;BRD2;ZMYND8;BRD9
prerank,ionotropic glutamate receptor binding (GO:0035255),0.6326230539690657,1.4668642223716748,0.07441860465116279,0.18754596263973217,1.0,6/10,24.13%,SHISA6;SHANK3;SHANK2;NSF;SHANK1;SHISA7
prerank,retinoid X receptor binding (GO:0046965),-0.6116701563909794,-1.4647454604195964,0.06324786324786325,0.26071701781757195,1.0,6/11,18.22%,PPARG;RARG;NSD1;NRIP1;ARID5A;NCOA6
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.3938948691655957,-1.4630634950694519,0.01353637901861252,0.26045803316428673,1.0,27/78,20.99%,CTSB;USP12;CTSZ;USP18;MALT1;CFLAR;USP8;USP9X;USP36;CASP4;CTSC;CTSH;CAPN15;CTSS;USP42;CASP7;CASP1;USP35;USP40;CAPNS1;USP30;USP7;CASP8;USP11;CASP2;SFRP1;USP9Y
prerank,endodeoxyribonuclease activity (GO:0004520),-0.5362679559733035,-1.4625544509800723,0.04599659284497445,0.2578596563244171,1.0,11/20,26.81%,DCLRE1C;EXO1;FEN1;ENDOG;APLF;ERCC4;DNA2;RPS3;RBBP8;ZRANB3;MRE11
prerank,triglyceride lipase activity (GO:0004806),-0.5177197311953551,-1.453586076099352,0.06140350877192982,0.27080418253895017,1.0,9/20,37.94%,DAGLB;LPL;ABHD5;LIPE;PLA2G15;LIPH;PNPLA1;LCAT;LIPG
prerank,Toll-like receptor binding (GO:0035325),-0.618412415389566,-1.4530146815309417,0.07167832167832168,0.2683092674957025,1.0,3/11,8.09%,CD36;UNC93B1;MYD88
prerank,hyaluronic acid binding (GO:0005540),-0.6447417475578855,-1.4520692580359265,0.03697183098591549,0.2668171803171667,1.0,2/10,1.49%,CD44;LYVE1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.45185953256100275,-1.451548644964422,0.03608247422680412,0.2643667190898739,1.0,11/38,11.50%,DENND1A;SH3PXD2B;ZFYVE26;SNX3;SNX27;TECPR1;KIF16B;HIP1;SESTD1;SNX13;NCF4
prerank,store-operated calcium channel activity (GO:0015279),0.6166057836700198,1.4503170523509579,0.09879518072289156,0.20426247906725298,1.0,2/10,2.25%,TRPC5;TRPC1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.5687710094878838,-1.4499434664329347,0.07863247863247863,0.2642864738014753,1.0,6/14,12.94%,APAF1;NOD1;ATP2A3;CTSH;EBAG9;CASP1
prerank,single-stranded DNA helicase activity (GO:0017116),-0.5191854816930214,-1.449206861106554,0.06548672566371681,0.2622111304572838,1.0,9/19,24.29%,DHX9;MCM6;RAD51;RFC2;MCM2;DNA2;CHTF18;RFC3;MCM5
prerank,SUMO transferase activity (GO:0019789),-0.5494003114573608,-1.4483902816288219,0.06484641638225255,0.2605063065613606,1.0,8/16,27.32%,NSMCE2;PIAS1;UBE2I;EGR2;TOPORS;RANBP2;TRIM28;PIAS2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5785898150720853,1.4472314650141005,0.08928571428571429,0.20529883545528663,1.0,2/12,2.99%,B3GALT1;B3GALT5
prerank,histone deacetylase binding (GO:0042826),-0.3861054425588004,-1.4387316931350245,0.026058631921824105,0.27556672101655616,1.0,25/88,18.35%,MEF2A;SPI1;AKAP8;NIPBL;TOP2A;MEF2B;MEF2D;MEF2C;YWHAE;SUDS3;HDAC10;IKZF3;RELA;NUDT21;HSP90AB1;MTA3;SP2;DHX36;HDAC5;ANKRA2;TFAP4;RBBP4;HSPA1A;RAD9A;MIER1
prerank,PDZ domain binding (GO:0030165),0.3961153035169475,1.4373308328688446,0.019230769230769232,0.21450670530612034,1.0,19/61,18.22%,NLGN1;GRID2;SYNJ2;GRIA1;TBC1D10A;FZD8;TMEM88;TMEM88B;SDC2;CLCN3;ADRB1;ATP2B4;PRKN;ATP2B2;SLC22A5;ADAM17;TGFBR3;CIT;FZD4
prerank,cGMP binding (GO:0030553),0.5979588328519022,1.4372352721360564,0.08293838862559241,0.2117605905214024,1.0,2/11,3.77%,PDE10A;PDE11A
prerank,protein serine/threonine kinase activity (GO:0004674),-0.3221353835109124,-1.4357245072211129,0.0,0.27828463188743907,1.0,110/334,24.24%,PRKCH;MAP3K8;MAP3K5;TAOK3;PRKCB;MAPKAPK3;FAM20C;DAPK1;SYK;PAK2;PRKCD;CDK6;ROCK1;MAP4K3;CAMK1D;MAP3K1;ERN1;MAP3K20;CSNK2A1;BRD4;CDK13;VRK2;RIPK1;TLK1;ALPK1;IRAK2;MINK1;SGK1;MAPKAPK2;GRK3;DYRK2;RIOK3;PIM1;PTK2B;DAPK3;PHKG2;IRAK4;STK3;MAPK14;ULK2;IRAK3;PLK2;GRK5;VRK3;STK38;EIF2AK2;CDK14;TGFBR1;NEK6;MASTL;MAPK7;SIK1;TAOK1;DYRK1A;CDK1;MAP2K1;STK17B;HTATIP2;PRKD3;CPNE3;MAP3K15;PLK3;STK11;STK24;ACVR2A;MKNK1;CAMKK1;MARK2;TGFBR2;TRIO;MAST2;MAP3K10;IKBKB;TTK;MKNK2;LATS2;CDKL4;PNCK;AURKA;PKN3;BRD2;TAOK2;STK10;MAK;MOK;BMPR2;PAK6;STK16;GSK3B;ATM;CDK16;CHEK1;CDC42BPG;WNK1;CSNK1G3;CCNK;GRK6;SRPK1;CDK5;ILK;MAP4K4;MAST3;SMG1;RPS6KA5;PIM2;MAPK1;STKLD1;PRKDC;NEK3;SIK3
prerank,GTP binding (GO:0005525),-0.346463316109346,-1.4347313711957579,0.008169934640522876,0.27693951181152987,1.0,72/172,28.52%,MFHAS1;RAC1;ARL8B;RAB7A;DNM2;RAP1B;RHOA;RAP2B;ARL8A;INSR;RAP2A;RAB31;RAP1A;CDC42;NOA1;ARL11;RHOQ;RAB32;NME1;GBP5;RAB5A;RAB21;ADSS1;GBP2;TGM2;RRAGD;RAB11B;SEPHS1;RAB29;EEF1A1;RAB10;ARL3;TUBD1;GCH1;ANXA6;ARL5A;RAB13;RND2;ARHGEF5;RAB39A;RALB;GTPBP10;ARL1;KRAS;NRAS;ARFIP2;RHEB;GBP3;RHOBTB1;GBP7;GBP6;TUBA4A;RHOF;TUBB1;TUBA8;RABL3;RND1;RAB26;RAB4A;RAB35;GBP4;RAB1B;REM1;RND3;NUDT16;RAB22A;TUBA1C;ARL4A;EIF2B2;GEM;GNL1;THG1L
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5841661436146321,-1.4332469481050303,0.07226890756302522,0.2767186697674189,1.0,3/12,6.72%,IGF1;INSR;ARRB1
prerank,dipeptidyl-peptidase activity (GO:0008239),0.597758557215474,1.4281642189450892,0.09502262443438914,0.21993014825178725,1.0,2/10,0.18%,DPP10;DPP6
prerank,1-phosphatidylinositol binding (GO:0005545),-0.5411429433839958,-1.4272021259453718,0.08216783216783216,0.28473178375957314,1.0,6/15,10.68%,SNX10;SNX9;WDFY3;PICALM;EEA1;SESTD1
prerank,CCR chemokine receptor binding (GO:0048020),-0.4780743553926861,-1.426283603874217,0.059336823734729496,0.2831977916172005,1.0,13/28,39.30%,CCR2;NES;CCL5;CCRL2;CNIH4;CCL7;CCL24;CCL4;CCL19;CCL25;CCL8;MSMP;CCL14
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.33881892002988634,-1.4238350949195757,0.0109204368174727,0.2846211148977701,1.0,54/181,22.34%,RBPJ;MDFIC;RB1;JUN;CREBBP;MEF2A;PPARD;ANXA4;NFE2L2;PPARG;PIAS1;SPI1;RERE;WWP2;STAT3;DHX9;ACTB;SMARCD3;MAPK14;TAF6;CTNNB1;BHLHE40;FIZ1;DNAJA1;ARID1A;SPEN;HIF1A;PARP9;ARNT;RELA;MTA3;RXRA;HDAC5;SIN3A;ID2;RNF25;TCF3;TAF4B;HCLS1;NRIP1;FAF1;MIER1;NFATC1;HSPB1;RBBP8;TAF4;LMO2;GSK3B;DTX3L;JUP;STAT1;KDM1A;EGR2;NR1H4
prerank,DNA secondary structure binding (GO:0000217),-0.46278095445914613,-1.4213628276174686,0.061191626409017714,0.2862314080060183,1.0,14/31,19.87%,RAD51B;BLM;NEIL3;MEF2C;GEN1;WRN;HMGB2;RAD51AP1;YY1;KMT2A;XRCC3;RBBP8;HMGB3;HMGB1
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.457023855580625,-1.4173644915726447,0.04436860068259386,0.2907369811050142,1.0,11/33,16.47%,AGO2;CTR9;DHX9;SMYD2;MAF1;RPRD2;WAC;ZNF326;ELOF1;SPTY2D1;ELP4
prerank,cadherin binding (GO:0045296),-0.31702807414590856,-1.4171203060055386,0.001445086705202312,0.2880401318605373,1.0,127/315,24.95%,IQGAP1;AHNAK;ABI1;ASAP1;ZC3HAV1;PAK2;MYH9;SWAP70;CBL;SNX2;NIBAN2;SNX9;PTPRJ;IDH1;RARS1;P2RX4;ANXA2;FLNA;CAPZB;WASF2;EHD4;TAGLN2;FXYD5;S100A11;ITGB1;RAB1A;CHMP5;USP8;ANXA1;TLN1;SNX5;ARHGAP18;MACF1;CAPG;PICALM;GOLGA3;ABCF3;CTNNB1;EIF5;BAIAP2;PPP1CA;EPS15;STK38;CAST;CKAP5;ESYT2;LIMA1;YWHAE;DIAPH3;MRTFB;SCRIB;PACSIN2;EEF2;RAB11B;PRDX1;FMNL2;EIF3E;CD46;STX5;RPL14;TMPO;PKM;RAB10;HSP90AB1;CLINT1;RPL34;CAPZA1;STK24;PLCB3;TJP2;RPL6;SH3GL1;SH3GLB1;MARK2;CRKL;EHD1;CDH24;EIF2A;VAPB;BAG3;HDLBP;VASN;HSPA1A;PTPRO;TWF2;EFHD2;ARFIP2;PTPN11;SNX1;RPL23A;BMPR2;PAK6;DDX3X;TRIM29;DDX6;UBAP2;CLIC1;JUP;STAT1;LRRFIP1;RACK1;KDR;TRIM25;PTPN1;PDLIM5;SFN;CHMP4B;HNRNPK;RANBP1;MPRIP;CNN2;RPL7A;PPFIBP1;ATXN2L;PDLIM1;ARGLU1;MICALL1;SPTAN1;TES;PPL;AHSA1;LASP1;CTNNA1;CHMP2B;SND1;CCNB2;ATIC
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.5747779716163429,-1.4165798144095805,0.08064516129032258,0.2859419011352977,1.0,4/14,28.60%,DHRS3;AKR1A1;RDH12;RDH10
prerank,phosphatidylglycerol binding (GO:1901611),-0.581236775840569,-1.416246079947795,0.0743362831858407,0.28359762314634845,1.0,4/13,8.89%,PLTP;PITPNC1;PITPNA;GSDME
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.6010727128882766,-1.4157073476490245,0.07432432432432433,0.28176290729172127,1.0,6/12,21.44%,CNOT1;CNOT2;PAN3;CNOT6L;CNOT8;PNLDC1
prerank,ubiquitin protein ligase binding (GO:0031625),-0.324421955224124,-1.4136270103983442,0.0029895366218236174,0.28277860274534916,1.0,80/254,21.36%,MFHAS1;RB1;JUN;SNX9;TNFRSF1B;RIPK1;TRAF5;ARRB2;BRCA1;HSPA9;RNF20;BCL2;PTPN22;UBXN7;RNF31;AXIN1;RPL11;TRAF3;TRIOBP;TSG101;ARRB1;DET1;SKI;LAPTM5;ATXN3;DNAJA1;WFS1;JAK1;TRIB1;NEK6;HIF1A;UBE2L3;UBC;RPS27A;YWHAE;TRIB2;RNF8;TRAF1;PCBP2;DERL1;LRPPRC;CUL4B;RELA;TPI1;TMBIM6;HSP90AB1;TRAF2;CUL2;CD40;ARRDC1;ARIH1;ANKRA2;GABARAP;POLR2A;RNF34;UBE2T;UBE2G1;HLTF;CXCR4;HM13;USP7;ISG15;ASB4;FAF1;RALB;CASP8;SMAD7;HSPA1A;FBXO7;UQCRC1;LAPTM4B;DTX1;WRAP53;GSK3B;TXNIP;UBXN1;FAF2;BLZF1;SMC6;BAG6
prerank,nuclease activity (GO:0004518),-0.40926118831061553,-1.4098092592617626,0.05699481865284974,0.28731150857358545,1.0,25/52,26.81%,SAMHD1;RNASEL;RNASE12;REXO5;RNASE4;REXO4;ISG20L2;RNASE7;NME1;DNASE1L1;WRN;EXO1;FEN1;RNASE6;ENDOG;MAP1S;DDX1;DNA2;ANG;ENPP1;ZC3H12A;XRN2;SND1;ERN2;MRE11
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.33580005320017264,-1.407869693410317,0.001567398119122257,0.2877925832604644,1.0,52/188,18.52%,FLI1;RUNX1;TFEB;JUN;ZNF568;ARID5B;NFE2L2;BRD7;NFYA;ATF3;PPARG;SPI1;BRCA1;STAT3;FOXO3;DHX9;CHD3;NFKB1;HHEX;CIITA;AHR;TBL1XR1;ATF6;CREB3L2;HNRNPL;ATMIN;MEF2C;EGR1;ZBTB20;XRCC6;RELA;KMT2D;FOXJ1;HMGB2;TCF7;ZBED4;CALCOCO1;DHX36;RXRA;HDAC5;PSPC1;TFAM;TFAP4;YY1;KLF11;SOX10;TAF9;TFE3;ATF5;GATA3;ARID5A;TCF12
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5363659893487296,1.4036792673203313,0.11325301204819277,0.24880415746263956,1.0,4/14,7.68%,SPOCK1;SPOCK3;TIMP3;COL4A3
prerank,phosphatidic acid binding (GO:0070300),-0.511902021327379,-1.4032090503780248,0.06451612903225806,0.2936847586532423,1.0,6/19,10.68%,PLTP;PITPNC1;GRAMD1B;PITPNM1;PACSIN2;SESTD1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.5810675720285674,-1.4006297126848835,0.1,0.2958084833318084,1.0,8/12,29.17%,GAB2;BLNK;STAP1;FRS2;TRADD;SHC1;SH2B1;TRAT1
prerank,growth factor activity (GO:0008083),0.37257074078483476,1.3991533181912248,0.03132530120481928,0.2520606184159412,1.0,13/74,10.24%,NRG3;NRG1;TGFA;EGF;PTN;GDNF;VEGFD;PGF;FGF10;BDNF;AMELX;AREG;CLEC11A
prerank,bHLH transcription factor binding (GO:0043425),-0.5117722160953924,-1.397212189952303,0.08492201039861352,0.2997190288351252,1.0,8/19,21.38%,CREBBP;USF2;BHLHE40;TCF3;MAP3K10;TCF12;LMO2;KDM1A
prerank,endopeptidase activator activity (GO:0061133),-0.6080308114013777,-1.3956144250239289,0.11498257839721254,0.29974884167958726,1.0,3/10,11.28%,PSME3;NLRC4;PSENEN
prerank,voltage-gated ion channel activity (GO:0005244),0.5346664725624198,1.3951230877883423,0.0971563981042654,0.2543870714414351,1.0,2/14,0.92%,KCND2;CACNA1E
prerank,pentosyltransferase activity (GO:0016763),-0.434138974200712,-1.3949891476313947,0.05565529622980251,0.2978998200803366,1.0,12/36,17.22%,ZC3HAV1;PARP11;PARP14;TIPARP;PARP4;SIRT3;PARP8;PARP9;QTRT1;TNKS2;LARGE1;PARP10
prerank,DNA-binding transcription factor binding (GO:0140297),-0.33021500972511203,-1.3930974602874362,0.009538950715421303,0.2985666171273984,1.0,54/189,21.88%,RBPJ;RB1;JUN;CREBBP;MEF2A;PPARD;NFE2L2;PPARG;PIAS1;SPI1;RERE;WWP2;STAT3;DHX9;USF2;HHEX;BCL2;DAPK3;CIITA;CTNNB1;SKI;BHLHE40;FIZ1;NEK6;SPEN;TLE3;MEF2D;MEF2C;SIK1;RELA;MTA3;CRTC3;HDAC5;SIN3A;ID2;TCF3;MAP3K10;HCLS1;TLE4;TAF9;MIER1;NFATC1;TCF12;HSPB1;RBBP8;LMO2;ZMYND8;GSK3B;HMGB1;STAT1;NLRP3;KDM1A;NBN;EGR2
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.3180028018308489,-1.3911726482602185,0.004518072289156626,0.299335217638947,1.0,99/269,26.61%,MFHAS1;RB1;JUN;SNX9;TNFRSF1B;RIPK1;TRAF5;ARRB2;BRCA1;HSPA9;RNF20;BCL2;PTPN22;UBXN7;RNF31;AXIN1;RPL11;TRAF3;TRIOBP;TSG101;ARRB1;DET1;SKI;LAPTM5;ATXN3;DNAJA1;WFS1;JAK1;TRIB1;NEK6;HIF1A;UBE2L3;UBC;RPS27A;YWHAE;TRIB2;RNF8;PARP9;TRAF1;PCBP2;DERL1;LRPPRC;CUL4B;RELA;TPI1;TMBIM6;HSP90AB1;TRAF2;CUL2;CD40;ARRDC1;ARIH1;ANKRA2;GABARAP;POLR2A;RNF34;UBE2T;UBE2G1;HLTF;CXCR4;HM13;USP7;UBE2C;ISG15;ASB4;FAF1;RALB;CASP8;SMAD7;HSPA1A;FBXO7;UQCRC1;LAPTM4B;DTX1;WRAP53;GSK3B;TXNIP;DTX3L;UBXN1;STAT1;FAF2;BLZF1;SMC6;BAG6;EGR2;BECN1;CCNB1;SLC22A18;SUMO3;TRIM28;SPOP;STAT2;UBE2N;RNF40;RPL5;VCP;PML;HSPA8;CUL3
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.4513817153512116,-1.3871507729016659,0.07293354943273905,0.3044819235015592,1.0,11/32,19.13%,SLC38A6;SLC6A6;MFSD12;SLC43A2;SLC38A7;SLC36A4;SFXN2;SLC7A5;SFXN1;SLC6A9;SLC38A2
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.54361326090541,-1.3867793190456645,0.09075342465753425,0.3024228466936635,1.0,9/15,19.84%,PI4K2A;PI4K2B;PIK3CB;PIK3CG;PI4KB;PIK3CA;PIK3CD;PIK3C2A;ATM
prerank,MHC protein binding (GO:0042287),-0.5018096448432807,-1.3834162344747594,0.08793103448275862,0.3062008528374168,1.0,13/20,35.60%,CD74;LILRB1;TAPBP;DERL1;TAP2;PILRA;ATP5F1B;KIR3DL2;CD8B;CD4;CD8A;ATP5F1A;COL2A1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3613443567894809,1.3803313304265383,0.04600484261501211,0.271907860598421,1.0,13/73,11.63%,SORCS1;HCRTR2;LGR5;SORCS3;GPR37;OPRD1;PTH1R;CX3CR1;CCKBR;OXTR;NPSR1;GALR1;LGR4
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.32145651521442803,-1.380065852995066,0.010954616588419406,0.31026049984032017,1.0,79/232,25.91%,NSMCE2;BIRC3;WWP1;ZNRF3;CBL;RNF150;HECTD1;BFAR;RNF19A;RNF149;NEURL3;RNF111;NFX1;MKRN2;PIAS1;WWP2;MYLIP;RNF41;AMFR;AREL1;RNF166;CDC42;PELI1;RC3H1;UHRF2;UBE3B;MGRN1;UBR2;CBLL1;RNF38;RFWD3;RNF8;NEDD4L;RNF180;TRIM24;RNF128;UBE3A;TRIM68;UHRF1;RNF185;TRIM11;ARIH1;RNF25;CBLB;KCMF1;RNF43;RNF34;HLTF;BRAP;RNF216;TRIM14;RNFT2;RNF121;HUWE1;DTX1;TRIM39;VPS18;TRIP12;DTX3;DTX3L;UBE3C;SMURF2;RNF125;TRIM25;EGR2;TOPORS;RNF135;MEFV;TRIM72;RNF115;ZNRF1;TRIM69;RNF187;RNF19B;LRSAM1;NEURL1B;VPS11;SIAH2;SMURF1
prerank,endoribonuclease activity (GO:0004521),-0.44848576188720213,-1.3790605932944728,0.08581436077057793,0.309576260536836,1.0,17/32,28.71%,ERN1;AGO2;RNASEL;INTS11;KHNYN;NYNRIN;ENDOG;CPSF3;TSNAX;ZC3H12A;YBEY;SND1;RCL1;LACTB2;ERN2;ZC3H12D;ZC3H12C
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.3916598281097867,1.3745761392575053,0.06531531531531531,0.2770665493166601,1.0,9/48,10.95%,UNC80;TRPM3;SLC12A2;NALCN;TRPC1;PKD1L3;TRPM1;SLC4A11;MMGT1
prerank,calcium activated cation channel activity (GO:0005227),0.49733273692210905,1.3728869793917806,0.11617312072892938,0.2759412844197933,1.0,3/17,2.05%,KCNN2;KCNMB2;KCNMB3
prerank,nuclear localization sequence binding (GO:0008139),-0.511213360038082,-1.3723496377624271,0.09854014598540146,0.3199426265008508,1.0,5/18,17.97%,KPNA4;IPO5;KPNA3;BRAP;NUP153
prerank,RNA polymerase binding (GO:0070063),-0.5001502908774054,-1.3708038412878922,0.1088560885608856,0.3201405298452602,1.0,6/18,10.19%,BRCA1;DHX9;ANP32B;STOM;YTHDC2;PHRF1
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.5422003601659791,1.370421630735312,0.11347517730496454,0.2762314027868705,1.0,8/13,25.52%,RYR2;SOX9;PKIA;PJA2;PRKAR1A;PRKAR2B;PRKAR1B;KCNQ1
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.573298817078006,-1.3628196690410266,0.10720268006700168,0.33330579652331105,1.0,6/12,16.52%,GNS;GALNS;ARSA;SULF2;ARSK;ARSJ
prerank,histone demethylase activity (GO:0032452),-0.4586628865323401,-1.361660001126364,0.0773109243697479,0.3327885705762776,1.0,13/27,30.51%,KDM3A;JMJD1C;KDM7A;KDM3B;JARID2;KDM2A;HR;KDM5B;KDM1A;FBXL19;KDM2B;KDM6A;RIOX2
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3755203919757524,1.3613280488472552,0.05489260143198091,0.286688741028656,1.0,17/55,15.09%,TRPC5;RYR2;SLC24A4;SLC24A2;TRPC1;CACNB2;SLC24A3;PKD1L3;TRPM1;SLC8A2;RYR1;PKD1;ATP2B4;ATP2A1;ATP2B2;CHRNA7;TRPV3
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.5461867843062842,-1.3603922168804676,0.11092715231788079,0.33231835712117747,1.0,11/13,40.08%,EIF5;ITGB1BP1;CCDC88A;RGS14;RANBP1;GDI2;GDI1;ARHGDIB;SH3BP4;ARHGDIA;ARHGDIG
prerank,anion channel activity (GO:0005253),0.3738574193137873,1.35990456033949,0.046189376443418015,0.2853650020510914,1.0,13/61,8.91%,GABRB3;GABRG3;GABRB1;GLRA1;GABRA2;ANO4;GABRA3;GABRA5;GABRB2;ANO3;GABRG2;ANO5;GLRA2
prerank,thyroid hormone receptor binding (GO:0046966),-0.4540764476308593,-1.359847195634541,0.07214765100671142,0.3304617384403376,1.0,10/28,21.19%,JMJD1C;PRMT2;MED24;MED4;OASL;NSD1;ARID5A;NCOA6;TRIP12;GAS2L1
prerank,neuropeptide hormone activity (GO:0005184),0.4728649102833339,1.3573822763835468,0.10772833723653395,0.28559533971400475,1.0,8/22,18.81%,PNOC;SPX;CORT;GHRH;CALCB;PENK;GRP;CRH
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.5108680368598001,1.3556165709031187,0.12254901960784313,0.2847191856022601,1.0,4/14,7.97%,SLC17A6;SLC1A2;SLC1A6;SLC1A1
prerank,ferrous iron binding (GO:0008198),-0.4854357441753184,-1.3493305285717458,0.10233393177737882,0.3489553753678009,1.0,7/21,15.11%,FTL;CDO1;ALKBH1;EGLN1;FTO;TET2;ACP5
prerank,ADP binding (GO:0043531),-0.4673232310391044,-1.3463927253126067,0.11131059245960502,0.352213384303497,1.0,6/25,7.88%,ABCG1;MYH9;MYO9B;ERN1;PRKAG2;COQ8A
prerank,ubiquitin protein ligase activity (GO:0061630),-0.3134537153104542,-1.3461531643184794,0.018633540372670808,0.3497771439451934,1.0,91/228,30.73%,BIRC3;WWP1;ZNRF3;CBL;RNF150;HECTD1;BFAR;RNF19A;RNF149;NEURL3;RNF111;NFX1;MKRN2;WWP2;MYLIP;RNF41;AMFR;AREL1;RNF166;CDC42;PELI1;RC3H1;UHRF2;UBE3B;MGRN1;UBR2;CBLL1;RNF38;RFWD3;RNF8;UBE4B;NEDD4L;RNF180;TRIM24;RNF128;UBE3A;TRIM68;UHRF1;RNF185;TRIM11;ARIH1;RNF25;CBLB;KCMF1;RNF43;RNF34;HLTF;BRAP;RNF216;TRIM14;RNFT2;RNF121;HUWE1;DTX1;TRIM39;VPS18;TRIP12;DTX3;DTX3L;UBE3C;SMURF2;RNF125;TRIM25;TOPORS;RNF135;MEFV;TRIM72;RNF115;ZNRF1;TRIM69;RNF187;RNF19B;LRSAM1;NEURL1B;VPS11;SIAH2;SMURF1;CUL3;UBE4A;COP1;RNF26;RNF2;RNF167;HACE1;TRIM41;RBBP6;XIAP;RNF10;TRAF6;MKRN3;GID4
prerank,heme binding (GO:0020037),-0.3779787452686074,-1.3461362670110264,0.060955518945634266,0.34689876761796906,1.0,20/65,25.02%,CYBB;TBXAS1;HEBP1;BACH1;CYP27A1;EIF2AK1;HMOX2;FLVCR1;RSAD1;CYB5B;CYP46A1;PGRMC1;CYP2R1;CYB5R4;CAT;PXDNL;HMOX1;CYP1B1;CYCS;CYB5A
prerank,SH2 domain binding (GO:0042169),-0.4363154281488098,-1.3451932257839398,0.08360655737704918,0.3459378041812815,1.0,11/31,21.40%,SH3PXD2B;LILRB1;BLNK;AFAP1L2;LCK;CRK;CCDC88A;LAT2;RACK1;LAX1;NUP62
prerank,metal ion binding (GO:0046872),0.27486077741165843,1.3420258337784816,0.0,0.30214761219947583,1.0,108/477,14.89%,KCNIP4;NRXN1;ADGRL3;ASTN2;CDH18;SPOCK1;CDH8;RYR3;CDH10;RYR2;SYT1;EML1;ADCY2;CDH2;SLIT3;SLIT2;CDH20;CDH11;PCLO;KCNIP1;SYT10;ENPP2;CDC42BPA;NCS1;CDH13;SCUBE1;TUBB4A;PAM;TESC;MMP12;SYT2;EYA2;RAN;CDH12;PITPNM3;CDH22;SLIT1;CDH19;CDH7;ACVR1C;PDCD6;MARK1;SPARCL1;SLC25A23;CASQ2;MAP2K7;DCHS1;GNAI1;PRNP;GSS;SYT5;YDJC;ENPP3;PLA2G4E;KCNIP2;GLCE;ADGRV1;HMGCLL1;CDH6;LETM1;PCDHB6;CALR3;CCDC47;SYT11;SYT12;DNER;CDH17;PLA2G10;CRP;RYR1;PCDHA4;MMP13;THTPA;DSC2;DSC3;CABCOCO1;CETN3;CDHR3;SMOC2;GSN;TTN;CDH9;CDK5R1;CAPN3;AMY1A;AMY1B;AMY1C;DYSF;NDUFAB1;BRSK1;RET;CALM1;F9;CALM3;SYT7;PRKACB;CALM2;MICU3;CDH1;NOL3;DYRK3;CDH5;CLEC3B;MVK;ATP2A1;BRAF;MCTP2;IDH3A
prerank,phospholipid transfer activity (GO:0120014),-0.4751041904673886,-1.3377895021933992,0.11131386861313869,0.3586819233181421,1.0,6/21,10.26%,PLTP;PITPNC1;PITPNA;PITPNM1;GLTP;PRELID2
prerank,deubiquitinase activity (GO:0101005),-0.3546716545671282,-1.3375709583801398,0.039723661485319514,0.3563434097222377,1.0,35/88,27.51%,USP12;USP50;OTUD5;USP18;UCHL5;USP8;MINDY2;USP9X;USP36;USP3;ATXN3;OTULIN;USP42;USP35;USP40;JOSD1;OTUD4;USP30;USP7;MINDY1;STAMBPL1;USP11;BRCC3;COPS5;BAP1;ZC3H12A;USP9Y;ZRANB1;EIF3H;USP16;MINDY3;USP34;STAMBP;USP28;JOSD2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.45956877285118436,-1.3367640771513805,0.09433962264150944,0.35532071444713276,1.0,8/25,14.87%,POR;CYP27A1;KMO;MICAL1;CH25H;MICAL2;FMO5;CYP46A1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.439820291062779,-1.3354500584077376,0.09800664451827243,0.35519752320144016,1.0,10/30,14.94%,BIRC3;TNFAIP8;BIRC6;GAS6;CAST;SERPINB9;PRDX5;CD27;CST7;CST3
prerank,sodium channel regulator activity (GO:0017080),0.4004733521964158,1.3341428085979314,0.11053984575835475,0.31114367250435104,1.0,6/37,8.73%,FGF14;FGF12;SCN2B;PTPN3;NEDD4;FXYD6
prerank,chemokine binding (GO:0019956),-0.44725197850690196,-1.3314072128512493,0.1116751269035533,0.36100102057722494,1.0,5/30,4.86%,ITGA4;CCR2;CCR1;ITGB1;ITGAV
prerank,protease binding (GO:0002020),-0.347352393784625,-1.3310444441623828,0.04,0.35890723826364357,1.0,25/99,14.94%,PSAP;CRADD;BFAR;ANXA2;AMFR;CFLAR;NLRC4;RIOK3;ITGB1;DPP4;RHBDD2;ITGAV;BCL2;FN1;TIMP2;CD28;SERPINB9;SELENOS;UBC;DERL1;FAP;ITGA3;SERPINE1;SART3;CST3
prerank,nuclear receptor binding (GO:0016922),-0.3417922211299858,-1.3289468498990546,0.036303630363036306,0.36056065046872715,1.0,39/111,24.92%,FOXP1;PRKCB;KDM3A;JMJD1C;CNOT1;SMARCD3;PRMT2;MED24;CTNNB1;STAT5B;ARID1A;TGFB1I1;WBP2;HIF1A;DDX5;ASXL1;STRN;MED4;OASL;TRIM68;RXRA;NSD1;NR4A1;NRIP1;ARID5A;NCOA6;PPARGC1B;MMS19;TRIP12;JUP;STAT1;DDX54;GAS2L1;KDM1A;NR1H4;ZBTB7A;DCAF1;TADA3;PRPF6
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.43613592336192264,-1.327813172221092,0.11577181208053691,0.35995159900577944,1.0,11/27,21.06%,PRIMPOL;POLR2F;POLR2L;POLR2A;POLR3B;POLR2G;PRIM1;POLR1F;POLR3A;MED20;POLR2I
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5852582240606117,-1.327526715209999,0.12931034482758622,0.35803191449901456,1.0,6/10,18.75%,CFLAR;CASP4;CASP7;CASP1;CASP8;CASP2
prerank,carbohydrate kinase activity (GO:0019200),-0.5557071492062685,-1.3246336723176946,0.13082437275985664,0.361381244980815,1.0,6/11,29.11%,FGGY;POMK;HK3;GALK2;GALK1;GNE
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5592594579797384,-1.324012786108072,0.13798977853492334,0.35971166362394696,1.0,6/11,18.75%,CFLAR;CASP4;CASP7;CASP1;CASP8;CASP2
prerank,protein heterodimerization activity (GO:0046982),-0.3132150351251539,-1.3228971386880395,0.030497592295345103,0.35934919929840453,1.0,56/178,22.26%,EXT1;CYBB;ABCG1;TCF4;HEXA;SDCBP;CYBA;MCL1;SNX2;MEF2A;ATF3;IRAK2;GTF2A1;TLR4;USF2;ITGB1;TOP2A;BCL2;TPM4;IRAK3;AHR;DGKD;ATF6;HIP1;BHLHE40;HIF1A;MEF2C;YWHAE;ARNT;XBP1;RRAGD;GADD45A;ITGA3;QTRT1;NOLC1;TCF3;RALGAPA2;IKBKB;NR4A1;VAPB;UBA2;LSM6;AURKA;MIGA2;FBXO7;SNX1;RCC1;SMC1A;PAFAH1B1;LSM5;PDGFA;KCNB1;BCL2L2;GTF2A2;SRI;CD3E
prerank,MHC class II protein complex binding (GO:0023026),-0.547959193927698,-1.3203135463795632,0.16104868913857678,0.36187961238090727,1.0,5/11,12.58%,CD74;ANXA11;YWHAE;PKM;HSP90AB1
prerank,transition metal ion binding (GO:0046914),-0.2923290945781096,-1.3198670193503839,0.005780346820809248,0.36025153748952127,1.0,111/397,20.93%,ADAM33;GDA;FAM20C;LITAF;TET3;SAMHD1;FTL;ANPEP;SLC30A5;ACER3;MGAT5;ETHE1;P2RX4;ARHGEF2;PPARG;KDM3A;ABL2;ZNF3;DHX58;TAB2;GYG1;DYRK2;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;CHD3;PIM1;RC3H1;ATP7A;LNPEP;GALT;BLM;ABCE1;PRIMPOL;KDM7A;PITRM1;CRIP1;GALNT3;KDM2A;SKI;TIMP2;QPCTL;EEA1;THAP1;IMPA1;ATAD3A;XXYLT1;AGMO;GALNT1;POLR2L;SIRT3;ADAM8;MSRB1;EGR1;RNF8;HDAC10;B4GALT7;MTPAP;SEC24A;CHMP1A;PRDM2;WRN;XYLT2;TRIM24;SEC24D;FEN1;POMGNT1;UHRF1;MT2A;SORD;AOC2;RXRA;GCH1;TET2;MOXD1;ARIH1;CBLB;NSD1;LARGE1;ARG2;PDXK;CYP2R1;IKZF4;TNFSF10;KMT2A;RPS27;LIMS1;ANG;XPNPEP3;MGAT2;MMP8;WDFY1;TYW5;MDM4;ENPP1;PAPOLA;RABGGTB;SLU7;ZMYND8;SLC11A2;B4GALT1;SIRT2;MPPE1;KDM5B;ZFPL1;RNF125
prerank,protein homodimerization activity (GO:0042803),-0.2817273366487574,-1.3194512484049081,0.0058823529411764705,0.3584063027797217,1.0,170/589,21.96%,EXT1;APOE;MAP3K5;ABCG1;LILRB1;PSAP;XDH;TPD52;MCL1;PLEK;MYH9;MYO9B;SNX2;GOLGA5;SNX9;IDH1;ERN1;PDCD6IP;ABCB7;FLNA;PIP4K2A;ATF3;KYNU;ABCD2;RIPK1;IL6R;IRAK2;S100A11;STAT3;GYG1;NLRC4;USF2;ATG7;RBPMS;DPP4;SNX6;HHEX;TOP2A;PRMT2;CENPF;MTHFD1L;SARS1;BCL2;KIF20B;TPST1;DAPK3;AXIN1;BLM;NRF1;TSG101;TPM4;TBC1D22A;LRP6;IRAK3;AHR;DGKD;CEP57;HIP1;ALS2;VEGFA;BHLHE40;MFSD1;GBP5;DCK;B2M;BST2;EEA1;EIF2AK1;THAP1;IMPA1;EXD1;NOD1;JAML;LPL;ST6GAL1;GBP2;RNF8;RPE;ARNT;AGXT;ZDHHC2;IKZF3;GEN1;MYOM1;SSBP1;TPR;CLN6;MTPAP;CHMP1A;CCDC88A;RELA;NUDT21;FAP;CPQ;GADD45A;RABEP1;WRN;QTRT1;KYAT1;TPI1;PPCS;HSP90AB1;CCL5;TRIM68;DEFA6;CST7;KNSTRN;SH3GLB1;GREM1;GCH1;TCF3;TFAP4;TKT;S100A6;PGRMC1;MAP3K10;IKBKB;KARS1;PAPSS1;HM13;NADK2;TRIM14;APPL2;PEX7;PDXK;CYP2R1;TARS2;VAPB;ACOX1;GALE;GALM;ABCD3;KMT2A;MIGA2;BNIP3L;DNTTIP1;PTPRO;ANG;XPNPEP3;STK10;MGAT2;SNX1;ADRB2;TYW5;GBP3;HSPB1;MMUT;ENPP1;SLC8B1;CARNMT1;CSF1;RBPMS2;PLN;CAT;APPL1;RBM11;DARS2;PNPO;JUP;STAT1;LRRFIP1;PDGFA;RACK1;CEBPB;BCL2L2;CHMP4B;CHMP4A;MASP1;GTF2A2;SHMT1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.4845797799294576,1.319450671922731,0.16521739130434782,0.33190533817536544,1.0,7/15,25.67%,ALDH1A1;ALDH1A3;ALDH7A1;ALDH1L1;ALDH9A1;ALDH3A2;ALDH2
prerank,ribonuclease P RNA binding (GO:0033204),0.5538831032695635,1.3173554706723571,0.14988290398126464,0.33154784542364046,1.0,6/10,21.61%,POP7;RPP25;RPP14;POP4;RPP21;RPP38
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.469971765771132,1.3155575368608223,0.14893617021276595,0.3307494962758093,1.0,10/18,30.20%,FAR2;ALDH18A1;ALDH1A1;ALDH1A3;ALDH9A1;ALDH3A2;ALDH2;AKR1B1;ALDH1A2;ALDH6A1
prerank,MHC class I protein binding (GO:0042288),-0.5312016104911346,-1.3149052970863424,0.14814814814814814,0.3649889179675455,1.0,9/13,34.09%,LILRB1;TAPBP;DERL1;TAP2;PILRA;ATP5F1B;CD8B;CD8A;ATP5F1A
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.48889362418918236,1.3120760428550888,0.14858490566037735,0.33273539543088926,1.0,4/15,7.97%,SLC17A6;SLC1A2;SLC1A6;SLC1A1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.5101949623454463,1.3117718169035604,0.1400862068965517,0.3296340262269893,1.0,6/13,25.74%,BMP7;BMP3;CDH5;GDF15;BMP5;PYCARD
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.434626867117898,-1.311168322851625,0.12100840336134454,0.3698920805155926,1.0,12/29,20.44%,MAPKAPK3;PTPRJ;MAPKAPK2;MAPK14;PRMT1;MAPK7;DUSP6;TPR;GCH1;NFATC1;DUSP5;ATF7
prerank,semaphorin receptor binding (GO:0030215),0.4429283400986641,1.3099372169063714,0.13333333333333333,0.32909409125654976,1.0,7/23,11.18%,RIT2;SEMA6D;SEMA6A;SEMA3E;SEMA5A;SEMA3F;SEMA5B
prerank,transcription coactivator binding (GO:0001223),0.4591678423544651,1.308657236770787,0.1377551020408163,0.32801681671931837,1.0,3/20,2.53%,RORA;PGR;THRB
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.4210384175708295,-1.308060922111891,0.10588235294117647,0.3737417837377975,1.0,13/34,22.31%,ERI3;CNOT1;CNOT2;ERI2;EXOSC5;PAN3;CNOT6L;EXOSC10;ANGEL1;CNOT8;EXOSC4;PNLDC1;XRN2
prerank,endonuclease activity (GO:0004519),-0.38436693908473896,-1.3069339102416127,0.08813559322033898,0.3736173192202352,1.0,25/49,28.71%,ERN1;AGO2;RNASEL;INTS11;REXO4;KHNYN;FEN1;NYNRIN;ENDOG;APLF;ERCC4;RPS3;ANG;CPSF3;TSNAX;ZC3H12A;YBEY;ZRANB3;SND1;RCL1;LACTB2;ERN2;MRE11;ZC3H12D;ZC3H12C
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.36270124908735546,1.306375775155153,0.08418367346938775,0.32832851256249845,1.0,20/60,17.26%,ERBB4;NTRK3;EPHA6;NTRK2;EPHA7;EPHA5;CSF1R;TIE1;EPHB1;ALK;EPHA10;ROS1;LTK;TYRO3;RET;EPHB4;EPHB3;ERBB3;EPHA3;ROR1
prerank,aspartic-type peptidase activity (GO:0070001),-0.5711943953295928,-1.3063101216051116,0.15411558669001751,0.37213031288133397,1.0,3/10,14.94%,CTSD;DDI2;CTSE
prerank,transcription cis-regulatory region binding (GO:0000976),-0.28414600538209045,-1.302348810021102,0.010144927536231883,0.377930365674473,1.0,95/406,18.53%,FOXP1;FLI1;RUNX1;TRPS1;TFEB;RREB1;RB1;JUN;ZNF568;ETV6;MEF2A;RUNX3;AGO2;ARID5B;NFE2L2;BRD7;IRF2;NFX1;NFYA;ATF3;PPARG;FOXN2;ELK3;SPI1;ZNF3;BRCA1;STAT3;FOXO3;E2F2;STAT6;CHD3;NFKB1;HHEX;MLXIP;TIPARP;CIITA;CUX1;AHR;TBL1XR1;ATF6;CREB3L2;HNRNPL;E2F1;ATMIN;E2F3;MEF2D;HIF1A;MEF2C;PRDX5;FOXN3;EGR1;ARNT;ZBTB20;XBP1;XRCC6;OSR1;RELA;KLF10;KMT2D;NFE2;PRDM2;FOXJ1;ZFP57;FOSL2;HMGB2;TCF7;ZBED4;ZFP41;UHRF1;CALCOCO1;DHX36;E2F8;RXRA;DR1;HDAC5;TCF3;PSPC1;TFAM;TFAP4;YY1;ZBTB46;ZNF177;TFCP2;KLF11;SOX10;TAF9;RARA;TFE3;ATF5;GATA3;RPS3;ARID5A;SNAPC3;TCF12;NR3C1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.4180435921119929,-1.2995633833887292,0.10671256454388985,0.38129515325213564,1.0,10/33,16.47%,AGO2;CTR9;DHX9;SMYD2;LLPH;RPRD2;WAC;ZNF326;ELOF1;ELP4
prerank,kinase binding (GO:0019900),-0.2820614059963721,-1.2987544160335325,0.005509641873278237,0.38062073554960424,1.0,136/434,22.26%,IQGAP1;SASH1;PTPRC;LYST;BCAR3;FGR;MSN;SP100;GRB2;PLCG2;PAK2;PRKCD;RB1;RAC1;ITGB2;PTPRJ;RHOA;MAP3K1;KIF13B;FLNA;IBTK;PRKAG2;VRK2;MAML1;STAT3;FOXO3;KIF11;CDC42;CCND3;BLNK;STAP1;ACTB;ADIPOR1;IRF5;PTPN22;IFNAR2;IRAK4;RPS6;AXIN1;DUSP3;CAB39;MVP;IRAK3;UTRN;CTNNB1;DGKD;SKI;AP2A2;NEK6;PTPN6;SLC12A7;HIF1A;SIK1;TPX2;TNIP2;SPRY2;SPRED1;KIF14;CDK5RAP1;LCK;EEF2;CDC25A;MYOM1;CRK;RELA;DCTN1;TICAM1;GADD45A;SPRED2;EEF1A1;CACUL1;HSP90AB1;TRIM68;CASP1;STK11IP;TRAF2;PPP1R12A;RB1CC1;BTG1;ANKRA2;POLR2A;RELB;RACGAP1;CSPG4;IKBKB;IL31RA;HCLS1;MAVS;SGO1;TRIM14;RND2;KIF20A;STRADA;GPRC5B;FAF1;CD226;EXOC2;MAP2K3;DNAJC3;AURKA;FBXO7;RAD9A;ATF5;LAPTM4B;CDKN2C;RPS3;LIMS1;FAM83D;NISCH;PTPN11;TRADD;NR3C1;PDGFRB;HSPB1;JTB;NOD2;RHOBTB1;PIP5K1A;SUFU;PRAM1;GSK3B;GDF3;PRC1;WNK1;MOB1B;MIDN;CEP192;CDC25C;LAX1;PRKAG1;CCNK;PTPN1;TUBA4A;ILK;RHOF;CD3E
prerank,acylglycerol lipase activity (GO:0047372),0.5258264946299158,1.2977166604806394,0.16058394160583941,0.33864720608294435,1.0,3/11,5.21%,ABHD16A;ABHD15;ABHD3
prerank,clathrin adaptor activity (GO:0035615),-0.5158954824048707,-1.2975055629669898,0.1371900826446281,0.38057372833886327,1.0,4/15,7.94%,DAB2;AP1G1;HIP1;AP2A2
prerank,cation:chloride symporter activity (GO:0015377),0.5679842680086239,1.2974999057726428,0.15274463007159905,0.33552849834976334,1.0,5/10,11.79%,SLC12A2;SLC12A8;SLC12A1;SLC6A1;SLC12A5
prerank,myosin binding (GO:0017022),0.3677287502617163,1.2965666136697391,0.09156626506024096,0.3336223998419967,1.0,19/55,17.68%,DMD;STXBP5L;RAB3C;RAB6B;SHROOM4;RAB27B;RAB6A;ACTA1;SHROOM1;MLPH;GSN;NKD2;CALD1;LARP6;USH2A;MYRIP;RAB3A;RAB3B;HAP1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.5468151813166311,-1.2964756961828139,0.1518324607329843,0.37989103167612387,1.0,6/12,23.49%,CDK6;BRD4;CDK13;CDK1;CCNK;MAPK1
prerank,ribosomal small subunit binding (GO:0043024),-0.4930425759746172,-1.2959305520456181,0.14309764309764308,0.37836999372083174,1.0,9/17,32.91%,PIM1;ABCE1;ERAL1;NME1;DDX3X;EIF1;EIF1B;MTIF3;EIF4H
prerank,magnesium ion binding (GO:0000287),-0.32175223037756395,-1.2927108499533435,0.05555555555555555,0.38253388913019526,1.0,36/135,19.06%,MAP3K5;PI4K2A;IDH1;ERN1;MAP3K20;RAP2A;ABL2;DYRK2;NLRC4;TOP2A;STK3;IRAK3;STK38;NME1;HPRT1;IMPA1;NEK6;XXYLT1;SIK1;GEN1;MTPAP;WRN;XYLT2;FEN1;STK11;DHX36;DUT;MARK2;MAST2;TKT;RP2;PDXK;UBA2;RHEB;ADPRS;PAPOLA
prerank,solute:sodium symporter activity (GO:0015370),0.4238818209817669,1.2925879855714872,0.14457831325301204,0.33640242562114675,1.0,5/27,10.02%,SLC4A10;SLC4A4;SLC5A7;SLC13A5;SLC5A10
prerank,tubulin binding (GO:0015631),0.2788221683253652,1.2916235164208991,0.014450867052023121,0.33453402072945854,1.0,80/295,17.70%,UNC5C;NAV3;MAP2;DNM3;AGBL4;KIF5C;SGIP1;TTLL11;MAP1B;MTUS2;EML1;NCALD;SNPH;MAPRE3;TTLL7;EML5;ARHGEF7;KIFC2;NEFH;IFT81;DST;KIF1B;KIF26B;CLASP2;KIF21A;DLEC1;PPP1R42;TTLL5;DYNC1I1;APC2;KIF5A;DNM1;SYBU;PRNP;KIF2A;HOOK3;MAP7D3;FYN;KIF6;REEP1;HOOK1;MTCL1;FMR1;FAM161A;MAP6D1;AGBL1;PACRG;MACO1;CETN3;EML2;MAP9;CDK5R1;FSD1;BRSK1;FNTA;GAS8;GAS2L2;CDK5RAP2;GOLGA2;KIF3A;EML6;PRKN;TTLL9;NDRG1;TUBGCP5;HDGFL3;CAPN6;RAD51D;CCDC170;MTUS1;SNCA;MAP1A;KIF3C;DIXDC1;TERF1;GABARAPL2;PRUNE1;TUBGCP3;NEFM;MAP1LC3A
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.34299058980446523,-1.2905773076329115,0.07082630691399663,0.38452925643449665,1.0,32/83,27.51%,USP12;USP50;OTUD5;USP18;UCHL5;USP8;USP9X;USP36;USP3;ATXN3;OTULIN;USP42;USP35;USP40;JOSD1;OTUD4;USP30;USP7;STAMBPL1;USP11;BRCC3;COPS5;BAP1;ZC3H12A;USP9Y;ZRANB1;USP16;MINDY3;USP34;STAMBP;USP28;JOSD2
prerank,E-box binding (GO:0070888),-0.4065244858640108,-1.2905086739123839,0.11992945326278659,0.3821260341631366,1.0,14/34,27.88%,MITF;TCF4;PPARG;AHR;BHLHE40;CIART;TCF3;TFAP4;GATA3;MAX;SNAI2;MYC;CLOCK;SCRT2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.5442453538975445,-1.2903766944121995,0.171334431630972,0.3798632184287715,1.0,8/11,38.96%,PRMT2;PRMT1;PRMT3;PRMT6;NDUFAF7;CARM1;PRMT5;PRMT8
prerank,protein phosphatase binding (GO:0019903),-0.32477575124520663,-1.2900490796999768,0.06310679611650485,0.37803285938496256,1.0,29/117,16.05%,IQGAP1;MAP3K5;MFHAS1;LILRB1;SNX3;STAT3;CD22;STAT6;MTMR3;MAPK14;TRAF3;MVP;CTNNB1;VRK3;SIRPA;JAK1;MASTL;SLC9A1;AKAP11;STYXL1;LCK;STRN;PPP6R3;HSP90B1;PPP1R3E;TRAF2;PPP1R9B;AP3B1;ANKLE2
prerank,GABA receptor binding (GO:0050811),-0.5622591601697402,-1.2885572570749777,0.15357766143106458,0.37850528789788374,1.0,4/11,14.33%,TRAK1;PLCL2;ARFGEF2;GABARAP
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.31005013519014274,-1.288153564513908,0.045813586097946286,0.37679978339188563,1.0,50/173,21.75%,MITF;ZEB2;FOXP1;TRPS1;BCL6;JUN;ETV6;PPARD;BACH1;ZBTB34;ZNF148;NFX1;ATF3;PPARG;ELK3;ZNF3;FOXO3;NFKB1;HHEX;ZBTB21;NFATC3;ZBTB2;NR2F1;SKI;BHLHE40;THAP1;TFEC;ZBTB20;RELA;PRDM2;ZFP57;SP2;E2F8;BATF3;TGIF1;TCF3;YY1;KLF8;ZNF177;ZBTB12;ZBTB25;GATA3;NR3C1;GTF2IRD1;LRRFIP1;MAX;CEBPB;TBX2;HEYL;SNAI2
prerank,protein kinase binding (GO:0019901),-0.278254022502822,-1.2870210592767897,0.004149377593360996,0.37668878956218177,1.0,150/479,22.49%,IQGAP1;SASH1;PTPRC;NEDD9;BANK1;LYST;PRKCB;FGR;MSN;GRB2;MAPKAPK3;PLCG2;PAK2;PLEK;PRKCD;RAC1;ITGB2;PTPRJ;RHOA;MAP3K1;KIF13B;IBTK;PRKAG2;VRK2;MAML1;MAPKAPK2;STAT3;FOXO3;KIF11;CDC42;ITGB1;CCND3;BLNK;STAP1;ACTB;TOP2A;ADIPOR1;ITGAV;IRF5;ADAM9;IFNAR2;IRAK4;RPS6;AXIN1;DUSP3;MVP;IRAK3;UTRN;GRK5;SKI;SIRPA;STK38;AP2A2;TRIB1;NEK6;PTPN6;SLC12A7;HIF1A;MAPK7;SIK1;TRIB2;TPX2;TNIP2;SPRY2;SPRED1;PIN1;KIF14;CDK5RAP1;LCK;EEF2;DUSP6;CDC25A;TPR;CRK;CCDC88A;RELA;DCTN1;TICAM1;SPRED2;EEF1A1;CACUL1;TRIM68;STK11IP;TRAF2;TJP2;GCH1;PPP1R12A;RB1CC1;HDAC5;ANKRA2;TCF3;RELB;RACGAP1;CSPG4;IKBKB;IL31RA;HCLS1;MAVS;TRIM14;RND2;KIF20A;GPRC5B;FAF1;CD226;EXOC2;SPAG9;MAP2K3;DNAJC3;AURKA;RARA;FBXO7;RAD9A;CDKN2C;RPS3;TWF2;LIMS1;FAM83D;TAOK2;NISCH;PTPN11;NR3C1;PDGFRB;DUSP5;HSPB1;JTB;BMPR2;NOD2;RHOBTB1;SUFU;PRAM1;GSK3B;GDF3;APPL1;PRC1;WNK1;ATF7;CEP192;CDC25C;RACK1;LAX1;PRKAG1;CCNK;PTPN1;PDLIM5;TUBA4A;ILK;RHOF;CD3E;CD247;PPP1CC
prerank,chemokine activity (GO:0008009),-0.419078326902626,-1.285988051074388,0.1413793103448276,0.3763199824593073,1.0,13/31,39.30%,CKLF;PF4;CXCL16;CCL5;CCL7;CCL24;CCL4;CCL19;CCL25;CCL8;CXCL9;CXCL1;CCL14
prerank,frizzled binding (GO:0005109),-0.41035664838614266,-1.2857495200058575,0.13195548489666137,0.374347707197424,1.0,13/34,27.85%,SDCBP;ZNRF3;LRP6;RNF43;RYK;WNT3;SFRP1;DVL2;CCDC88C;WNT7B;FZD1;FZD7;WNT6
prerank,peptidase activator activity (GO:0016504),-0.46195992274182673,-1.2849270045661227,0.151618398637138,0.37361099446844026,1.0,5/22,11.28%,PSME4;PSME3;NLRC4;EBAG9;PSENEN
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.3752411554023933,-1.28403133795166,0.09764309764309764,0.3730072839816589,1.0,21/53,26.17%,CYBB;XDH;POR;CYB5R1;GSR;CYB5R3;KMO;GFER;MICAL1;MICAL2;ACOX1;DLD;PPOX;FOXRED2;KDM1A;MTHFR;ACADVL;ACOXL;CYB5R2;QSOX1;NQO2
prerank,guanyl ribonucleotide binding (GO:0032561),-0.30309180487433063,-1.27681431496136,0.04866562009419152,0.3850420568605292,1.0,77/196,28.52%,RAB8B;MFHAS1;RAC1;ARL8B;RAB7A;DNM2;RAP1B;RHOA;RAP2B;ARL8A;GNAI3;INSR;RAP2A;RAB31;RAP1A;CDC42;NOA1;ARL11;RHOQ;RAB32;NME1;GBP5;RAB5A;RAB21;ADSS1;GBP2;TGM2;RRAGD;RAB11B;SEPHS1;RAB29;EEF1A1;RAB10;ARL3;TUBD1;GCH1;ANXA6;ARL5A;RAB13;RND2;ARHGEF5;RAB39A;RALB;GTPBP10;ARL1;KRAS;NRAS;ARFIP2;RHEB;GBP3;RAB12;RHOBTB1;GBP7;GBP6;TUBA4A;RHOF;TUBB1;TUBA8;RABL3;RND1;RAB26;RAB4A;RAB35;GBP4;RAB1B;REM1;RND3;NUDT16;RAB22A;CNGB3;RAPGEF2;TUBA1C;ARL4A;EIF2B2;GEM;GNL1;THG1L
prerank,deoxyribonuclease activity (GO:0004536),-0.5131006106881331,-1.273148732692065,0.16782006920415224,0.389900925507969,1.0,8/14,26.81%,NME1;DNASE1L1;APLF;MAP1S;ERCC4;RPS3;ZRANB3;MRE11
prerank,regulatory RNA binding (GO:0061980),-0.3911227550832403,-1.2701202276029895,0.15924657534246575,0.39351910238399374,1.0,7/38,8.35%,AGO2;TLR7;TUT7;DHX9;RC3H1;ZC3H7B;PUM2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.5118770227530927,-1.269701076400643,0.15425531914893617,0.39188271252685175,1.0,4/14,10.28%,IREB2;CIAO3;RSAD2;RSAD1
prerank,BMP receptor binding (GO:0070700),0.5102111121646948,1.268654308045491,0.16481069042316257,0.36983857173555346,1.0,6/12,25.74%,BMP7;BMP3;CDH5;GDF15;BMP5;PYCARD
prerank,protein kinase activator activity (GO:0030295),-0.36086001946631363,-1.2685842163941647,0.11589403973509933,0.3917324930173878,1.0,21/60,16.69%,IQGAP1;ABI1;PAK2;PRKAG2;ERCC6;INCENP;STK3;CAB39;GAS6;ALS2;NCKAP1L;TPX2;AFAP1L2;SPRY2;DBF4;TAOK1;MAP2K1;STK11;MARK2;STRADA;GPRC5B
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.4890218851809621,1.266784483364815,0.189010989010989,0.3693772206798112,1.0,7/13,25.67%,ALDH1A1;ALDH1A3;ALDH7A1;ALDH1L1;ALDH9A1;ALDH3A2;ALDH2
prerank,beta-tubulin binding (GO:0048487),-0.418483527003629,-1.2636192200220004,0.16557377049180327,0.3997583808549873,1.0,13/31,20.05%,ARL8B;PEX14;ARL8A;EML4;TAOK1;LRPPRC;GABARAP;MAP1S;RACGAP1;VAPB;UXT;PDCD5;APPL1
prerank,I-SMAD binding (GO:0070411),-0.5248960081007108,-1.2633639668925165,0.1658206429780034,0.39782426846555297,1.0,9/13,32.63%,AXIN1;CTNNB1;TGFBR1;TGFB1I1;SMAD7;SMURF1;SMAD4;SMAD2;SMAD1
prerank,iron ion binding (GO:0005506),-0.38213102050368236,-1.263298952074961,0.12920353982300886,0.39559916451108634,1.0,19/48,26.90%,FTL;CDO1;ETHE1;KDM3A;ABCE1;KDM7A;ALKBH1;EGLN1;AGMO;FTO;TET2;ACP5;CYP2R1;TYW5;ALKBH3;FTH1;FDX1;ALOX15;LCN2
prerank,titin binding (GO:0031432),0.5028074402732143,1.2610337390836697,0.18115942028985507,0.37567453664103434,1.0,4/13,13.42%,CAPN3;CALM1;CALM3;CALM2
prerank,receptor ligand activity (GO:0048018),0.27747480223962817,1.260751523735109,0.03523035230352303,0.37258485860927526,1.0,35/245,12.79%,NRG3;NRG1;TAFA1;SEMA6D;TAFA2;EPHA7;SEMA6A;TGFA;SEMA3E;EGF;EDA;SEMA5A;WNT9A;PTN;TAFA5;GDNF;VEGFD;PGF;FGF10;APLN;BDNF;BMP7;SEMA3F;TGFB2;AMELX;AREG;BMP15;EDN1;CLEC11A;NBL1;SEMA5B;ANGPTL3;SCG2;NTS;BMP3
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.519458117106451,-1.258442916057785,0.20631970260223048,0.403276550993005,1.0,7/12,42.78%,SLC25A42;ENTPD6;ENTPD3;NUDT15;ENTPD7;NUDT5;ENTPD1
prerank,NAD+ binding (GO:0070403),-0.5169895654540058,-1.2551853038856624,0.19829059829059828,0.40786865937152916,1.0,3/12,10.13%,ZC3HAV1;SIRT3;PARP9
prerank,cell-cell adhesion mediator activity (GO:0098632),0.37579890822920897,1.2534140842385082,0.14321608040201006,0.3814541982443779,1.0,8/42,10.31%,LRRC4C;CNTN6;CNTN4;DSCAM;NTNG1;DSCAML1;CD200;ROBO3
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.28965144780758817,-1.2519842969841597,0.05972434915773354,0.4120917028731951,1.0,70/248,20.12%,ATP2B1;RAB8B;RNF213;GNB1;MYH9;RAC1;ARL8B;RAB7A;KLC1;DNM2;RAP1B;RHOA;RAP2B;ARL8A;GNAI3;RAP2A;RAB31;ABCD2;GNA12;RAB20;GSPT1;RAP1A;CDC42;DHX9;CHD3;RAB1A;KIF20B;KIF15;GNA15;RHOQ;RAB32;GNA11;GBP5;RAB5A;RAB21;MYO1E;GBP2;EFL1;PIN1;KIF14;EEF2;GNA13;GTPBP1;RRAGD;RAB24;RAB11B;SAR1A;RAB29;EEF1A1;GCH1;GNA14;RND2;TBC1D24;RALB;DNA2;HSPA1A;GTPBP10;ARL1;KIF18B;KRAS;NRAS;RHEB;GBP3;MMUT;DDX3X;RHOBTB1;GBP7;GBP6;RAB11A;ABCA4
prerank,ubiquitin-specific protease binding (GO:1990381),-0.4631098588420094,-1.251639937194674,0.16695652173913045,0.4103785150346553,1.0,7/19,26.23%,AMFR;RHBDD2;SELENOS;DERL1;SART3;BAG6;VCP
prerank,myosin II binding (GO:0045159),0.5118943429775467,1.2511006593313032,0.18693693693693694,0.381948950969984,1.0,4/10,10.89%,STXBP5L;SHROOM4;SHROOM1;GSN
prerank,sequence-specific DNA binding (GO:0043565),-0.2662981477699327,-1.2499975777618098,0.012345679012345678,0.4111826171398201,1.0,147/590,23.77%,RBPJ;ZEB2;FOXP1;ELF4;FLI1;BACH2;TFEB;TCF4;ELF2;TET3;BCL6;JUN;MEF2A;RUNX3;PPARD;BPTF;NFE2L2;MBNL2;IRF2;ZNF148;NFIC;ATF3;ELF1;UBP1;PPARG;FOXN2;ELK3;ETV1;FOXO3;KLF13;E2F2;USF2;HHEX;ZBTB21;RUNX2;RARG;IRF5;BCL2;MEF2B;KLF6;MAF;BATF;CUX1;TEF;ETV3;CHTOP;NFATC3;ZBTB2;AHR;KLF3;NR2F1;ATF6;KDM2A;BHLHE40;E2F1;PRMT1;CEBPG;CBFB;THAP1;E2F3;MEF2D;HIF1A;TFEC;MEF2C;SIRT3;OLIG2;EGR1;ARNT;UPF2;IKZF3;ZBTB20;XBP1;XRCC6;OSR1;KLF10;NFE2;PRDM2;TCF7;ZFP41;UHRF1;FOXJ3;SP2;CALCOCO1;E2F8;BATF3;RXRA;KLF2;TGIF1;TEN1;TFAM;TFAP4;YY1;NCL;ZNF177;TFCP2;NR4A1;ZBTB12;KLF11;FOXJ2;IRX5;SOX10;KMT2A;LRWD1;RARA;TFE3;ATF5;CSRNP1;ERH;GATA3;ARID5A;CXXC1;NFATC1;TCF12;NR3C1;GMEB2;MEIS3;HOXD8;WDR77;SP9;ATF7;KDM5B;PKNOX1;MAX;POU3F1;NLRP3;HOXB2;KDM1A;CEBPB;TBX2;SNAI2;EGR2;MTF1;ZNF296;BARX2;MYRFL;NR1H4;HOXD9;HES7;SOX7;ZNF32;ZBTB7A;SMG1;RFX5;MAFF;BBX;PAX6;HES6
prerank,metalloendopeptidase activity (GO:0004222),0.329107657597828,1.2494027086761197,0.10552763819095477,0.381420958548349,1.0,23/76,17.21%,OMA1;MMP16;ADAMTS17;MMP12;MME;ADAMTS16;ADAMTSL1;ECE2;IDE;MMP15;THSD4;MMEL1;MMP13;ADAMTS12;EEF1AKMT4-ECE2;PMPCB;ADAMTS5;TRABD2B;ADAMTS6;ECE1;ADAM17;ADAMTSL2;PHEX
prerank,phospholipase C activity (GO:0004629),0.41530701346555277,1.246744127524831,0.16784869976359337,0.3824329917868866,1.0,8/25,12.36%,PLCB1;PLCL1;CHRM3;PLCH2;PLCE1;PLCZ1;PLCD3;F2RL2
prerank,tRNA binding (GO:0000049),-0.37987524125984784,-1.2466603742858806,0.14662273476112025,0.41588188357205147,1.0,14/43,20.55%,FARS2;XPOT;SARS1;ELP5;ALKBH1;DALRD3;ELP1;PUS1;EEF1A1;KARS1;EIF2A;TYW5;AARS1;DARS2
prerank,omega peptidase activity (GO:0008242),-0.32769371732373437,-1.2421726263720216,0.10806174957118353,0.42282619635599156,1.0,27/89,21.29%,USP12;USP50;OTUD5;USP18;UCHL5;USP8;USP9X;USP36;USP3;ATXN3;OTULIN;USP42;USP35;GGH;USP40;JOSD1;OTUD4;USP30;USP7;STAMBPL1;USP11;BRCC3;COPS5;BAP1;ZC3H12A;USP9Y;ZRANB1
prerank,motor activity (GO:0003774),-0.35497516477044466,-1.2415250743706965,0.12211221122112212,0.4218090817595755,1.0,22/60,17.93%,MYH9;KLC1;KIF13B;KIF3B;KIF11;KIF16B;KIF20B;KIF23;KIF15;STARD9;KIF4A;CENPE;DNAH8;MYO1E;KIFC1;PIN1;KIF14;KIF21B;KIF2C;KIF20A;DNAH3;KIF18B
prerank,transaminase activity (GO:0008483),0.5058506006789409,1.2396149622744839,0.21123595505617979,0.391103528842314,1.0,5/11,18.39%,GOT1;BCAT1;ABAT;PSAT1;BCAT2
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.4845670607831603,1.2394032284085326,0.21171171171171171,0.38794011085336844,1.0,3/14,6.79%,KCND3;KCNJ3;KCNIP2
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.3472586802501775,-1.2372069173539333,0.12054329371816638,0.4282619820997711,1.0,12/60,10.76%,PPM1H;PPP4C;CTDSPL2;MTMR3;LRRC39;PPM1B;PPP1CA;LRRK1;SSU72;MTMR6;LCK;CDKN3
prerank,kinase activator activity (GO:0019209),-0.3984853761811001,-1.2349035950674727,0.17666666666666667,0.43072076736450965,1.0,19/30,37.11%,PRKAG2;MALT1;CAB39;NCKAP1L;TPX2;STK11;MARK2;STRADA;GPRC5B;WNK1;MOB1B;MT3;GPRC5C;IL2;BCL10;FGF13;GPRC5A;GPRC5D;WNT11
prerank,endopeptidase regulator activity (GO:0061135),-0.3855505781360867,-1.233903016305558,0.16134453781512606,0.43027206513454747,1.0,9/40,14.94%,UCHL5;PSME3;NLRC4;TFPI;PROS1;CAST;PSENEN;CST7;CST3
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.40797764368937683,-1.229508987981989,0.16433566433566432,0.43754651688667195,1.0,11/28,22.23%,RIPK1;TRAF5;TRAF3;BABAM2;MYD88;TRAF1;TRAF2;BID;STAT1;FEM1B;TNFSF9
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.40649933184478715,1.2292450920875928,0.19901719901719903,0.40251917259522624,1.0,7/26,17.54%,B3GALT1;CHSY3;B3GALT5;B3GNT5;B4GALNT4;B4GALNT2;B3GALT4
prerank,ubiquitin binding (GO:0043130),-0.33153339610253213,-1.2245915996727552,0.12563667232597622,0.4457299101506593,1.0,32/73,32.72%,GGA3;TOP2A;UBXN7;RNF31;RBCK1;DDI2;TSG101;UBAP1;WDR48;RAE1;MVB12B;RNF185;USPL1;CXCR4;FAF1;FBXO7;HSPB1;SIRT2;UBXN1;FAF2;NUP62;CKS2;RNF19B;UBE2N;USP16;ASCC2;MARK4;MVB12A;AUP1;SQSTM1;RNFT1;USP5
prerank,double-stranded DNA binding (GO:0003690),-0.2630262753816692,-1.2191121530409104,0.02538787023977433,0.4549883391836995,1.0,134/531,23.77%,FOXP1;ELF4;FLI1;BACH2;TFEB;TCF4;RBMS1;ELF2;BCL6;JUN;CGAS;RUNX3;PPARD;RAD51B;MBNL2;IRF2;NFIC;ATF3;ELF1;UBP1;PPARG;FOXN2;ELK3;ETV1;FOXO3;KLF13;E2F2;DHX9;USF2;RUNX2;RARG;IRF5;AIM2;MEF2B;KLF6;MAF;BATF;CUX1;TEF;DDX60;ETV3;NFATC3;ZBTB2;WDR48;AHR;KLF3;REXO4;NR2F1;ATF6;BHLHE40;E2F1;CEBPG;E2F3;NEIL3;RAD51;MEF2D;TFEC;MEF2C;OLIG2;NUCKS1;EGR1;ARNT;APTX;ZBTB20;XBP1;XRCC6;OSR1;KLF10;MAU2;NFE2;FEN1;HMGB2;TCF7;ZFP41;UHRF1;FOXJ3;SP2;E2F8;BATF3;RXRA;KLF2;TGIF1;RAD51AP1;TFAP4;YY1;ZNF177;TFCP2;NR4A1;ZBTB12;KLF11;FOXJ2;IRX5;SOX10;ZCCHC3;RARA;TFE3;GATA3;RPS3;NFATC1;TCF12;NR3C1;GMEB2;RBBP8;MEIS3;HOXD8;HMGB3;SP9;HMGB1;ATF7;KDM5B;PKNOX1;DMC1;STAT1;MAX;POU3F1;HOXB2;CEBPB;TBX2;SNAI2;EGR2;MTF1;ZNF296;BARX2;HOXD9;HES7;SOX7;ZNF32;ZBTB7A;POLG2;RFX5;MAFF;BBX;PAX6;HES6
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.2591025460646689,-1.2169286234012924,0.016574585635359115,0.4572207163399395,1.0,151/597,23.77%,FOXP1;ELF4;FLI1;RUNX1;BACH2;TFEB;TCF4;ELF2;BCL6;JUN;ZNF568;RUNX3;PPARD;ARID5B;NFE2L2;BRD7;MBNL2;IRF2;NFIC;NFYA;ATF3;ELF1;UBP1;PPARG;FOXN2;ELK3;SPI1;BRCA1;ETV1;STAT3;FOXO3;KLF13;E2F2;DHX9;USF2;CHD3;NFKB1;HHEX;RUNX2;RARG;IRF5;MEF2B;KLF6;MAF;CIITA;BATF;CUX1;TEF;ETV3;NFATC3;ZBTB2;AHR;KLF3;TBL1XR1;NR2F1;ATF6;BHLHE40;MCM6;CREB3L2;HNRNPL;E2F1;ATMIN;CEBPG;E2F3;MEF2D;TFEC;MEF2C;OLIG2;EGR1;MCM9;ARNT;MCM3;ZBTB20;XBP1;XRCC6;OSR1;RELA;KLF10;KMT2D;ORC5;NFE2;FOXJ1;HMGB2;KAT7;TCF7;ZBED4;ZFP41;MLH3;FOXJ3;SP2;CALCOCO1;DHX36;E2F8;BATF3;RXRA;HDAC5;KLF2;TGIF1;PSPC1;TFAM;TFAP4;YY1;KIF2C;ZNF177;TFCP2;MCM2;NR4A1;ZBTB12;KLF11;FOXJ2;IRX5;SOX10;TAF9;RARA;TFE3;ATF5;GATA3;ARID5A;NFATC1;TCF12;NR3C1;GMEB2;MEIS3;HOXD8;SP9;HMGB1;ATF7;KDM5B;PKNOX1;MAX;POU3F1;HOXB2;CEBPB;TBX2;SNAI2;EGR2;MTF1;ZNF296;BARX2;NONO;CDC45;HOXD9;HES7;SOX7;ZNF32;ZBTB7A;RFX5;MAFF;BBX;PAX6;HES6
prerank,mRNA binding (GO:0003729),-0.2771767604114267,-1.2136914701405712,0.07786259541984733,0.46194915704396683,1.0,82/249,25.39%,RBM47;PTBP3;RBMS1;IREB2;YTHDF3;AGO2;DCP1A;TRA2B;RPL7;DHX9;RBPMS;RC3H1;RNF20;SF3B6;EIF4G3;SNRNP35;PUM3;EIF3A;SECISBP2;RPS14;HNRNPL;CNBP;RPS13;PUM2;LARP4B;KHNYN;LARP4;DDX5;XPO5;PCBP2;EIF4A1;TPR;NUDT21;CELF1;HNRNPLL;RBM14;PKM;NYNRIN;METTL14;BOLL;YTHDC1;MRPS11;DHX36;UNK;RBMS2;NCBP1;EIF4G1;DAZAP1;THOC2;NCL;EIF2A;HDLBP;RBM4B;TDRD7;G3BP1;MARF1;RPS3;RNPS1;SNRNP70;NSRP1;DDX3X;RBPMS2;DDX6;C1QBP;SF3B1;GRSF1;CPEB4;ZC3H12A;LSM14A;HNRNPK;SHMT1;PABPC1L;EIF2S2;PCBP4;PUM1;RPL41;TARDBP;ESRP1;MRPS7;ANGEL2;RNF40;RPL5
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.3911461041638383,-1.2114885443321854,0.2067137809187279,0.4643570465622174,1.0,14/34,24.56%,IQGAP1;INCENP;STK3;CAB39;ALS2;SPRY2;DBF4;TAOK1;MAP2K1;STRADA;DDX3X;CCNK;CCNB1;CKS2
prerank,alpha-actinin binding (GO:0051393),0.4026142411348575,1.2105039802752822,0.2100456621004566,0.4330395872785746,1.0,8/24,17.51%,CACNA1C;KCNN2;PRICKLE4;SYNPO2;TTN;PDLIM4;MAGI1;PDLIM7
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.46888372233369385,-1.2092517282444029,0.23251748251748253,0.4667211805802236,1.0,8/16,36.11%,CDO1;ETHE1;BCO2;IDO2;ALOX15;HGD;HAAO;ALOX12
prerank,actinin binding (GO:0042805),0.41945044852194935,1.2003214395113697,0.21307506053268765,0.44848383069205533,1.0,7/21,15.69%,CACNA1C;KCNN2;SYNPO2;CSRP1;TTN;PDLIM4;MAGI1
prerank,acid-thiol ligase activity (GO:0016878),0.47084023299171446,1.1990967860285031,0.26136363636363635,0.4469939066690473,1.0,4/13,20.43%,SLC27A2;ACSS2;ACSM3;ACSS1
prerank,syntaxin binding (GO:0019905),0.32534973586267407,1.1979772584019188,0.16267942583732056,0.4452600479113355,1.0,17/61,14.45%,STXBP5L;SYT1;UNC13C;SYT10;SNPH;SNAP25;CPLX1;SYT2;SYT5;SYT12;PRRT2;STXBP2;NAPB;UNC13B;GOLGA2;SCFD1;VAMP8
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.49203724532229975,1.1971857249428548,0.2511520737327189,0.44300633951270535,1.0,2/11,5.23%,KCND3;KCNJ3
prerank,amyloid-beta binding (GO:0001540),-0.3220058891326284,-1.1965184674792604,0.17363344051446947,0.4923418874788283,1.0,13/79,4.10%,APOE;MSR1;CD74;GSAP;LILRB3;LILRB1;LRP1;ITGB2;C1QA;CD36;INSR;APBB2;TLR4
prerank,lipid phosphatase activity (GO:0042577),0.46011407100288365,1.1963022344791685,0.2433734939759036,0.4410043446370459,1.0,2/14,2.70%,PLPPR1;PLPPR4
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.4901485654727978,-1.19550983510398,0.23777403035413153,0.49215221106920515,1.0,5/12,13.44%,TRAF5;TRAF3;BABAM2;TRAF1;TRAF2
prerank,protein kinase C activity (GO:0004697),-0.4758855326470783,-1.195058558649629,0.2328042328042328,0.49058086585352956,1.0,3/14,1.35%,PRKCH;PRKCB;PRKCD
prerank,poly(U) RNA binding (GO:0008266),-0.4270140700689676,-1.192685892060419,0.22357019064124783,0.49347331293853613,1.0,8/20,23.22%,RBMS1;PATL1;HNRNPH1;RBMS2;DAZAP1;ATXN1;RBM11;PABPC1L
prerank,metallocarboxypeptidase activity (GO:0004181),0.3902182954361705,1.1922564924722963,0.2103960396039604,0.4448838721063097,1.0,5/26,12.63%,AGBL4;AGBL1;CPE;FOLH1;CPA2
prerank,sterol binding (GO:0032934),-0.34377451027857064,-1.191833284703607,0.2030716723549488,0.4930218090349057,1.0,13/56,14.81%,OSBPL8;ABCA1;ABCG1;OSBPL3;GRAMD1B;VDAC2;OSBPL5;ERLIN1;OSBPL11;NPC2;STARD5;ANXA6;NPC1
prerank,myosin V binding (GO:0031489),0.4483507121618352,1.1917122379702896,0.24145785876993167,0.4422335288391421,1.0,4/15,5.70%,RAB3C;RAB6B;RAB27B;RAB6A
prerank,GDP binding (GO:0019003),-0.3373382221046692,-1.1888287207934691,0.18635607321131448,0.497524989395586,1.0,21/63,19.29%,RAB8B;ARL8B;RAB7A;RAP1B;RAP2B;GNAI3;RAP2A;RAB31;RAP1A;RAB5A;RAB21;RRAGD;RAB11B;RAB29;RAB10;ARL3;RALB;KRAS;NRAS;RHEB;RAB12
prerank,proton transmembrane transporter activity (GO:0015078),-0.3674117946510887,-1.1874123348847732,0.2322695035460993,0.498013457824443,1.0,16/39,28.57%,CLCN5;SLC33A1;CTNS;COX4I1;SLC9A1;MFSD3;COX10;UQCRC1;COX8A;NNT;SLC11A2;NDUFA4;CYB5A;COX5A;COX6A2;UQCRQ
prerank,3'-5' exonuclease activity (GO:0008408),-0.35478469197677936,-1.1868370891451727,0.20465890183028287,0.49663367404270164,1.0,16/45,22.31%,ERI3;RAD1;REXO4;ERI2;EXOSC5;EXD1;WRN;APLF;CNOT6L;RAD9A;EXOSC10;ANGEL1;CNOT8;EXOSC4;PNLDC1;XRN2
prerank,voltage-gated anion channel activity (GO:0008308),-0.4581053960074628,-1.1853832016386896,0.24033613445378152,0.49740903516817275,1.0,3/15,6.14%,ANO6;VDAC2;CLCN5
prerank,LRR domain binding (GO:0030275),0.45954539056801735,1.185045671202938,0.2456575682382134,0.4516176685285668,1.0,2/14,5.30%,ROBO1;MRTFA
prerank,mannose binding (GO:0005537),-0.48716196784269317,-1.1802008915370108,0.2469982847341338,0.506528055629054,1.0,7/12,40.50%,CLEC4D;CLEC6A;LMAN2L;ACR;LMAN2;LMAN1L;CLN5
prerank,estrogen receptor binding (GO:0030331),-0.38387863465456673,-1.1792147387195029,0.22380106571936056,0.5062524043972784,1.0,15/32,29.05%,CNOT1;PRMT2;CTNNB1;WBP2;STRN;NSD1;NRIP1;ARID5A;NCOA6;PPARGC1B;MMS19;DDX54;DCAF1;LEF1;ESR1
prerank,lipoprotein particle receptor binding (GO:0070325),-0.39750995370493547,-1.176426326845096,0.24734982332155478,0.5096746554568512,1.0,6/27,14.17%,APOE;LRP1;PICALM;DNAJA1;HSP90B1;ANKRA2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.5008186085369584,-1.175492519031982,0.26174496644295303,0.5091761297209957,1.0,3/11,14.48%,SASH1;STK38;TCF3
prerank,SUMO binding (GO:0032183),-0.4729611504301261,-1.174210764707555,0.25749559082892415,0.5096163296147795,1.0,6/13,26.34%,RNF111;RNF4;USPL1;UBA2;SIMC1;PML
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.5068556747666874,-1.1728067061413916,0.2679509632224168,0.5101996819925172,1.0,4/10,14.50%,NSD3;ASH1L;SMYD2;NSD1
prerank,lipase activity (GO:0016298),-0.3502756196079993,-1.1713390457836748,0.23591549295774647,0.51102736829585,1.0,9/43,14.40%,LIPA;DDHD1;PLBD1;ABHD12;PLBD2;DAGLB;LPL;ABHD5;LDAH
prerank,GTPase activity (GO:0003924),-0.2791571416839609,-1.1709242579360022,0.12244897959183673,0.509357858507065,1.0,55/192,20.12%,RAB8B;GNB1;RAC1;ARL8B;RAB7A;DNM2;RAP1B;RHOA;RAP2B;ARL8A;GNAI3;RAP2A;RAB31;GNA12;RAB20;GSPT1;RAP1A;CDC42;RAB1A;GNA15;RHOQ;RAB32;GNA11;GBP5;RAB5A;RAB21;GBP2;EFL1;EEF2;GNA13;GTPBP1;RRAGD;RAB24;RAB11B;SAR1A;RAB29;EEF1A1;GCH1;GNA14;RND2;TBC1D24;RALB;GTPBP10;ARL1;KRAS;NRAS;RHEB;GBP3;MMUT;DDX3X;RHOBTB1;GBP7;GBP6;RAB11A;ABCA4
prerank,alanine transmembrane transporter activity (GO:0022858),-0.48872520628798916,-1.1704808139929561,0.2696245733788396,0.5078178656598489,1.0,3/12,8.52%,SLC6A6;SLC38A7;SLC36A4
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.4629196423902522,1.1659465686127464,0.2827102803738318,0.48628486931925463,1.0,2/12,3.49%,PDE4B;PDE4D
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.365334546159004,-1.1650200265261093,0.22950819672131148,0.5177158523185779,1.0,14/35,28.28%,FOXP1;AGO2;GTF2A1;RELA;KLF10;DR1;SNAPC3;NR3C1;TAF4;STAT1;DRAP1;MYC;UBTF;ZBTB17
prerank,hexosyltransferase activity (GO:0016758),0.28930313704316174,1.163981130171062,0.16710875331564987,0.4866328814156753,1.0,13/101,5.26%,MGAT4C;B3GALT1;TMTC2;TMTC1;FUT9;CHSY3;B3GALT5;HEXB;DPY19L1;B4GALT4;TMTC3;POMT2;DPY19L2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.3158052700976548,-1.1625206542991329,0.19015280135823429,0.520985954679561,1.0,32/74,30.40%,FAM20C;PANK2;DGKZ;NADK;PIK3CB;PIK3CG;PI4KB;DGKD;FGGY;POMK;HK3;PIK3CA;PKM;PIK3CD;PIK3C2A;PAPSS1;DGKG;NADK2;PDXK;SPHK2;GALK2;NMRK1;NOL9;PIK3C2G;DGKA;GALK1;FCSK;GK5;IDNK;GNE;TKFC;FAM20B
prerank,RNA cap binding (GO:0000339),-0.45007911300452785,-1.1591751120402516,0.26161790017211706,0.5261184814474068,1.0,4/16,14.79%,AGO2;EIF4A1;NCBP1;SNUPN
prerank,metallopeptidase activity (GO:0008237),0.2857275766977003,1.1579560795232238,0.16707021791767554,0.4952217361370527,1.0,30/113,17.21%,OMA1;ADAM12;METAP2;MMP16;ADAMTS17;MMP12;MME;ADAMTS16;ADAMTSL1;ADAM23;ECE2;IDE;MMP15;THSD4;MMEL1;MMP13;ADAMTS12;BMP1;EEF1AKMT4-ECE2;PMPCB;ADAMTS5;TRABD2B;METAP1;ADAMTS6;ADAM11;ECE1;ADAM18;ADAM17;ADAMTSL2;PHEX
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.44579609407892784,-1.1577577452048473,0.2894736842105263,0.526892796003161,1.0,2/15,2.56%,P2RX7;P2RX4
prerank,protein kinase regulator activity (GO:0019887),-0.3050005652481599,-1.1569066457708945,0.20473773265651438,0.5263039295932422,1.0,39/95,32.29%,TAOK3;CCNL1;PRKAG2;CCND3;CCNY;CAB39;TRIB1;NCKAP1L;TPX2;CCNL2;STK11;GMFG;MARK2;CCNE1;GMFB;ELP4;STRADA;GPRC5B;FAF1;DNAJC3;CNPPD1;SOCS3;WNK1;PRKAG1;CCNK;CCNF;CCNB1;ITPRIP;CCNB2;MT3;SH3BP5;NCK1;GPRC5C;ANKRD54;CSNK2B;FGF13;KIDINS220;GSKIP;CCNJL
prerank,3'-5' DNA helicase activity (GO:0043138),-0.44073730575881803,-1.1539158773587845,0.26631393298059963,0.5311229233554924,1.0,8/16,25.70%,DHX9;BLM;MCM6;WRN;MCM2;MCM5;ASCC3;RECQL5
prerank,nuclear import signal receptor activity (GO:0061608),-0.4512651102681568,-1.1529646671584244,0.27629233511586454,0.5308734443027074,1.0,4/15,20.27%,KPNA4;IPO5;KPNA3;TNPO3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.4984513853481617,-1.1525771354718493,0.292894280762565,0.5292795100556948,1.0,2/10,0.73%,APOBEC1;GDA
prerank,transferrin receptor binding (GO:1990459),-0.4967091772146287,-1.1514931345033101,0.3068391866913124,0.5293504184631903,1.0,4/10,18.48%,SNX2;IKBKB;SNX4;SNX1
prerank,potassium ion antiporter activity (GO:0022821),0.44568318998270967,1.1492206097767004,0.28672985781990523,0.5096365127160188,1.0,4/15,5.39%,SLC24A4;SLC24A2;SLC24A3;SLC9A2
prerank,peptidoglycan binding (GO:0042834),-0.5119819101732825,-1.1475866796978569,0.31608133086876156,0.5359683752066172,1.0,5/10,28.87%,RNASE7;NOD1;NOD2;NLRP3;PGLYRP2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.33463561903392225,-1.1462308694347192,0.21869782971619364,0.5367428385975325,1.0,14/55,20.05%,SLC16A7;SLC38A6;SLC6A6;SLC38A10;SLC38A7;SLC36A4;ABCC1;SLC7A5;SLC16A6;SLC23A1;SLC23A2;SLC38A2;SLC25A10;SLC16A1
prerank,ATPase regulator activity (GO:0060590),-0.35703578762134525,-1.142960834752013,0.2529711375212224,0.5415262231381067,1.0,13/38,19.79%,FNIP2;DNAJC1;ATP1B3;DNAJA1;SIL1;FNIP1;TOR1AIP1;HSPH1;BAG3;GRPEL2;MYBPC3;PLN;DNAJB6
prerank,DNA polymerase binding (GO:0070182),-0.41754470951091494,-1.14058990817777,0.2847571189279732,0.5448130490224444,1.0,10/18,32.29%,RTEL1;RAD51;PCNA;HSP90AB1;HMGB1;FANCD2;POLG2;CDK2AP1;LONP1;FANCI
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.3650472430879956,-1.1360552952488032,0.2837370242214533,0.5533985675133902,1.0,10/32,20.81%,TET3;KDM7A;KDM2A;ALKBH1;EGLN1;FTO;TET2;TMLHE;TYW5;ALKBH3
prerank,chemokine receptor binding (GO:0042379),-0.361565865353353,-1.1358264854752556,0.26260869565217393,0.5513914988274304,1.0,14/35,39.30%,CKLF;PF4;CXCL16;CCL5;CCRL2;CCL7;CCL24;CCL4;CCL19;CCL25;CCL8;CXCL9;CXCL1;CCL14
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.43933150577820973,-1.1310682787511328,0.29711375212224106,0.5600382610762686,1.0,6/15,28.30%,CCR2;CCR1;CCRL2;CMKLR1;GPR17;XCR1
prerank,miRNA binding (GO:0035198),-0.3702646706234371,-1.1309381129355414,0.28646748681898065,0.5578652449473656,1.0,18/30,42.47%,AGO2;TUT7;RC3H1;ZC3H7B;PUM2;RBM10;HNRNPA1;ZC3H12A;PUM1;ZC3H7A;SPOUT1;YBX1;AGO3;DDX21;ZC3H10;ELAVL1;TRIM71;SOX2
prerank,microtubule binding (GO:0008017),0.2523343278216851,1.1309294137148929,0.162534435261708,0.5444044250406272,1.0,61/222,17.70%,NAV3;MAP2;DNM3;KIF5C;SGIP1;MAP1B;MTUS2;EML1;SNPH;MAPRE3;EML5;KIFC2;NEFH;DST;KIF1B;KIF26B;CLASP2;KIF21A;DYNC1I1;APC2;KIF5A;DNM1;SYBU;PRNP;KIF2A;CLIP4;HOOK3;MAP7D3;KIF6;REEP1;HOOK1;MTCL1;FMR1;FAM161A;MAP6D1;MACO1;CETN3;EML2;CEP290;MAP9;FSD1;FNTA;GAS8;GAS2L2;CDK5RAP2;GOLGA2;KIF3A;EML6;NDRG1;TUBGCP5;HDGFL3;CAPN6;CCDC170;MTUS1;MAP1A;KIF3C;TERF1;GABARAPL2;TUBGCP3;NEFM;MAP1LC3A
prerank,voltage-gated chloride channel activity (GO:0005247),-0.4901263389305933,-1.129881435956118,0.31686541737649065,0.557798972781428,1.0,2/10,6.14%,ANO6;CLCN5
prerank,ATP hydrolysis activity (GO:0140603),-0.3471298271147913,-1.1275042900329442,0.2608695652173913,0.5608941244226721,1.0,12/41,20.12%,ATP2B1;RNF213;ABCD2;DHX9;CHD3;KIF20B;MYO1E;KIF14;DNA2;HSPA1A;DDX3X;ABCA4
prerank,zinc ion binding (GO:0008270),-0.25672086006129335,-1.1274954620964448,0.16862170087976538,0.5583985094462399,1.0,72/293,19.41%,ADAM33;GDA;LITAF;TET3;SAMHD1;ANPEP;SLC30A5;ACER3;P2RX4;ARHGEF2;PPARG;ZNF3;DHX58;TAB2;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;CHD3;RC3H1;LNPEP;GALT;BLM;PRIMPOL;KDM7A;PITRM1;CRIP1;KDM2A;SKI;TIMP2;QPCTL;EEA1;THAP1;ATAD3A;POLR2L;SIRT3;ADAM8;MSRB1;EGR1;RNF8;HDAC10;SEC24A;CHMP1A;PRDM2;TRIM24;SEC24D;UHRF1;MT2A;SORD;RXRA;GCH1;TET2;ARIH1;CBLB;NSD1;PDXK;IKZF4;TNFSF10;KMT2A;RPS27;LIMS1;MMP8;WDFY1;MDM4;ENPP1;RABGGTB;SLU7;ZMYND8
prerank,chloride channel regulator activity (GO:0017081),-0.4529696776646388,-1.1272180839972819,0.3127208480565371,0.5566570938242184,1.0,3/14,5.23%,STX7;SGK1;STX8
prerank,R-SMAD binding (GO:0070412),-0.41958183039577707,-1.1260510104168697,0.29037800687285226,0.5568888350358852,1.0,9/18,31.95%,JUN;PMEPA1;DDX5;LDLRAD4;PAX6;SMURF1;SMAD4;SMAD2;DROSHA
prerank,methyl-CpG binding (GO:0008327),-0.40262931109608024,-1.1259536181381269,0.30204778156996587,0.5545891581984047,1.0,8/22,19.40%,TET3;ZBTB21;CHTOP;PRMT1;UHRF1;LRWD1;ERH;WDR77
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.23495552936541808,-1.1244012686759346,0.1111111111111111,0.5558728140444268,1.0,118/732,14.70%,RBPJ;MITF;ZEB2;FOXP1;ELF4;RUNX1;BACH2;TFEB;TCF4;RREB1;REL;LITAF;BCL6;JUN;ZNF568;MEF2A;RUNX3;PPARD;BPTF;BACH1;ZBTB34;NFE2L2;DNMT3A;IRF2;ZNF148;NFIC;NFYA;ATF3;ZSCAN12;ELF1;UBP1;PPARG;FOXN2;ELK3;SPI1;ETV1;STAT3;FOXO3;KLF13;E2F2;LYL1;ZSCAN26;DHX9;IKZF1;STAT6;USF2;NLRC5;NFKB1;HHEX;RUNX2;RARG;IRF5;MLXIP;SARS1;MEF2B;KLF6;MAF;TIPARP;NR1H2;BATF;NRF1;TEF;NFATC3;ZBTB2;MYNN;AHR;KLF3;STAT5B;STAT4;NR2F1;ATF6;SKI;BHLHE40;E2F1;CEBPG;THAP1;E2F3;WBP2;MEF2D;HIF1A;TFEC;MEF2C;OLIG2;FOXN3;EGR1;ARNT;PROX2;CIART;IKZF3;ZBTB20;XBP1;ZNF319;ZNF569;RELA;KLF10;NFE2;SALL3;FOXJ1;FOSL2;HMGB2;TCF7;UHRF1;FOXJ3;SP2;CALCOCO1;DHX36;E2F8;BATF3;RXRA;HDAC5;KLF2;TGIF1;TCF3;NSD1;RELB;TFAP4;ZNF628;YY1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",-0.30520020663426173,-1.1225851218199001,0.2461799660441426,0.5579745445643223,1.0,29/75,36.93%,DHRS3;PGD;IMPDH2;ME2;NSDHL;CBR3;CBR1;ABCC4;HSD17B7;SORD;AKR1A1;KDSR;MDH1;MDH2;DHRS4;RDH12;KCNAB3;HSD17B10;RDH10;HSD3B2;SDR42E1;PTGR1;HADH;ADH5;CBR4;DHRS11;LDHAL6B;AKR1C1;MDH1B
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.44527446964562023,-1.1221360443051802,0.32616487455197135,0.5565498312166542,1.0,7/13,19.46%,PIP4K2A;PIK3CB;PIK3CG;PIK3CA;PIK3CD;PIK3C2A;PIP5K1A
prerank,epidermal growth factor receptor binding (GO:0005154),0.3652745714583461,1.1204894048089213,0.28205128205128205,0.5627746068040329,1.0,7/25,12.72%,ERBB4;LINGO1;TGFA;EGF;FAM83B;AREG;CNOT9
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.3306165389827919,-1.1183181468446832,0.28622540250447226,0.5626411629926505,1.0,20/49,22.53%,OPTN;TAB2;RNF169;ABRAXAS1;MINDY2;EPS15;BABAM2;ZFAND6;PRPF8;TNIP2;UBQLN4;TNIP3;MINDY1;PARP10;BRCC3;PSMD4;UBXN1;ZRANB1;BAG6;ZRANB3
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.42784855856526316,-1.1134375837454373,0.3235294117647059,0.5714288069373346,1.0,7/15,26.53%,WDR5;KMT2C;KMT2D;KMT2A;CXXC1;RBBP5;ASH2L
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.35990807218751897,-1.1098456786101507,0.296551724137931,0.5776814539492438,1.0,12/33,25.38%,ERI3;ERI2;EXOSC5;DCP2;CNOT6L;EXOSC10;ANGEL1;CNOT8;EXOSC4;PNLDC1;XRN2;ANGEL2
prerank,poly-pyrimidine tract binding (GO:0008187),-0.38382676537733884,-1.1076035778601172,0.31543624161073824,0.5807843895193568,1.0,9/23,27.00%,RBMS1;PATL1;HNRNPH1;RBMS2;DAZAP1;ATXN1;RBM11;PABPC1L;U2AF2
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.47384681440931187,-1.104585856188352,0.3385416666666667,0.585565691460205,1.0,4/10,12.52%,DCLRE1C;DCLRE1A;EXO1;FEN1
prerank,endopeptidase activity (GO:0004175),-0.2535651738927881,-1.104220243237978,0.2280431432973806,0.5839111111157879,1.0,87/257,27.99%,CTSB;ADAM33;USP12;CTSZ;PLAU;USP18;MALT1;MBTPS2;PSMB7;DPP4;USP8;ADAM9;PREP;PSMB9;HGF;DDI2;PITRM1;PCSK7;USP9X;USP36;RHBDF1;TPP2;RHBDF2;ADAMTS10;CASP4;CTSC;PSMA8;CTSH;KLK3;PRSS36;F7;FAP;ADAMTS18;CTSS;USP42;CASP7;HTRA3;CASP1;USP35;PSMB10;USP40;PSMA1;ADAMTSL5;CTSE;USP30;CD5L;TPP1;USP7;CASP8;ADAM19;USP11;PSMB8;MMP8;CASP2;MMP17;GZMM;F10;PSMA5;RHBDD3;MMP27;PSMB3;ADAMTS1;MMP1;MMP2;SFRP1;USP9Y;HPR;HP;MASP1;ADAMTS20;PDIA3;ADAMTSL3;RCE1;PSMB1;PSEN2;FURIN;ZMPSTE24;PRTN3;ADAMTS2;USP16;USP34;BACE1;USP28;PSMA7;ADAMTS14;ACR;F11
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.28478360010414555,1.1040214558253372,0.25870646766169153,0.5959189652555591,1.0,23/91,15.99%,FRMPD4;PLCB1;PLEKHA5;PARD3;SNAP91;CLVS1;KCNH1;SNX14;MARK1;TIRAP;PLA2G4E;SNX21;PLCZ1;PIRT;GSDMD;AMER2;GSN;SYTL2;SYT7;OSBPL2;MYO1B;RPH3A;SNX20
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.39472523322358744,-1.1026333846370189,0.31542461005199307,0.5828390544724421,1.0,11/21,33.07%,CDK6;CDK13;CDK14;CDK1;CDKL4;CCNK;CDK5;CDK20;CDKL1;CDK8;CDK12
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.39472523322358744,-1.1026333846370189,0.31542461005199307,0.5828390544724421,1.0,11/21,33.07%,CDK6;CDK13;CDK14;CDK1;CDKL4;CCNK;CDK5;CDK20;CDKL1;CDK8;CDK12
prerank,Wnt-activated receptor activity (GO:0042813),0.40520670174165613,1.1023356556074622,0.2989949748743719,0.5951854013530073,1.0,6/15,20.52%,FZD8;TSPAN12;PKD1;ROR1;FZD4;FZD10
prerank,receptor antagonist activity (GO:0048019),-0.41924745719914125,-1.1016115786584373,0.3316151202749141,0.5829435368918001,1.0,7/17,32.87%,DKK2;CCL5;ESR2;DKK3;WFIKKN1;AGTR2;IL18BP
prerank,potassium:proton antiporter activity (GO:0015386),-0.48151687149710104,-1.0994065767550565,0.35663082437275984,0.5860151555003245,1.0,3/10,9.34%,SLC9A9;SLC9A8;SLC9A1
prerank,poly-purine tract binding (GO:0070717),-0.3608574779029116,-1.0965330690091533,0.31802721088435376,0.5905640470202667,1.0,11/27,19.23%,RBMS1;RBPMS;PATL1;HNRNPDL;LARP4;ZC3H14;RBMS2;DAZAP1;DDX1;ATXN1;DDX3X
prerank,C-C chemokine receptor activity (GO:0016493),-0.39075029646587955,-1.0959491148393656,0.33500837520938026,0.5894968262098844,1.0,4/21,15.66%,CCR2;CCR1;CCRL2;CXCR4
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.22890852517525573,-1.0953788930540214,0.15384615384615385,0.5884158428407126,1.0,174/731,23.77%,RBPJ;MITF;ZEB2;FOXP1;ELF4;RUNX1;BACH2;TFEB;TCF4;RREB1;REL;LITAF;BCL6;JUN;ZNF568;MEF2A;RUNX3;PPARD;BPTF;BACH1;ZBTB34;NFE2L2;DNMT3A;IRF2;ZNF148;NFIC;NFYA;ATF3;ZSCAN12;ELF1;UBP1;PPARG;ELK3;SPI1;ETV1;STAT3;FOXO3;KLF13;E2F2;LYL1;ZSCAN26;DHX9;IKZF1;STAT6;USF2;NLRC5;NFKB1;HHEX;RUNX2;RARG;IRF5;MLXIP;SARS1;MEF2B;KLF6;MAF;NR1H2;BATF;NRF1;TEF;NFATC3;ZBTB2;MYNN;AHR;KLF3;STAT5B;STAT4;NR2F1;ATF6;SKI;BHLHE40;CREB3L2;E2F1;CEBPG;THAP1;E2F3;WBP2;MEF2D;HIF1A;TFEC;MEF2C;OLIG2;EGR1;ARNT;PROX2;CIART;IKZF3;ZBTB20;XBP1;ZNF319;ZNF569;RELA;KLF10;NFE2;SALL3;TRIM24;FOXJ1;FOSL2;TCF7;FOXJ3;SP2;CALCOCO1;DHX36;E2F8;BATF3;RXRA;HDAC5;KLF2;TGIF1;TCF3;NSD1;RELB;TFAP4;ZNF628;YY1;KLF8;TFCP2;NR4A1;ZBTB12;NRIP1;KLF11;FOXJ2;IRX5;IKZF4;SOX10;ZBTB25;RARA;ZBTB24;TFE3;GATA3;MYB;SNAPC3;PLAG1;NFATC1;TCF12;NR3C1;GMEB2;MEIS3;SP9;EHF;ZFP28;MAZ;ATF7;GTF2IRD1;PKNOX1;STAT1;LRRFIP1;ZFP2;ZSCAN21;MAX;POU3F1;ZKSCAN1;HOXB2;CEBPB;TBX2;HEYL;SNAI2;EGR2;MTF1;ZNF296;NR1H4;HOXD9;E2F5;HES7;ESR2;SOX7;ZNF32;ZBTB7A;ZNF394;RFX5;MAFF;ZNF395;PAX6;HES6
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.374069209254134,1.0952712499401764,0.30660377358490565,0.6069134872705616,1.0,7/23,12.36%,PLCB1;CHRM3;PLCH2;PLCE1;PLCZ1;PLCD3;F2RL2
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.4429907077037399,-1.0919859224397008,0.37435008665511266,0.5944774680792476,1.0,7/13,30.85%,SLC38A7;SLC7A7;SLC66A1;SLC15A4;SLC7A4;SLC7A2;SLC7A1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.42541943299603957,-1.091801070332069,0.35431654676258995,0.5924218418756985,1.0,6/14,16.95%,OTUD5;MINDY2;USP9X;ATXN3;USP7;MINDY1
prerank,vitamin D receptor binding (GO:0042809),-0.43212685069547674,-1.0916821092189768,0.3454861111111111,0.5902670048639793,1.0,3/14,13.88%,MED24;MED4;RXRA
prerank,peptidase inhibitor activity (GO:0030414),-0.35567242634723395,-1.0907912269212674,0.3254637436762226,0.5898180549191673,1.0,11/33,27.44%,UCHL5;TFPI;PROS1;TIMP2;CAST;CST7;CST3;RENBP;SPINT2;SIMC1;A2M
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.4061847544128768,1.0896737635580624,0.35514018691588783,0.6149807445719817,1.0,5/17,15.15%,DPYD;PECR;DHCR24;DHCR7;DECR2
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.4600850330748998,-1.0894648258715975,0.3610169491525424,0.5906338896230048,1.0,4/11,22.77%,SGMS1;GNPTAB;SAMD8;AASDHPPT
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.47845656706480777,-1.088517703727383,0.37364620938628157,0.5903237053894316,1.0,5/10,16.78%,DSE;RPE;FUOM;GALE;GALM
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.3857822966394092,-1.0853780719732657,0.3396880415944541,0.5955117202432716,1.0,8/24,18.43%,OSBPL8;SNX3;GOLPH3L;OSBPL5;SESTD1;PLA2G4A;ARFIP1;ARFIP2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4534273581359244,1.0830069855894082,0.3691588785046729,0.6261310625858596,1.0,2/10,2.99%,B3GALT1;B3GALT5
prerank,metalloexopeptidase activity (GO:0008235),0.3068251901555459,1.0825853746120293,0.3226600985221675,0.6223966112617967,1.0,11/51,15.18%,METAP2;AGBL4;MMP16;TRHDE;MMP15;AGBL1;CPE;FOLH1;CPA2;METAP1;LTA4H
prerank,retinoid binding (GO:0005501),-0.38462665924773065,-1.0790840411650875,0.3470790378006873,0.6077452181417582,1.0,11/22,33.76%,RXRA;RARA;ABCA4;CYP26C1;RBP4;UGT1A7;UGT1A4;UGT1A6;UGT1A8;UGT1A1;RBP1
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.32269027688820684,-1.078478286260668,0.3300653594771242,0.6069307574582073,1.0,10/47,14.58%,SLC38A6;SLC6A6;SLC43A2;SLC38A10;SLC38A7;SLC7A7;SLC36A4;SLC66A1;SLC7A5;SLC25A44
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.4360711897801696,-1.0783426954978808,0.3612099644128114,0.6048432612641192,1.0,4/13,7.75%,ITGA5;PTPRJ;ERN1;VEGFA
prerank,microtubule motor activity (GO:0003777),-0.317279163662619,-1.0773533264740052,0.32727272727272727,0.6047681730650053,1.0,18/51,17.93%,KIF13B;KIF3B;KIF11;KIF16B;KIF20B;KIF23;KIF15;STARD9;KIF4A;CENPE;DNAH8;KIFC1;KIF14;KIF21B;KIF2C;KIF20A;DNAH3;KIF18B
prerank,calcium channel regulator activity (GO:0005246),0.3292431778271887,1.0752981302982507,0.33756345177664976,0.635581413187927,1.0,5/37,7.31%,NRXN1;PRKG1;NRXN2;NPY2R;CACNG4
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.38697822282292116,-1.072129336884629,0.3584558823529412,0.6147113732877493,1.0,7/20,22.17%,USP50;OTUD5;USP9X;SENP3;USP7;COPS5;EIF3H
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.3550897855454386,-1.0709516154167016,0.3401015228426396,0.6152839770553232,1.0,16/29,38.92%,ACER3;HPSE;GUSB;NEU1;GANC;PGGHG;ADPRS;CTBS;GANAB;ACER2;PARG;GALC;MGAM;CHIT1;LCT;NEU3
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.3554010903538392,-1.0706423194486345,0.3573825503355705,0.6135508380770686,1.0,9/27,21.06%,POLR2F;POLR2L;POLR2A;POLR3B;POLR2G;POLR1F;POLR3A;MED20;POLR2I
prerank,ephrin receptor binding (GO:0046875),-0.38000338125982713,-1.06862154373382,0.375886524822695,0.6160245492978422,1.0,4/21,6.51%,LYN;GRB2;CBL;PIK3CG
prerank,calcium-dependent phospholipid binding (GO:0005544),0.300866563879683,1.067798999694315,0.3508771929824561,0.6495748146028845,1.0,15/49,15.28%,SYT1;PCLO;SYT10;SYT2;CPNE4;SYT5;PLA2G4E;SYT11;SYT12;CPNE8;DYSF;SYT7;CPNE5;MCTP2;RPH3A
prerank,cation transmembrane transporter activity (GO:0008324),-0.3192553167262756,-1.0672245490571508,0.3606010016694491,0.6168438266275512,1.0,12/48,19.13%,SLC38A6;SLC6A6;MFSD12;SLC38A7;SLC36A4;SFXN2;SLC66A1;SLC7A5;SFXN1;SLC6A9;SLC8B1;SLC38A2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.40983983393502477,1.0658025410814338,0.38799076212471134,0.6497046119106733,1.0,3/15,13.15%,SLC26A3;SLC4A11;SLC26A8
prerank,steroid hydroxylase activity (GO:0008395),-0.41298589296813704,-1.0652335611376602,0.3939393939393939,0.619222420653207,1.0,6/16,29.38%,CYP27A1;CH25H;CYP46A1;CYP2R1;CYP1B1;CYP2S1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.46367802006254044,-1.0649161113909855,0.4065180102915952,0.6175596511314488,1.0,7/10,25.47%,PIK3CB;PIK3CG;PIK3CA;PIK3CD;PIK3C2A;ATM;PIK3C2G
prerank,protein tyrosine phosphatase activity (GO:0004725),0.28058582193532433,1.0636332651653317,0.30864197530864196,0.6500037348632665,1.0,16/71,14.68%,PTPRD;PTPRG;PTPRN2;PTPRR;PTPRT;EYA2;PTPRK;PTPN3;TNS2;PTPRB;PTPRZ1;DUSP4;DUSP18;PTPRS;PTPN4;PTP4A3
prerank,"DNA binding, bending (GO:0008301)",-0.426798308751844,-1.0611859751009685,0.39327731092436974,0.623866300235063,1.0,6/14,19.87%,HHEX;TOP2A;HMGB2;TFAM;HMGB3;HMGB1
prerank,tropomyosin binding (GO:0005523),0.3921629467019612,1.0603431871585607,0.37636761487964987,0.6533392718797941,1.0,4/16,11.45%,SMTNL2;NEBL;TNNT2;CALD1
prerank,insulin-like growth factor binding (GO:0005520),-0.4231895038162631,-1.0580351619029444,0.4109347442680776,0.6288399107186998,1.0,7/15,24.12%,INSR;IGF1R;ITGAV;IGF2R;IGFBP3;IGFALS;LRP2
prerank,chemokine receptor activity (GO:0004950),-0.3644305144147606,-1.0570909441395524,0.37061769616026713,0.6286224091444231,1.0,11/24,38.82%,CCR2;CCR1;CCRL2;CXCR4;CMKLR1;GPR17;XCR1;CXCR2;ACKR3;CCR7;CCR9
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.43461357018787206,1.0558166473004875,0.397196261682243,0.6594081791442638,1.0,2/11,1.18%,RYR3;RYR2
prerank,exopeptidase activity (GO:0008238),0.30285535685700304,1.0542740276334979,0.35824175824175825,0.6585828329384837,1.0,5/50,4.17%,DPP10;DPP6;METAP2;MME;TRHDE
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.35435383534880294,-1.053413963094327,0.38275862068965516,0.6353330045202803,1.0,10/29,21.68%,PRKAG2;PKIB;INCA1;SPRY2;SPRED1;SPRED2;CIB1;CDKN2C;HSPB1;SFN
prerank,DNA replication origin binding (GO:0003688),-0.3642516347892716,-1.049988414762542,0.3802559414990859,0.641423770982356,1.0,9/23,24.29%,DHX9;MCM6;MCM9;MCM3;ORC5;KAT7;MCM2;CDC45;MCM5
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.37338127586626413,-1.0474774637788775,0.40325497287522605,0.6449827922733318,1.0,5/22,14.17%,APOE;PICALM;DNAJA1;HSP90B1;ANKRA2
prerank,phosphatase binding (GO:0019902),-0.26843824006308126,-1.045015888407297,0.3836065573770492,0.648670711736074,1.0,20/105,11.65%,IQGAP1;MAP3K5;SNX3;STAT3;CD22;STAT6;MTMR3;MAPK14;TRAF3;MVP;CTNNB1;VRK3;SIRPA;JAK1;CTSC;SPRED1;STYXL1;LCK;PPP6R3;HSP90B1
prerank,leak channel activity (GO:0022840),0.3800815856727656,1.044133736143312,0.3765281173594132,0.678860347652271,1.0,4/18,8.99%,KCNK10;NALCN;KCNK2;TMEM175
prerank,exonuclease activity (GO:0004527),-0.31320827236292914,-1.0439555221937298,0.3904109589041096,0.6489175355538397,1.0,22/46,26.81%,DCLRE1C;RAD1;REXO5;REXO4;ISG20L2;EXOSC5;EXD1;WRN;EXO1;FEN1;APLF;RAD9A;EXOSC10;ENPP1;CPSF3;ZC3H12A;EXOSC4;FAN1;XRN2;DCLRE1B;EXOSC8;MRE11
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.21633587853636188,-1.0434442468796816,0.2953929539295393,0.6477851052856612,1.0,191/831,23.77%,RBPJ;MITF;ZEB2;FOXP1;ELF4;RUNX1;TRPS1;BACH2;TFEB;TCF4;RREB1;REL;LITAF;BCL6;RB1;JUN;ZNF568;ETV6;MEF2A;RUNX3;PPARD;BPTF;BACH1;ZBTB34;NFE2L2;DNMT3A;IRF2;ZNF148;NFIC;NFX1;NFYA;ATF3;ZSCAN12;ELF1;UBP1;PPARG;ELK3;SPI1;GTF2A1;ZNF3;ETV1;STAT3;FOXO3;KLF13;E2F2;LYL1;ZSCAN26;DHX9;IKZF1;STAT6;USF2;NLRC5;NFKB1;HHEX;RUNX2;RARG;IRF5;MLXIP;SARS1;MEF2B;KLF6;MAF;NR1H2;BATF;CUX1;NRF1;TEF;NFATC3;ZBTB2;MYNN;KLF3;STAT5B;STAT4;NR2F1;ATF6;SKI;BHLHE40;E2F1;CEBPG;THAP1;E2F3;WBP2;MEF2D;HIF1A;TFEC;MEF2C;OLIG2;EGR1;ARNT;PROX2;CIART;IKZF3;ZBTB20;XBP1;ZNF319;ZNF569;OSR1;RELA;KLF10;NFE2;PRDM2;SALL3;FOXJ1;ZFP57;FOSL2;TCF7;ZFP41;FOXJ3;SP2;CALCOCO1;DHX36;E2F8;BATF3;RXRA;HDAC5;KLF2;TGIF1;TCF3;NSD1;RELB;TFAP4;ZNF628;YY1;ZBTB46;KLF8;ZNF177;TFCP2;NR4A1;ZBTB12;NRIP1;KLF11;FOXJ2;IRX5;IKZF4;SOX10;ZBTB25;RARA;ZBTB24;TFE3;ATF5;GATA3;MYB;RPS3;SNAPC3;PLAG1;NFATC1;TCF12;NR3C1;GMEB2;MEIS3;HOXD8;SP9;EHF;CASZ1;ZFP28;MAZ;ATF7;CIC;GTF2IRD1;PKNOX1;STAT1;LRRFIP1;ZFP2;ZSCAN21;MAX;POU3F1;ZKSCAN1;HOXB2;CEBPB;TBX2;HEYL;SNAI2;EGR2;MTF1;ZNF296;BARX2;NR1H4;HOXD9;E2F5;HES7;ESR2;SOX7;ZNF32;ZBTB7A;ZNF394;RFX5;MAFF;BBX;ZNF395;PAX6;HES6
prerank,C-C chemokine binding (GO:0019957),-0.36883076358306327,-1.0432120885442904,0.3902027027027027,0.645960736214524,1.0,10/22,38.93%,CCR2;CCR1;CCRL2;CXCR4;XCR1;CXCR2;ACKR3;CCR7;CCR9;ZFP36
prerank,protein tyrosine kinase activity (GO:0004713),-0.2690544132937194,-1.0405325713636062,0.3682539682539683,0.6501431606715045,1.0,27/108,18.56%,LYN;FGR;SYK;AXL;INSR;PEAK1;IGF1R;FES;ABL2;TEC;DYRK2;FLT1;PTK2B;PKDCC;CAMKK2;JAK1;LCK;DYRK1A;ITK;FRK;TXK;TTK;WEE1;ZAP70;HCK;RYK;PDGFRB
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3665918822601065,1.039009958747645,0.3691588785046729,0.6870747139295665,1.0,3/21,3.29%,AKAP6;RYR2;WASF1
prerank,signal sequence binding (GO:0005048),-0.32867827367753566,-1.0388402342770773,0.3765112262521589,0.6516869109999431,1.0,10/35,22.68%,KPNA4;IPO5;BABAM2;TIMM22;KPNA3;BRAP;NUP153;CAT;TOMM70;TOMM20L
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.2765740696167556,1.0377692842998967,0.3623853211009174,0.6853137825409961,1.0,18/72,15.99%,FRMPD4;PLCB1;PARD3;SNAP91;MARK1;TIRAP;PLA2G4E;SNX21;PLCZ1;GSDMD;AMER2;GSN;SYTL2;SYT7;OSBPL2;MYO1B;RPH3A;SNX20
prerank,mRNA 5'-UTR binding (GO:0048027),-0.358086670126305,-1.0376796727404252,0.3873239436619718,0.6520703045469795,1.0,9/24,25.39%,RPS14;RPS13;MRPS11;DHX36;NCL;DDX3X;SHMT1;RPL41;RPL5
prerank,cytokine receptor binding (GO:0005126),-0.2750614854251552,-1.0353604979086828,0.39864864864864863,0.6553549186208452,1.0,27/83,32.70%,SDCBP;SYK;CD300LF;IL6R;PIBF1;IL18;VEGFA;JAK1;SPRED1;SPRED2;CCL5;CCRL2;IL34;IL27RA;CSF1;TNFSF9;IL6;TYK2;KITLG;IL12RB1;IL2;IL27;SMAD2;TRAF6;CCL19;IL13RA1;CCL25
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.4339437221380529,-1.0348914333878592,0.42454394693200664,0.6540171116171195,1.0,5/11,37.86%,PADI4;ARG2;ARG1;AGMAT;PADI1
prerank,ribonuclease P activity (GO:0004526),0.42291419903002675,1.034474678687974,0.41013824884792627,0.6889891180838803,1.0,6/11,21.61%,POP7;RPP25;RPP14;POP4;RPP21;RPP38
prerank,alpha-tubulin binding (GO:0043014),-0.3351016496193633,-1.032500018447158,0.41754385964912283,0.6575045182228207,1.0,8/31,14.82%,ARL8B;ARL8A;EML4;EFHC2;TAOK1;TBCE;RACGAP1;INO80
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.42049351930991713,-1.031414929193771,0.4368421052631579,0.6579126690579198,1.0,7/12,25.47%,PIK3CB;PIK3CG;PIK3CA;PIK3CD;PIK3C2A;ATM;PIK3C2G
prerank,nuclear receptor coactivator activity (GO:0030374),-0.29569188514030365,-1.0306518735269192,0.40635451505016723,0.6573939479451101,1.0,13/52,19.40%,ZMIZ1;PRKCB;SS18;MED24;RNF4;HELZ2;MED4;RBM14;CALCOCO1;ZMIZ2;NCOA6;PPARGC1B;WDR77
prerank,histone deacetylase activity (GO:0004407),-0.384092662626728,-1.0297845567959178,0.43166666666666664,0.6572041018297905,1.0,7/19,23.05%,SIRT3;SUDS3;HDAC10;HDAC5;MIER1;SIRT2;HDAC8
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.4264909453502863,1.028083439603541,0.42206235011990406,0.70039687891734,1.0,2/11,2.25%,TRPC5;TRPC1
prerank,methylated histone binding (GO:0035064),-0.29195514670506373,-1.0279522212189223,0.400329489291598,0.6594319140044462,1.0,21/62,27.20%,BPTF;NCAPG2;KDM7A;DPF2;WDR5;MORC3;SPIN1;TRIM24;UHRF1;CHD8;NCAPD3;LRWD1;CXXC1;ZMYND8;PHF13;MORC4;RRP8;CDYL;RBBP5;CBX8;CBX2
prerank,translation elongation factor activity (GO:0003746),-0.4070657559650381,-1.0264806206399124,0.4375,0.6607259086688979,1.0,6/14,18.30%,TUFM;EEF1B2;EEF2;GTPBP1;EEF1A1;GTPBP2
prerank,single-stranded RNA binding (GO:0003727),-0.31180920787858835,-1.02647773143896,0.40854700854700854,0.6583867848657089,1.0,13/43,20.47%,TLR8;AGO2;TLR7;DHX58;DHX9;DDX60;CNBP;PUS1;POLR2G;HNRNPA1;EXOSC10;DDX3X;RBM11
prerank,TBP-class protein binding (GO:0017025),-0.37146159002976675,-1.0261494626219199,0.444636678200692,0.6568095921873711,1.0,13/21,45.16%,GTF2A1;HHEX;AHR;DR1;GTF2A2;DRAP1;ESR1;YEATS2;RUVBL2;PSMC1;TAF1B;TAF13;PSMC2
prerank,general transcription initiation factor binding (GO:0140296),-0.359231637002235,-1.026106226287794,0.43327556325823224,0.6545815510730862,1.0,15/25,45.16%,GTF2A1;HHEX;AHR;RELA;DR1;GTF2A2;DRAP1;ESR1;THAP7;YEATS2;RUVBL2;PSMC1;TAF1B;TAF13;PSMC2
prerank,mRNA 3'-UTR binding (GO:0003730),-0.27604286256683785,-1.0259161100632899,0.3873720136518771,0.6527066318716103,1.0,29/79,26.79%,RBMS1;RC3H1;RNF20;SECISBP2;PUM2;LARP4B;LARP4;DDX5;NUDT21;CELF1;BOLL;DHX36;RBMS2;DAZAP1;RNPS1;CPEB4;ZC3H12A;EXOSC4;PABPC1L;PCBP4;PUM1;RPL41;TARDBP;CPSF1;ANGEL2;RNF40;RPL5;ZFP36L1;EXOSC8
prerank,neuropeptide receptor binding (GO:0071855),0.3939407591056617,1.0247906574338692,0.4158878504672897,0.7037638432962783,1.0,3/14,12.38%,APLN;GHRH;NTS
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.2969525536794622,1.0232250248364951,0.3990498812351544,0.7029124642910369,1.0,5/46,3.99%,MGAT4C;B3GALT1;B3GALT5;HEXB;MGAT3
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.3080573644560099,1.018487740552495,0.4360730593607306,0.7103671436704126,1.0,6/38,11.96%,SPOCK1;SERPINI1;SERPING1;SERPINB5;WFDC3;SERPINE3
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.3328338194001691,-1.0170740073829567,0.4420529801324503,0.6714703496126517,1.0,8/31,16.45%,BIRC6;UBE2R2;UBE2L3;UBE2H;UBE2T;UBE2G1;CDC34;UBE2C
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.40178001366477956,1.0170103324517619,0.4331065759637188,0.7092613056678903,1.0,3/12,5.16%,BMPR1B;ACVR1;LTBP1
prerank,microtubule minus-end binding (GO:0051011),-0.41565962270690743,-1.0161972850533971,0.445578231292517,0.6711796234440621,1.0,7/13,27.11%,MACF1;TUBGCP4;HAUS4;HAUS7;CAMSAP2;CAMSAP1;TUBGCP2
prerank,galactosyltransferase activity (GO:0008378),-0.4315311998337482,-1.0157408932172656,0.46619217081850534,0.6699459299355934,1.0,4/11,19.95%,B4GALT5;B4GALT7;B4GALT3;B4GALT1
prerank,methylation-dependent protein binding (GO:0140034),-0.28971913457862525,-1.0157321922599576,0.4297385620915033,0.6676353419162285,1.0,20/57,27.20%,BPTF;NCAPG2;KDM7A;WDR5;MORC3;SPIN1;TRIM24;UHRF1;CHD8;NCAPD3;LRWD1;CXXC1;ZMYND8;PHF13;MORC4;RRP8;CDYL;RBBP5;CBX8;CBX2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.43083303406629037,1.0144278387787697,0.4236111111111111,0.7108229038369613,1.0,4/10,13.20%,IDE;ANKRD13A;FAAP20;DNAJB2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.38641381164541827,1.0121079755313194,0.4361948955916473,0.7118517529726713,1.0,6/14,16.37%,CAPN3;CAPN10;CAPN6;CAPNS2;CAPN2;CAPN5
prerank,NADP binding (GO:0050661),0.31492003496791526,1.0120205742405044,0.4224343675417661,0.707379998431742,1.0,14/32,24.26%,CRYZ;DPYD;ME3;DHCR7;HSD11B1;DHFR;ME1;CRYZL1;DUS2;KCNAB1;GMDS;GRHPR;NOS1;DECR1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.32311659146978633,-1.0108927548896351,0.44193548387096776,0.6769905205733208,1.0,9/34,17.22%,BIRC6;UBE2R2;UBE2L3;UBE2H;UBE2T;UBE2G1;CDC34;UBE2C;UBE2I
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.4268570682188097,1.009620727940507,0.4396355353075171,0.7089516648369425,1.0,3/11,22.12%,PPP1R14C;PABIR1;PPP1R17
prerank,insulin-like growth factor I binding (GO:0031994),-0.4167788986379549,-1.0088175838339042,0.455026455026455,0.6797309374536422,1.0,3/13,4.86%,INSR;IGF1R;ITGAV
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.3865243388872668,-1.0077036678946232,0.44839255499153974,0.6800682057251441,1.0,7/16,18.94%,CD38;MACROD1;NEIL3;BST1;NEIL2;RPS3;ADPRS
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.41661645632573996,1.0067766820484303,0.4315068493150685,0.7115014591454455,1.0,2/11,9.26%,HCN2;HCN1
prerank,protein tyrosine kinase binding (GO:1990782),-0.2741786557537422,-1.0035981368434457,0.4540983606557377,0.6872222742062939,1.0,18/71,14.41%,NEDD9;BANK1;CBL;RNF41;ITGB1;BLNK;PITPNM1;DUSP3;GAS6;SIRPA;FIZ1;ANGPT2;ITGAX;CRK;PCNA;CPNE3;TJP2;CBLB
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.34779107091731254,-1.0001488243844256,0.4473684210526316,0.6933053151922279,1.0,3/26,4.09%,SLC16A7;SLC6A6;SLC27A1
prerank,kinesin binding (GO:0019894),-0.3369902481673083,-0.9976675173428159,0.4852173913043478,0.6972204040313695,1.0,10/27,20.17%,PLEKHM2;ACTB;ARHGEF10;AP1G1;NEK6;RAB29;SPAG9;KIF18B;FAM83D;PRC1
prerank,receptor tyrosine kinase binding (GO:0030971),-0.2842996472161164,-0.997531218022803,0.4540901502504174,0.6952046447191023,1.0,14/56,12.46%,GAB2;CBL;RNF41;BLNK;STAP1;PITPNM1;DUSP3;GAS6;FIZ1;FRS2;ANGPT2;ITGAX;PCNA;CPNE3
prerank,FMN binding (GO:0010181),-0.421999842619333,-0.9960903979334554,0.46572934973637964,0.6963710443988292,1.0,6/11,39.04%,POR;PNPO;NDOR1;NOS2;HAO1;PPCDC
prerank,sulfotransferase activity (GO:0008146),0.30747479073163964,0.9959062979100164,0.43707093821510296,0.7340900999986832,1.0,8/33,13.88%,GAL3ST3;HS3ST1;CHST5;CHST7;CHST8;CHST9;CHST14;SULT4A1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.41861911943807745,0.994849087016323,0.4891566265060241,0.732246931002544,1.0,4/10,20.62%,SLC6A1;SLC6A13;SLC6A11;SLC10A1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.32015459587462697,-0.9911284589696507,0.4817391304347826,0.7060901966302731,1.0,18/34,34.79%,NSD3;SMYD2;SMYD3;EZH2;KMT5B;SMYD1;SETDB1;DOT1L;KMT5A;EEF2KMT;SETD6;METTL21A;TTLL12;SETD7;ETFBKMT;SETD2;ANTKMT;SETD4
prerank,signaling receptor complex adaptor activity (GO:0030159),0.29639276943320264,0.9901488524984998,0.4607594936708861,0.7387443410770056,1.0,3/38,0.79%,MAGI2;SORBS1;GRIP1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.3165169344055916,-0.9901354572790202,0.4696969696969697,0.7062180902585183,1.0,15/37,34.07%,RARS1;FARS2;SARS1;CARS2;DARS1;KARS1;TARS2;AARS1;DARS2;IARS1;EARS2;TARS3;WARS2;VARS2;RARS2
prerank,telomerase RNA binding (GO:0070034),-0.35036075873698264,-0.9862111282978426,0.46048109965635736,0.7128994649594165,1.0,7/22,18.67%,TEP1;DCP2;DHX36;GAR1;TENT4B;WRAP53;EXOSC10
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.40503313186758605,-0.980858803449543,0.4827586206896552,0.7232584420669762,1.0,3/12,15.76%,DDI2;CTSE;HM13
prerank,kinase activity (GO:0016301),-0.24850103645817503,-0.979963953489343,0.5125208681135225,0.7229988702059761,1.0,28/109,20.07%,LYN;ITPKB;CSNK2A1;PANK2;DGKZ;NADK;PIK3CB;PIK3CG;PI4KB;DGKD;COQ8A;MASTL;POMK;TAOK1;PIK3CA;SEPHS1;PRKD3;PIK3CD;PIK3C2A;PAPSS1;DGKG;NADK2;PDXK;SPHK2;PGK1;IP6K3;GSK3B;NMRK1
prerank,channel activity (GO:0015267),-0.29822648039543326,-0.978782297292837,0.4958263772954925,0.7233867090976976,1.0,10/41,28.45%,BCL2;MCUB;PANX1;TMEM120B;MPV17;KCNK3;TRPV2;PRF1;PDPN;AQP1
prerank,microtubule plus-end binding (GO:0051010),0.3464162642064203,0.9775480682214253,0.4610091743119266,0.7659718664728259,1.0,4/20,6.98%,MAPRE3;DST;CLASP2;CLIP4
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.4055318409802829,-0.9765358400459071,0.4809688581314879,0.7263355038812557,1.0,7/12,31.76%,TENT5A;MTPAP;TENT4B;TENT5C;PAPOLA;TENT5D;TUT1
prerank,protein phosphatase 2A binding (GO:0051721),0.3279583565302523,0.9753341143956819,0.5228310502283106,0.7668753037737364,1.0,4/23,8.64%,ADCY8;GRIN3A;BOD1;SMG5
prerank,snRNA binding (GO:0017069),-0.29659777840087764,-0.9749077472553546,0.528695652173913,0.7278601934581329,1.0,20/42,41.76%,SNRNP35;COIL;SF3B3;PRPF8;SNRPA;SART3;SNRNP70;SNU13;RBM22;DDX39B;LARP7;ISG20;TUT1;SNRPA1;LSM8;SNRPD3;DDX21;MEPCE;RBM41;NCBP2
prerank,O-acyltransferase activity (GO:0008374),0.30587576659313415,0.973991232173056,0.5071428571428571,0.7657638115956693,1.0,7/30,14.52%,MOGAT3;LPCAT2;GPAM;MBOAT2;DGAT2L6;GPAT3;SOAT1
prerank,gamma-tubulin binding (GO:0043015),0.33558377695270525,0.9731244835110027,0.4693396226415094,0.7632685153498762,1.0,11/21,21.66%,ARHGEF7;BRSK1;CDK5RAP2;NDRG1;TUBGCP5;RAD51D;DIXDC1;TUBGCP3;B9D2;PAK1;BRCA2
prerank,nucleotidyltransferase activity (GO:0016779),-0.365083056560689,-0.9721620175216819,0.506108202443281,0.7319038108418736,1.0,6/19,17.48%,CGAS;TUT7;MTPAP;MOCS3;PAPSS1;TENT4B
prerank,cytochrome-c oxidase activity (GO:0004129),-0.37885207511234853,-0.9702429801334533,0.5043478260869565,0.7340412744396233,1.0,7/15,27.79%,COX4I1;COX10;COX8A;NDUFA4;CYB5A;COX5A;COX6A2
prerank,ATPase binding (GO:0051117),-0.2694292617944801,-0.9685428847737462,0.5034013605442177,0.7357851486953624,1.0,18/71,17.19%,ABCA1;SNX10;ATP6V1E1;TCIRG1;PEX26;ATP1B3;NR1H2;ATXN3;WFS1;SELENOS;ATP6V1G1;LCK;DERL1;BBC3;TOR1AIP1;NUFIP1;TAF9;RALB
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.33676329118504433,-0.9681202269061608,0.5084745762711864,0.7343979214298386,1.0,5/23,10.68%,SH3PXD2B;SNX3;KIF16B;HIP1;SESTD1
prerank,serine-type peptidase activity (GO:0008236),-0.2544904038223715,-0.9676605310024192,0.5040783034257749,0.7332170884869822,1.0,31/96,29.32%,PLAU;DPP4;PREP;HGF;PCSK7;RHBDF1;RHBDF2;CTSH;KLK3;PRSS36;F7;FAP;HTRA3;CD5L;TPP1;MMP8;GZMM;F10;RHBDD3;MMP2;HPR;HP;MASP1;FURIN;PRTN3;TMPRSS7;ACR;F11;GZMK;PRSS53;KLK9
prerank,aminopeptidase activity (GO:0004177),0.3156106488193581,0.9666594004340388,0.5045454545454545,0.7751604371400816,1.0,4/26,5.63%,METAP2;MMP16;TRHDE;MMP15
prerank,growth factor receptor binding (GO:0070851),-0.2516533884802641,-0.9633600803196924,0.5326633165829145,0.7411357499382007,1.0,12/95,8.46%,GRB2;SDCBP;SNX2;ITGA5;PTPRJ;ERN1;CD300LF;IL6R;PIBF1;HIP1;VEGFA;FRS2
prerank,tau protein binding (GO:0048156),-0.2946324976378423,-0.9598890659332394,0.5041876046901173,0.747234538349246,1.0,10/40,13.95%,APOE;ROCK1;ACTB;PICALM;PIN1;TAOK1;DYRK1A;DCTN1;HSP90AB1;MARK2
prerank,calcium channel inhibitor activity (GO:0019855),-0.4034536281430713,-0.9582486413102516,0.5257048092868989,0.7489957041993969,1.0,2/11,5.34%,ITPR1;MCUB
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.37422115869186984,-0.9563467865828321,0.534453781512605,0.7512120902884705,1.0,4/15,15.04%,SH3PXD2B;SNX3;SESTD1;PLA2G4A
prerank,palmitoyltransferase activity (GO:0016409),-0.3195457757897239,-0.9549718497721268,0.5254833040421792,0.752127097485202,1.0,10/28,24.98%,ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;ZDHHC1;ZDHHC5;GOLGA7;HHAT;ZDHHC13;ZDHHC6
prerank,actin binding (GO:0003779),-0.2291882076180555,-0.9528974606787656,0.6074766355140186,0.754644678113755,1.0,49/170,23.06%,IQGAP2;MTSS1;MYH9;PHACTR2;MYO9B;MYO1F;EPS8;CAPZB;GAS2L3;FXYD5;ABL2;PARVB;ITGB1;MACF1;CAP1;UTRN;NRAP;LCP1;LIMA1;CORO7;MSRB1;CCDC88A;MICAL1;MAEA;SSH3;ARPC1A;MICAL2;CAPZA1;SPEF1;MAP1S;COTL1;TMSB4X;SSH1;CXCR4;TWF2;ANG;NOD2;SYNPO;TNNT3;PDLIM2;MYL4;RUSC1;PDLIM5;FLII;PHACTR4;P4HB;PDLIM1;MEFV;HPCA
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.2386220727450254,-0.9515589678172821,0.5666131621187801,0.755267249046183,1.0,53/134,34.77%,SLC16A7;SLC38A6;CD36;SLC6A6;MFSD12;SLC27A1;SLC25A24;SLC35D2;SLC38A7;SLC36A4;CTNS;SFXN2;SLC25A25;SLC25A42;ABCC1;SLC66A1;ABCC4;SLC7A5;SFXN1;SLC23A1;SLC23A2;SLC6A9;SLC6A8;SLCO5A1;SLC38A2;SLC16A1;SLC25A22;SLC52A2;SLC25A13;SLC15A4;SLC35B3;SLC17A9;SLC22A3;SLC25A18;SLC52A1;PDPN;SLC4A1;SLC35B1;SLC26A4;SLC2A2;SLC7A2;SLC4A8;SLC7A1;SLC36A3;SLCO1B1;SLC19A1;GJA1;SLC25A17;SLC26A7;SLC38A9;SLC25A1;SLC7A8;SLC2A6
prerank,protein kinase inhibitor activity (GO:0004860),-0.29130789354646264,-0.9512155569419369,0.5202108963093146,0.7535830508733432,1.0,15/42,26.65%,TAOK3;IBTK;TRIB1;SPRY2;SPRED1;SPRED2;CIB1;GMFG;GMFB;DNAJC3;SOCS3;RACK1;ITPRIP;SH3BP5;NCK1
prerank,transforming growth factor beta binding (GO:0050431),-0.33684328652274254,-0.947689641531422,0.5329949238578681,0.7591869162130661,1.0,7/23,16.99%,CD36;NRROS;ITGAV;TGFBR1;LTBP4;TGFBR2;VASN
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.4056149392529037,-0.9471223458300234,0.5168738898756661,0.7582900019288168,1.0,4/11,17.03%,SLC5A11;SLC5A3;SLC23A1;SLC23A2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.30760695936000243,0.9412804780765622,0.5164319248826291,0.8351160449482341,1.0,6/29,13.15%,SLC1A6;SLC26A3;SLC1A1;SLC13A5;SLC25A11;SLC26A8
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.4063864914529846,-0.938429481339914,0.542907180385289,0.7765993157715484,1.0,4/10,17.00%,OTUD5;ATXN3;OTUD4;STAMBPL1
prerank,kinase inhibitor activity (GO:0019210),-0.3000955792799714,-0.9372389800508262,0.5432525951557093,0.7770659661939766,1.0,10/33,26.65%,TAOK3;LRP6;TRIB1;GMFG;GMFB;DNAJC3;SOCS3;ITPRIP;SH3BP5;NCK1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",-0.26254050149969993,-0.9351873409669431,0.5947368421052631,0.7794314727973713,1.0,25/69,30.49%,CREBBP;ZDHHC7;ZDHHC8;ZDHHC2;DGAT1;ZDHHC12;PLAAT3;PLA2G4A;MCAT;PLAAT1;ZDHHC1;LPCAT3;ZDHHC5;ESCO2;NAA16;HHAT;ZDHHC13;NMT1;ZDHHC6;CERS3;PLA2G15;SCP2;EP300;LPCAT4;AWAT2
prerank,filamin binding (GO:0031005),0.387620201146293,0.934761086005813,0.513126491646778,0.8469598933254996,1.0,5/11,11.94%,NEBL;TMEM67;SYNPO2;DPYSL4;DPYSL3
prerank,histone acetyltransferase activity (GO:0004402),-0.3095426296088859,-0.9334675217755112,0.5801801801801801,0.7810503399501396,1.0,7/30,16.90%,CREBBP;ARRB1;NAA50;BAZ1A;KAT7;EPC1;TAF9
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.3286797975181379,0.9330458990059912,0.5523114355231143,0.8462918338922762,1.0,4/21,15.95%,GRIK2;CHRNA5;CHRNA7;P2RX6
prerank,phospholipase activity (GO:0004620),0.25124209040705336,0.9316589992199638,0.5764705882352941,0.844961916491921,1.0,9/67,6.75%,PLCL1;ENPP2;PITPNM3;ABHD16A;ABHD3;GDPD1;PLCE1;FAM83B;PLA2G4E
prerank,glutathione transferase activity (GO:0004364),0.3131079726405705,0.9283365246850872,0.5482456140350878,0.848584916786781,1.0,8/23,22.60%,GSTZ1;GSTP1;GSTK1;GSTM5;LANCL1;GSTA4;GSTT1;GSTT2
prerank,tau-protein kinase activity (GO:0050321),-0.3379333267024246,-0.9282005796124668,0.568760611205433,0.7906734290652904,1.0,10/20,27.32%,ROCK1;PHKG2;TAOK1;DYRK1A;MARK2;TAOK2;GSK3B;CDK5;SIK3;MARK4
prerank,dynactin binding (GO:0034452),0.3824683685225992,0.926690226834547,0.5635103926096998,0.8478208587269078,1.0,3/12,7.11%,BICD1;BICDL1;HOOK3
prerank,gap junction channel activity (GO:0005243),0.31955342481837284,0.9261891269054173,0.5654205607476636,0.8440379454512718,1.0,6/22,16.25%,GJC3;GJC2;GJC1;GJD3;PANX2;GJD2
prerank,ubiquitin-dependent protein binding (GO:0140036),0.39013134185203846,0.9260358173988122,0.5296703296703297,0.8394307515579336,1.0,4/10,13.20%,IDE;ANKRD13A;FAAP20;DNAJB2
prerank,FAD binding (GO:0071949),-0.32023686647334754,-0.9250792103066553,0.5581395348837209,0.79546987176524,1.0,9/24,26.17%,CYB5R1;CYB5R3;KMO;MICAL1;MICAL2;MTHFR;CYB5R2;QSOX1;NQO2
prerank,MAP kinase kinase activity (GO:0004708),0.34561098883788,0.9248049291008529,0.5424528301886793,0.8377429108714733,1.0,4/15,5.90%,MAPK10;PAK3;MAP2K6;MAP2K7
prerank,sialyltransferase activity (GO:0008373),0.3196206782727946,0.9247671178298444,0.5523385300668151,0.8329480787280144,1.0,8/20,20.07%,ST8SIA2;ST8SIA3;ST6GAL2;ST6GALNAC3;ST3GAL6;ST8SIA5;ST8SIA1;ST6GALNAC5
prerank,nuclear export signal receptor activity (GO:0005049),-0.3939793247756277,-0.9245526505212853,0.5736301369863014,0.7942672806907314,1.0,3/11,10.17%,NUP42;XPO6;XPO5
prerank,BMP binding (GO:0036122),-0.38952143787733184,-0.9238524264163228,0.5570934256055363,0.7934818960522163,1.0,4/11,26.92%,GREM1;BMPR2;GREM2;ENG
prerank,UDP-glycosyltransferase activity (GO:0008194),0.2450514995408082,0.9199527429888296,0.625974025974026,0.8398242898157194,1.0,5/70,3.46%,MGAT4C;B3GALT1;CHSY3;B3GALT5;HEXB
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.3270093047455293,0.9190890628256115,0.5384615384615384,0.8372695375368626,1.0,5/20,14.97%,MOGAT3;LPCAT2;AGPAT3;GPAT3;AGPAT2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.2787821501208494,-0.917046356392772,0.6070796460176991,0.8066045957265215,1.0,13/42,24.84%,CCNL1;CCND3;CCNY;INCA1;CCNL2;CCNE1;CDKN2C;CNPPD1;CCNK;CCNF;CCNB1;CKS2;CCNB2
prerank,poly(A) binding (GO:0008143),-0.32767260836418866,-0.9167837400050196,0.612280701754386,0.8047366464470618,1.0,7/21,15.37%,RBMS1;RBPMS;HNRNPDL;LARP4;ZC3H14;RBMS2;DDX1
prerank,chloride transmembrane transporter activity (GO:0015108),0.3500458499308867,0.9141052176969985,0.5602836879432624,0.8443204806581837,1.0,4/16,13.15%,SLC26A3;SLC1A1;SLC12A5;SLC26A8
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.34599302952114447,-0.9136462071653988,0.5951940850277264,0.8093388977906636,1.0,13/17,42.96%,ACOT9;ACOT13;ACAA2;ACOT2;ACOT4;PLA2G6;PPT1;ACOT11;ACOT6;BAAT;ACSBG2;THEM4;ACOT1
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.24392667440600202,-0.913451110782308,0.6132231404958678,0.8073356947683511,1.0,24/85,26.49%,LIPA;AOAH;ABHD12;PAFAH2;DAGLB;LPL;PNPLA7;ABHD5;PLAAT3;PLA2G4A;PON2;PLA2G7;PGLS;TARS2;PLAAT1;PLA2G12A;AARS1;PLA2G6;LYPLA1;PGAP1;LIPE;PON3;ESD;PLA2G15
prerank,chloride channel inhibitor activity (GO:0019869),-0.4026458934639535,-0.9133742342022314,0.5985790408525755,0.8050819413330634,1.0,2/10,5.23%,STX7;STX8
prerank,NAD binding (GO:0051287),-0.30621741297044297,-0.9101796736962624,0.5859106529209622,0.809821805671903,1.0,7/26,20.16%,ZC3HAV1;SIRT3;PARP9;SORD;QDPR;NNT;SIRT2
prerank,potassium ion leak channel activity (GO:0022841),0.34983595141464735,0.909533631551033,0.5817307692307693,0.850274425512033,1.0,3/15,8.99%,KCNK10;KCNK2;TMEM175
prerank,ion gated channel activity (GO:0022839),0.3107207504056992,0.9091261719520128,0.6,0.8463246755005511,1.0,4/24,7.90%,KCNT2;ANO4;ANO3;ANO5
prerank,pre-mRNA binding (GO:0036002),-0.3065186784720531,-0.9088216318579114,0.5728813559322034,0.8106181621535515,1.0,8/28,19.24%,TRA2B;HNRNPL;DDX5;PRPF8;CELF1;ZRSR2;HNRNPA1;SLU7
prerank,sodium:proton antiporter activity (GO:0015385),-0.38388569192205807,-0.9076904958492336,0.5976027397260274,0.8107299087768582,1.0,3/11,9.34%,SLC9A9;SLC9A8;SLC9A1
prerank,water transmembrane transporter activity (GO:0005372),0.36635191911373866,0.9065871562085455,0.5552941176470588,0.8474026191680947,1.0,3/11,20.20%,SLC4A11;AQP11;AQP4
prerank,endopeptidase inhibitor activity (GO:0004866),-0.24409708114952464,-0.9060118817946601,0.6611295681063123,0.8120475043076799,1.0,16/82,14.94%,ROCK1;BIRC6;GAPDH;ANXA2;UCHL5;TFPI;PROS1;TIMP2;BST2;CAST;SERPINB9;APP;AGT;SERPINE1;CST7;CST3
prerank,cardiolipin binding (GO:1901612),0.3831744309004953,0.9052144990358503,0.5898617511520737,0.8457408235788509,1.0,2/10,10.87%,MME;GSDMD
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.3009472465844029,-0.9051615018884015,0.6037414965986394,0.8116466673983742,1.0,8/28,17.34%,MAPKAPK3;SGK1;MAPK14;MAP2K5;MAP2K1;TTK;MAP2K3;AURKA
prerank,carboxypeptidase activity (GO:0004180),-0.2855617138622899,-0.903463496949187,0.6292517006802721,0.8130537347037488,1.0,4/35,5.65%,CTSZ;PEPD;CTSA;MINDY2
prerank,U6 snRNA binding (GO:0017070),-0.35763249842412326,-0.9034007777021188,0.5611510791366906,0.8108038467530347,1.0,7/14,34.98%,PRPF8;SART3;RBM22;DDX39B;LARP7;TUT1;LSM8
prerank,glucose transmembrane transporter activity (GO:0005355),0.32934368619464494,0.9002516845938124,0.6031746031746031,0.8529349713486877,1.0,3/17,10.02%,SLC2A5;MFSD4A;SLC5A10
prerank,CoA-ligase activity (GO:0016405),0.34959548141662355,0.8988508982045381,0.5833333333333334,0.8514721691302046,1.0,4/14,20.43%,SLC27A2;ACSS2;ACSM3;ACSS1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.3177273584204191,0.897667313237743,0.5960264900662252,0.8494764838032798,1.0,1/20,0.06%,DLG2
prerank,snoRNA binding (GO:0030515),-0.2951468778147615,-0.8973011650418072,0.6139455782312925,0.8217440087407206,1.0,17/30,40.34%,NOP14;DHX37;GAR1;NUFIP1;UTP6;SNU13;PRKDC;NHP2;NUDT16;IMP4;WDR3;ISG20;TBL3;NUDT1;BMS1;DDX21;NUDT5
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.37755624023779777,-0.8961318683142016,0.6112084063047285,0.8196196640656381,1.0,6/11,32.08%,SIL1;HSPH1;BAG3;GRPEL2;PFN1;HSPBP1
prerank,adenyl nucleotide binding (GO:0030554),-0.37755624023779777,-0.8961318683142016,0.6112084063047285,0.8196196640656381,1.0,6/11,32.08%,SIL1;HSPH1;BAG3;GRPEL2;PFN1;HSPBP1
prerank,symporter activity (GO:0015293),0.3695304082789047,0.8922055529673153,0.5933806146572104,0.8572064208331887,1.0,2/10,11.01%,SLC4A4;MFSD2A
prerank,glucuronosyltransferase activity (GO:0015020),-0.3242166711474046,-0.8903022256356509,0.6284722222222222,0.829870051002079,1.0,1/19,0.08%,EXT1
prerank,serine-type endopeptidase activity (GO:0004252),-0.24089170486859765,-0.8898518987961717,0.6722129783693843,0.8284562473791011,1.0,26/80,29.32%,PLAU;DPP4;HGF;PCSK7;RHBDF1;RHBDF2;CTSH;KLK3;PRSS36;F7;FAP;CD5L;MMP8;GZMM;F10;RHBDD3;MMP2;HPR;HP;MASP1;FURIN;PRTN3;ACR;F11;PRSS53;KLK9
prerank,NF-kappaB binding (GO:0051059),-0.307414182901674,-0.8878790097082492,0.6294326241134752,0.8302790613646323,1.0,10/24,30.78%,ANXA4;RELA;RNF25;TAF4B;FAF1;GSK3B;SETD6;MTDH;EP300;BCL10
prerank,disordered domain specific binding (GO:0097718),-0.30987627103116694,-0.8868399151774432,0.6294416243654822,0.8299715236207972,1.0,8/23,21.66%,RB1;GAPDH;FN1;HSP90AB1;HSPA1A;HSPA2;PPIL1;BCL2L2
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.37006158454049476,-0.8863406950882781,0.6224489795918368,0.8286575585926415,1.0,2/12,13.94%,AGO2;NCBP1
prerank,pyridoxal phosphate binding (GO:0030170),0.3069311878296076,0.885327583524945,0.6128266033254157,0.8683558086887955,1.0,11/20,27.15%,GLDC;ABAT;PSAT1;CTH;CBS;THNSL2;ACCS;SHMT2;PLPBP;SDS;PYGM
prerank,gated channel activity (GO:0022836),-0.3571891184640197,-0.88511927182789,0.6303571428571428,0.8288293303040051,1.0,3/14,10.10%,PIEZO1;PACC1;TMC6
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.28459669997885034,0.881725855380997,0.6108374384236454,0.8716876928846629,1.0,7/27,13.97%,ZMYM2;RNF144A;UBE3D;SIAH3;RNF217;DCUN1D2;PRKN
prerank,fatty acid synthase activity (GO:0004312),0.36929448033006584,0.8813524990115658,0.6292682926829268,0.8678513018332286,1.0,4/10,23.00%,ELOVL7;ELOVL6;ELOVL2;OXSM
prerank,actin monomer binding (GO:0003785),-0.31547081835819524,-0.8790271821461979,0.6352313167259787,0.8390994050695381,1.0,6/22,21.34%,MTSS1;ABL2;LIMA1;TMSB4X;TWF2;MYL4
prerank,protein phosphatase regulator activity (GO:0019888),0.24651308223279822,0.8780962259222711,0.6683417085427136,0.8706113230494742,1.0,11/53,13.42%,PPP2R2B;RCAN2;PTN;BOD1;PPP2R1B;PPP2R2A;PPP1R16B;CALM1;CALM3;CALM2;PPP4R4
prerank,lysophospholipase activity (GO:0004622),0.31744562490608,0.8774010505671448,0.6612529002320185,0.8675839679347412,1.0,3/20,6.16%,ENPP2;ABHD16A;GDPD1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.32454441565743597,0.8767544581264275,0.6036036036036037,0.8644231653753403,1.0,4/16,11.39%,SLC1A6;SLC1A1;SLC13A5;SLC25A11
prerank,histone methyltransferase binding (GO:1990226),-0.3771028996086346,-0.8755009202468972,0.631578947368421,0.8439705380107415,1.0,3/11,19.41%,CTNNB1;HSP90AB1;LCORL
prerank,muscle alpha-actinin binding (GO:0051371),0.3298864795147694,0.8747792699541997,0.6112359550561798,0.8639385713023867,1.0,5/15,17.51%,PRICKLE4;SYNPO2;TTN;PDLIM4;PDLIM7
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.3358766889689439,0.8746162170796145,0.5995370370370371,0.8597200899193612,1.0,6/14,21.61%,POP7;RPP25;RPP14;POP4;RPP21;RPP38
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.38265575430215265,-0.8744050610349814,0.6558219178082192,0.843979349071549,1.0,2/10,7.70%,KDM7A;KDM2A
prerank,calcium-release channel activity (GO:0015278),-0.327527699112078,-0.8723841284345037,0.655536028119508,0.8456415378446158,1.0,4/17,6.50%,RASA3;ITPR1;MCOLN2;MCOLN3
prerank,phosphatase activator activity (GO:0019211),-0.3390324796668086,-0.8711155284425988,0.6410714285714286,0.8457845189779517,1.0,7/14,27.04%,FRS2;PHACTR4;PPP2R5B;GTF2F1;PPP2R5A;BMP2;PPP2R5E
prerank,hexose transmembrane transporter activity (GO:0015149),0.3504535786497144,0.8684471098735592,0.6332574031890661,0.8684506353648026,1.0,2/12,6.73%,SLC2A5;MFSD4A
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.3340316672554373,-0.8682903726830201,0.6627118644067796,0.8464334269114172,1.0,3/16,7.94%,ANO6;TTYH3;TTYH2
prerank,intracellular chloride channel activity (GO:0061778),-0.3340316672554373,-0.8682903726830201,0.6627118644067796,0.8464334269114172,1.0,3/16,7.94%,ANO6;TTYH3;TTYH2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.3054946078776949,-0.868093899670193,0.6637781629116117,0.8444206737599551,1.0,13/22,34.42%,OPTN;TAB2;RNF169;MINDY2;PRPF8;PARP10;ZRANB1;ZRANB3;UIMC1;ZBTB1;SQSTM1;TAB3;IKBKE
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.2517102451879394,-0.8625565733250663,0.6939443535188216,0.8532911185585866,1.0,16/54,29.51%,ACER3;DARS1;SUDS3;KLK3;TGM2;HDAC10;HDAC5;MIER1;SIRT2;ASAH1;AMDHD2;HDAC8;UPB1;AGA;ACR;NADSYN1
prerank,G protein-coupled receptor binding (GO:0001664),-0.21604124633088817,-0.8608322168332155,0.8051529790660226,0.8543272121171572,1.0,40/132,28.47%,SDCBP;ZNRF3;GNAI3;PDCD6IP;FLNA;GNA12;ARRB2;GRK3;GNA15;ARRB1;LRP6;GNA11;DNAJA1;GNA13;ARHGEF11;CCL5;CCRL2;CALCA;RNF43;GNA14;GPRC5B;HSPA1A;RYK;RSPO1;C1QBP;WNT3;SFRP1;S1PR2;NPB;DVL2;ADM;CCDC88C;WNT7B;FZD1;FZD7;HSPA8;PPY;WNT6;UTS2B;GHRL
prerank,phospholipase A2 activity (GO:0004623),-0.29037738624981513,-0.8594014191330926,0.6994906621392191,0.8547624739080822,1.0,13/26,37.40%,PLAAT3;PLA2G4A;PLA2G7;PLAAT1;PLA2G5;PLA2G12A;PLA2G6;PNPLA8;PLA2G15;PLA2G3;PLA2G4B;PLB1;PLAAT5
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.3138166491589764,0.8546544555237947,0.6572890025575447,0.8930619569311128,1.0,3/18,5.16%,BMPR1B;ACVR1;LTBP1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.3608024432580319,-0.8537776187994447,0.6705107084019769,0.8636334969206233,1.0,5/11,17.95%,ALKBH1;NEIL3;APLF;NEIL2;RPS3
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.37763169262623614,-0.853299751927899,0.6808873720136519,0.8621867795499463,1.0,5/10,24.85%,SIRPA;CXADR;JUP;CD47;DSP
prerank,platelet-derived growth factor binding (GO:0048407),-0.35328365340599177,-0.8530689113328118,0.6625,0.8602632606680874,1.0,7/11,43.39%,PDGFRB;PDGFA;COL2A1;PDGFB;PDGFRA;COL1A2;COL4A1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.28873675199145143,0.853019480272865,0.6834862385321101,0.8920322087657732,1.0,2/22,2.66%,RBMS3;ELAVL4
prerank,methyltransferase activity (GO:0008168),-0.25885896346663,-0.8518913330529233,0.7186440677966102,0.8603171031291696,1.0,14/46,25.42%,NSUN3;ARMT1;NSUN4;PRMT1;METTL4;MGMT;PRMT3;COMT;CARNMT1;BCDIN3D;RRP8;BUD23;MRM2;NDUFAF7
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.35861574294218074,0.8517089969834617,0.6584158415841584,0.890219976912905,1.0,3/10,15.50%,SLCO4A1;SLCO2B1;SLCO3A1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.24753570913082198,-0.8469318794926373,0.7378640776699029,0.8674586558599632,1.0,14/53,23.13%,SLC38A6;SLC43A2;SLC38A7;SLC7A7;SLC36A4;CTNS;SLC66A1;SLC7A5;SFXN1;SLC6A9;SLC38A2;SLC25A22;SLC25A13;SLC15A4
prerank,wide pore channel activity (GO:0022829),0.2873224314606535,0.8464317508558944,0.7021276595744681,0.8966531038057304,1.0,6/23,16.25%,GJC3;GJC2;GJC1;GJD3;PANX2;GJD2
prerank,RNA stem-loop binding (GO:0035613),-0.3552199623165485,-0.8446309275413196,0.6618962432915921,0.8692664235795404,1.0,5/12,20.67%,DHX9;RC3H1;CSDE1;DDX3X;ZC3H12A
prerank,lipase activator activity (GO:0060229),0.36035839601447955,0.8414793100644156,0.6749435665914221,0.9020462924000053,1.0,2/10,7.73%,ARHGAP6;FYN
prerank,Hsp90 protein binding (GO:0051879),-0.26688807773396084,-0.8402789870338481,0.7194127243066885,0.8749627919817471,1.0,10/33,23.65%,ERN1;CSNK2A1;AHR;HIF1A;RPS3;NR3C1;NOD2;KDR;HDAC8;AHSA1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.34718250395799716,-0.8393903348691765,0.6818181818181818,0.8743880253593174,1.0,7/12,33.03%,SLC25A24;SLC25A25;SLC25A42;SLC35B3;SLC17A9;SLC19A1;SLC25A17
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.3377021803759509,0.8382175229519341,0.6713947990543735,0.9037299623991505,1.0,4/13,14.97%,LPCAT2;AGPAT3;GPAT3;AGPAT2
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.34959321951195915,-0.8370009218146608,0.6942003514938488,0.8764318634820724,1.0,4/12,13.84%,ITGA5;VEGFA;CCDC88A;GREM1
prerank,protein kinase C binding (GO:0005080),-0.2562587237816013,-0.8362486489795491,0.735191637630662,0.8753422296386689,1.0,12/43,21.58%,PRKCB;PLEK;TOP2A;ITGAV;ADAM9;GRK5;CCDC88A;HDAC5;TWF2;HSPB1;RACK1;PDLIM5
prerank,phospholipase activator activity (GO:0016004),0.3521485102311951,0.8354403988245781,0.6763392857142857,0.9045934119546993,1.0,2/10,7.73%,ARHGAP6;FYN
prerank,phosphatase inhibitor activity (GO:0019212),0.290522491545691,0.8348118057667091,0.7032710280373832,0.9014214063159658,1.0,3/20,5.33%,TESC;PTN;BOD1
prerank,phospholipase binding (GO:0043274),-0.3418471400190606,-0.8316155398763313,0.6980802792321117,0.8813290649991722,1.0,3/13,10.65%,SYK;BLNK;LCK
prerank,protein phosphatase inhibitor activity (GO:0004864),0.27777884942217246,0.8281672934953107,0.714622641509434,0.9093590583683965,1.0,3/26,5.33%,PPP1R14C;PTN;BOD1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.3496677573663248,-0.8281206174471009,0.7068965517241379,0.8853797842612859,1.0,7/11,33.03%,SLC25A24;SLC25A25;SLC25A42;SLC35B3;SLC17A9;SLC19A1;SLC25A17
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.3404002562556617,0.8251311907849138,0.6690307328605201,0.9108484599275505,1.0,2/11,14.99%,CHRNA5;CHRNA7
prerank,pseudouridine synthase activity (GO:0009982),-0.33810496978736104,-0.8229174946851949,0.6953528399311532,0.8920782731532977,1.0,2/13,10.03%,PUS7;PUS1
prerank,sequence-specific mRNA binding (GO:1990825),0.33978173003921747,0.8216610004257543,0.6813953488372093,0.9128324756195817,1.0,3/10,14.85%,FMR1;LARP6;DHFR
prerank,Hsp70 protein binding (GO:0030544),0.25693307505253044,0.8187454353267037,0.7548543689320388,0.9138345621458693,1.0,9/31,16.32%,SACS;GPR37;TSC1;PACRG;HIKESHI;CYP1A1;DNAJB2;PRKN;SNCA
prerank,ATPase activator activity (GO:0001671),-0.2929367986987817,-0.8153851726369511,0.7399650959860384,0.902852827908405,1.0,8/20,27.46%,DNAJC1;ATP1B3;DNAJA1;TOR1AIP1;MYBPC3;DNAJB6;AHSA1;FXYD2
prerank,chemoattractant activity (GO:0042056),0.27070236267319714,0.8143242378732909,0.7645631067961165,0.9172552335836435,1.0,5/26,12.15%,GDNF;VEGFD;PGF;FGF10;SCG2
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.3128385391342426,0.8135790701084642,0.7126436781609196,0.9141183687103626,1.0,4/15,14.97%,LPCAT2;AGPAT3;GPAT3;AGPAT2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.35451294904610997,-0.8125747978964976,0.7333333333333333,0.9051203293166136,1.0,2/10,7.66%,PRKAG2;PKIB
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.33539948239248785,-0.8114804189795335,0.7370184254606366,0.9046374653137871,1.0,3/12,9.34%,SLC9A9;SLC9A8;SLC9A1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.23107303245715596,0.8081454739575691,0.797979797979798,0.9194646327549572,1.0,14/49,17.31%,MPPED2;PXYLP1;GDPD1;ACP6;PLCXD3;ENPP6;DUSP4;DUSP10;DUSP18;PLCXD2;APEX1;DUSP8;PHOSPHO2;PRUNE1
prerank,transcription coregulator binding (GO:0001221),0.23009454503311044,0.8072927392145702,0.8170426065162907,0.9165770348622652,1.0,13/50,20.13%,RORA;PGR;THRB;MTF2;CHD6;NR1D1;PER2;WIZ;CTCF;CIT;TERT;PHF1;PER1
prerank,ankyrin binding (GO:0030506),-0.2982754829889767,-0.8049053289504365,0.7469670710571924,0.9134664751265775,1.0,2/19,9.21%,PTPRC;SLC8A1
prerank,death receptor activity (GO:0005035),-0.3425097740191761,-0.80250076470647,0.7436363636363637,0.9149534548985084,1.0,5/11,36.87%,TNFRSF1B;TNFRSF25;NGFR;TNFRSF14;EDA2R
prerank,cAMP response element binding (GO:0035497),0.33457704916641234,0.7997202332883923,0.7334851936218679,0.9252856340316834,1.0,4/10,12.98%,ATF2;CREB5;HMGA2;CREB3L1
prerank,hormone activity (GO:0005179),0.22493965734683116,0.7954003589198521,0.8268292682926829,0.9281524875526417,1.0,13/54,18.81%,PNOC;SPX;APLN;CORT;EDN1;GHRH;CALCB;INHBB;INHBA;PENK;GRP;INSL6;CRH
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.22686308178269268,-0.7939157383399267,0.84375,0.9264483548217975,1.0,19/57,29.14%,NDUFA9;COX4I1;NDUFB2;COX10;NDUFS5;UQCRC1;COX8A;NDUFA1;CYB561A3;NDUFA4;NDUFA3;CYB5A;COX5A;NDUFB8;NDUFC2;NDUFC1;COX6A2;UQCRQ;NDUFS6
prerank,ion channel inhibitor activity (GO:0008200),-0.2492347219425079,-0.7917560882017032,0.8194207836456558,0.9274101261839219,1.0,9/35,21.11%,ITPR1;STX7;STX8;MCUB;NEDD4L;RASA1;SCN3B;WNK1;RACK1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.24674824867176337,-0.7911061977681849,0.7900172117039587,0.9260546312589181,1.0,10/40,22.83%,DNMT3A;ARMT1;METTL4;METTL9;COMT;GNMT;CARNMT1;METTL2A;METTL2B;RRP8
prerank,O-methyltransferase activity (GO:0008171),-0.3395231515156887,-0.7888212819726961,0.7653631284916201,0.9271268477195276,1.0,3/10,20.35%,CMTR2;COMT;BCDIN3D
prerank,antiporter activity (GO:0015297),0.2776084230893251,0.7886051647233143,0.767337807606264,0.9351178687687949,1.0,10/20,27.07%,ATP1A3;SLC35E4;SLC25A11;CLCN3;SLC35C1;SLC25A30;SLC35C2;SLC35A1;CLCN4;SLC35E3
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.26131944611989666,-0.7874203595311418,0.7983333333333333,0.9267551620851414,1.0,14/27,32.64%,ATP2B1;ITPR1;MAGT1;ATP2A3;CNNM4;SLC23A1;SLC11A2;ZDHHC13;ITPR2;AQP1;SLC12A3;SLC4A8;CNNM2;SLC11A1
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.28410570899651966,-0.7867871331254576,0.7671232876712328,0.9252639527019508,1.0,11/21,43.38%,FRS2;FGF9;FGF20;FGF18;FGF16;FGF2;FGF23;KLB;FGF22;FGF7;NPTN
prerank,cytokine activity (GO:0005125),-0.19675695194480589,-0.7859894186440923,0.9245585874799358,0.9241580703559521,1.0,48/131,39.30%,IL15;IL18;CKLF;PF4;VEGFA;CXCL16;CCL5;IL34;CSF1;IL7;GDF3;WNT3;HMGB1;FAM3C;INHA;IL6;TGFB1;CCL7;KITLG;WNT7B;BMP2;IL36G;WNT6;CCL24;IL2;IL16;CCL4;FGF2;CCL19;CCL25;TNF;FAM3D;WNT10B;BMP8B;IL12A;CNTF;CCL8;CXCL9;LEFTY1;GDF6;IL12B;WNT11;WNT2;INHBC;CTF1;IL17F;CXCL1;CCL14
prerank,NADPH binding (GO:0070402),0.3112580420351245,0.7852919900214986,0.7653508771929824,0.9359606287513155,1.0,6/13,24.26%,CRYZ;DHFR;DUS2;KCNAB1;GRHPR;DECR1
prerank,metalloaminopeptidase activity (GO:0070006),0.2940583524178838,0.7849864327573226,0.7735849056603774,0.93209261324962,1.0,3/16,5.63%,MMP16;TRHDE;MMP15
prerank,N-acyltransferase activity (GO:0016410),-0.25077572296515316,-0.7847928349350819,0.8174204355108877,0.9235591105143718,1.0,14/32,38.17%,SAT1;TGM2;NAA50;PLAAT3;PLAAT1;SAT2;NMT1;CERS3;EP300;GNPNAT1;CERS2;BAAT;PLAAT5;SATL1
prerank,vinculin binding (GO:0017166),0.322740056319587,0.7840035212318262,0.7557077625570776,0.9293162811859764,1.0,2/11,7.50%,DMD;SYNM
prerank,mRNA methyltransferase activity (GO:0008174),-0.3285306136160344,-0.7828004318078958,0.7634782608695653,0.9241522677453268,1.0,9/12,44.73%,PCIF1;CMTR2;METTL14;METTL3;TRMT61A;TRMT61B;METTL8;METTL16;TRMT10C
prerank,metal ion:proton antiporter activity (GO:0051139),-0.3167172168822179,-0.7825500001033786,0.7697478991596639,0.9221394590609661,1.0,3/13,9.34%,SLC9A9;SLC9A8;SLC9A1
prerank,transcription corepressor binding (GO:0001222),0.259340943106257,0.7820017705565403,0.7908653846153846,0.9281336301933911,1.0,4/27,11.97%,RORA;MTF2;NR1D1;PER2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.3274462047013435,-0.7809364328327815,0.78719723183391,0.9222274595476262,1.0,1/12,1.17%,XDH
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.2698526798027443,-0.780266707437376,0.7982758620689655,0.9209165341635489,1.0,7/24,24.98%,ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;ZDHHC1;GOLGA7;ZDHHC6
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.254709142839771,0.7755551492563644,0.8160919540229885,0.9338800362711154,1.0,5/27,10.11%,SLC8A3;SLC9B2;SLC9A2;SLC8A2;SLC4A11
prerank,adenylyltransferase activity (GO:0070566),-0.2768075655142664,-0.7684566126807746,0.8031358885017421,0.9355544041907576,1.0,8/21,19.86%,MTPAP;OASL;OAS3;KARS1;TENT4B;SELENOO;PAPOLA;OAS2
prerank,telomeric DNA binding (GO:0042162),-0.24362552947074884,-0.7676435660337675,0.8303130148270181,0.9343221236040492,1.0,8/32,23.08%,BLM;UPF2;XRCC6;WRN;TEN1;NCL;KDM1A;SMG1
prerank,C2H2 zinc finger domain binding (GO:0070742),0.3239375686008741,0.7673450994487325,0.755868544600939,0.9415712863223374,1.0,2/11,7.74%,WT1;HMGA2
prerank,acetyltransferase activity (GO:0016407),-0.25163348589614926,-0.7598244442110395,0.8443316412859561,0.9423963156692692,1.0,7/31,20.39%,CREBBP;SAT1;PAFAH2;NAA50;SAT2;ESCO2;NAA16
prerank,AMP binding (GO:0016208),0.3102187795942134,0.7595699389442391,0.7732997481108312,0.9486300535627807,1.0,1/11,1.20%,MPPED2
prerank,phosphatase activity (GO:0016791),0.19800791456872294,0.7501461946448781,0.9384236453201971,0.9574809398445516,1.0,23/73,24.55%,PLPP4;PLPPR1;PLPPR4;PXYLP1;ACP6;HDDC2;DUSP4;DUSP10;DUSP18;NOCT;PLPPR2;DUSP8;PHOSPHO2;PRUNE1;PGAM5;BPNT2;NT5M;FRA10AC1;SACM1L;DUSP28;DUSP26;PDXP;MDP1
prerank,sulfate transmembrane transporter activity (GO:0015116),0.28666393197983664,0.7451174125415367,0.8053097345132744,0.9596604409522447,1.0,3/14,13.15%,SLC26A3;SLC25A11;SLC26A8
prerank,solute:proton symporter activity (GO:0015295),-0.2911857907628013,-0.7444879512147936,0.8312387791741472,0.9599557880953142,1.0,5/16,23.13%,SLC33A1;CTNS;MFSD3;SLC11A2;SLC15A4
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.31742378672061716,-0.7432497990436984,0.8044596912521441,0.9591470285187861,1.0,2/11,10.22%,AMFR;UBE4B
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.31098638913738996,-0.7425376114110196,0.8148788927335641,0.9576661312089472,1.0,3/12,20.91%,GTF2A1;RELA;STAT1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.3038779846952946,0.7422493349443132,0.789598108747045,0.959174550068537,1.0,3/11,19.70%,DHRS13;RDH11;RDH14
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.25177924791558365,0.7380355758716229,0.8484848484848485,0.9600979644506147,1.0,7/24,17.01%,NME2;IP6K2;ITPKA;AK4;PPIP5K2;AK5;AK3
prerank,hydro-lyase activity (GO:0016836),-0.22893421992716764,-0.7362222860408213,0.8902027027027027,0.9632572489261372,1.0,2/41,1.62%,TBXAS1;IREB2
prerank,protein phosphatase 1 binding (GO:0008157),-0.2697197857328786,-0.7342483183158852,0.8348457350272233,0.9631575617762844,1.0,4/21,15.88%,LILRB1;AKAP11;PPP1R3E;PPP1R9B
prerank,lysine N-methyltransferase activity (GO:0016278),-0.2658382515583967,-0.7334062785750015,0.8405017921146953,0.9617188376524494,1.0,10/20,34.79%,SMYD2;KMT5A;EEF2KMT;SETD6;METTL21A;SETD7;ETFBKMT;SETD2;ANTKMT;SETD4
prerank,diacylglycerol kinase activity (GO:0004143),0.30368839292205374,0.731671511047079,0.7891156462585034,0.9639428131466908,1.0,1/11,0.90%,DGKB
prerank,anion transmembrane transporter activity (GO:0008509),-0.3009826971026977,-0.7313927689666814,0.8160136286201022,0.9616262274569539,1.0,5/12,38.01%,SLC26A11;SLC22A3;SLC4A1;SLC19A1;SLC22A6
prerank,N-methyltransferase activity (GO:0008170),0.2492242927627022,0.7306202540750082,0.8521939953810623,0.960783656465374,1.0,5/20,14.79%,TRMT1;METTL18;FDXACB1;TRMT11;SETD3
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.31751292480930615,-0.7290439733396067,0.8213689482470785,0.962024700879696,1.0,2/10,17.86%,INCA1;CDKN2C
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.2685637468523303,-0.7255611351014711,0.8659966499162479,0.9635631281441618,1.0,8/18,36.76%,HSD17B7;SRD5A2;HSD17B10;HSD3B2;HSD17B14;DHRS11;AKR1C1;HSD17B3
prerank,death receptor binding (GO:0005123),-0.27833312939687616,-0.7228632034164292,0.8327526132404182,0.9642124720100209,1.0,4/15,21.90%,RIPK1;MYD88;BID;FEM1B
prerank,active ion transmembrane transporter activity (GO:0022853),-0.22586202845834594,-0.7211871645111515,0.8932874354561101,0.963633038765618,1.0,18/37,39.69%,SLC16A7;COX4I1;COX10;UQCRC1;SLCO5A1;COX8A;NDUFA4;CYB5A;COX5A;SLC4A1;COX6A2;UQCRQ;SLCO1B1;SLC22A6;COX7A1;ATP13A3;UQCRFS1;SLCO1C1
prerank,5'-nucleotidase activity (GO:0008253),-0.29093812678421266,-0.7189686092672474,0.8413793103448276,0.9637095658657192,1.0,3/13,30.62%,NT5C2;NT5DC1;ACP3
prerank,phosphate ion binding (GO:0042301),0.2991199247148581,0.7146873532353964,0.8129496402877698,0.9747966146442109,1.0,3/10,15.28%,G6PC1;CHST14;RPH3A
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.23383192254860802,-0.7143034296510871,0.8765432098765432,0.9661143900901454,1.0,5/30,19.48%,SLC30A5;ATP7A;SLC31A1;SLC39A3;SLC11A2
prerank,CXCR chemokine receptor binding (GO:0045236),-0.30889182474639426,-0.7132854408605889,0.8385899814471243,0.9647906729211302,1.0,1/11,5.98%,PF4
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.2680909614195164,-0.7127559989019971,0.8568994889267462,0.9630126716667532,1.0,5/18,22.52%,PIK3R5;WDR91;SOCS6;SOCS3;SOCS5
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.30226546513155295,0.7122715637642325,0.8263736263736263,0.9731396861126879,1.0,2/11,8.15%,NUDT11;NUDT7
prerank,MAP kinase activity (GO:0004707),0.2690972844702304,0.7112060856418607,0.8366445916114791,0.9700468287716089,1.0,5/14,20.66%,MAPK10;MAPK4;MAPK11;NLK;MAPK8
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.22067245744887873,0.7108084208753187,0.9073170731707317,0.9661466104419898,1.0,7/33,13.97%,ZMYM2;RNF144A;UBE3D;SIAH3;RNF217;DCUN1D2;PRKN
prerank,nucleosomal DNA binding (GO:0031492),-0.2599731458887848,-0.7099738236817069,0.8879159369527145,0.9635202174514482,1.0,5/21,22.28%,ACTB;SMARCC2;RBBP4;RCC1;GATAD2B
prerank,hexosaminidase activity (GO:0015929),-0.2868654231196605,-0.6975549571335207,0.8640776699029126,0.9732677696466845,1.0,1/12,0.77%,HEXA
prerank,hormone receptor binding (GO:0051427),-0.2785273182997132,-0.697334960876753,0.8789473684210526,0.9711124701914989,1.0,5/14,29.04%,JAK1;NCOA6;TYK2;VIP;CCK
prerank,RNA methyltransferase activity (GO:0008173),-0.250093938497213,-0.6909387234522782,0.8846815834767642,0.974753615505094,1.0,10/19,43.88%,METTL4;BCDIN3D;TGS1;MRM2;METTL3;FTSJ1;MEPCE;METTL8;TRDMT1;LCMT2
prerank,copper ion binding (GO:0005507),-0.21004161704987293,-0.6895996367047438,0.9435897435897436,0.9735737672632588,1.0,10/42,29.66%,P2RX4;ATP7A;AOC2;MOXD1;ANG;MT3;DCT;ACR;ATP13A2;ATOX1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.2580986986573997,0.6722181696107347,0.8806682577565632,0.9992474670098518,1.0,2/15,9.66%,PLA2G4E;PLA2G10
prerank,ribosome binding (GO:0043022),-0.20300540335742054,-0.6664600664511839,0.9671848013816926,0.9905634198501909,1.0,11/46,21.36%,YTHDF3;EFL1;EEF2;EIF2A;MAIP1;C1QBP;NAA16;CPEB4;ZC3H12A;RACK1;BAG6
prerank,exoribonuclease activity (GO:0004532),-0.2744210097798242,-0.6620429089789335,0.8927272727272727,0.9916319681745829,1.0,5/12,26.79%,EXOSC5;EXOSC10;ZC3H12A;EXOSC4;EXOSC8
prerank,fibroblast growth factor binding (GO:0017134),-0.23796486648540122,-0.6589376231243188,0.9186046511627907,0.9916286570242313,1.0,2/21,7.49%,ITGAV;CEP57
prerank,mechanosensitive ion channel activity (GO:0008381),-0.2764029277645119,-0.6570108095449035,0.9018181818181819,0.9906765257513792,1.0,2/12,10.10%,PIEZO1;TMC6
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.22779108413082738,-0.6433313486362301,0.9389179755671903,0.9976283315378806,1.0,5/21,24.38%,POLE2;PRIMPOL;POLN;POLB;POLD4
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.2781084554250751,-0.6422501888937946,0.9024390243902439,0.9959986288297602,1.0,3/11,20.39%,NAA25;NAA50;NAA16
prerank,H4 histone acetyltransferase activity (GO:0010485),0.27324739780962204,0.64135329496313,0.888641425389755,1.0,1.0,2/10,12.83%,ATF2;NAA60
prerank,anion:anion antiporter activity (GO:0015301),0.23251928071266575,0.6350852630672608,0.9428571428571428,1.0,1.0,3/17,13.15%,SLC26A3;SLC25A11;SLC26A8
prerank,MAP kinase phosphatase activity (GO:0033549),-0.2657360059537951,-0.6347022033229416,0.898989898989899,0.9983999534634685,1.0,4/12,23.90%,DUSP3;DUSP6;DUSP5;DUSP2
prerank,alkali metal ion binding (GO:0031420),-0.25763151348608593,-0.6303176668328854,0.9237749546279492,0.9985675313740949,1.0,4/13,33.11%,IMPA1;PDXK;ATP1A1;DRG1
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.2810947234323268,-0.6289669887918161,0.9294320137693631,0.996960138829804,1.0,3/10,20.39%,NAA25;NAA50;NAA16
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.24979250779261122,-0.626231196922431,0.921146953405018,0.9960760907868343,1.0,7/14,36.63%,BLVRB;QDPR;MTHFR;PYCR3;MTHFD1;PYCR2;CRYM
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.27048875060378164,-0.6240066044726771,0.9156829679595279,0.9950080318375143,1.0,2/10,13.56%,ASH1L;SETDB1
prerank,CoA hydrolase activity (GO:0016289),-0.24130980222864262,-0.6236657477832354,0.9349904397705545,0.9928057112759123,1.0,9/16,38.15%,ACOT9;ACOT13;ACAA2;ACOT2;ACOT4;ACOT11;ACOT6;BAAT;ACSBG2
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.22819688657292492,0.6191464801418181,0.9504504504504504,1.0,1.0,4/17,17.01%,NME2;AK4;AK5;AK3
prerank,protein phosphatase activator activity (GO:0072542),-0.2460372357169931,-0.6112822119035428,0.9219600725952813,0.9968792153321684,1.0,6/13,31.06%,IGFBP3;PHACTR4;PPP2R5B;PPP2R5A;PPP2R5E;PTPA
prerank,secondary active transmembrane transporter activity (GO:0015291),0.17419524151753757,0.6097727876163296,0.9921465968586387,1.0,1.0,18/51,26.14%,SLC4A4;SLCO4A1;SLC35E4;SLCO2B1;MFSD2A;SLC25A11;CLCN3;SLC16A2;SLCO3A1;SLC35C1;SLC25A30;SLC35C2;SLC35A1;SLC28A1;SLCO4C1;SLC22A8;CLCN4;MCU
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.23495721845997142,0.6095984772232963,0.937046004842615,1.0,1.0,3/15,8.71%,SOCS4;SOCS7;CCKBR
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.25502652782661794,-0.6082057620589226,0.9279112754158965,0.9959524440861031,1.0,7/12,36.06%,CBR1;NQO1;DHRS4;NQO2;AIFM2;CBR4;AKR1C1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.21586722760579097,-0.6058279996527833,0.9586919104991394,0.9946750351646223,1.0,4/22,10.95%,MTMR3;DUSP3;CDKN3;DUSP6
prerank,tRNA methyltransferase activity (GO:0008175),-0.22808714880375974,-0.6043478960128802,0.9584026622296173,0.9930647272391566,1.0,4/16,20.76%,TRMT44;BCDIN3D;METTL2A;METTL2B
prerank,pyrophosphatase activity (GO:0016462),-0.17448684390972763,-0.6027029110127227,0.9876760563380281,0.9914390324539811,1.0,24/50,40.58%,DHX9;DCP2;ENTPD6;NUDT14;BNIP2;ENTPD3;ENPP1;DDX3X;NUDT22;BNIPL;NUDT15;NUDT6;NUDT16;ALPL;DCTPP1;NUDT10;ENTPD7;LHPP;NUDT1;CILP;DOLPP1;NUDT5;PLPP1;DXO
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.23951789778471988,0.6017808216626224,0.9437939110070258,1.0,1.0,3/14,15.12%,NME2;AK4;AK5
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.18276964101111204,0.6010397621316744,0.9729119638826185,1.0,1.0,6/34,15.68%,NDUFB7;NDUFV2;NDUFA2;NDUFB9;NDUFA8;NDUFV3
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.18276964101111204,0.6010397621316744,0.9729119638826185,1.0,1.0,6/34,15.68%,NDUFB7;NDUFV2;NDUFA2;NDUFB9;NDUFA8;NDUFV3
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.20216915515194347,-0.6004901757951938,0.9628975265017667,0.9901480195607885,1.0,8/27,29.26%,SLC26A11;XPR1;GET3;ANKH;SLC25A10;SLC4A1;SLC26A4;SLC5A5
prerank,glycerophospholipid flippase activity (GO:0140333),0.2477618972883291,0.5989110686759672,0.9295774647887324,1.0,1.0,1/11,2.36%,ATP8A2
prerank,organic cation transmembrane transporter activity (GO:0015101),0.2178485631879611,0.5960056024860236,0.9702517162471396,1.0,1.0,3/16,15.20%,SLC5A7;SLC18A3;SLC22A5
prerank,solute:anion antiporter activity (GO:0140323),-0.2324369255380028,-0.5907694539690928,0.9513513513513514,0.9920964305807762,1.0,1/14,4.03%,SLC26A11
prerank,peptide hormone receptor binding (GO:0051428),-0.2476135048655301,-0.589844070965767,0.9422066549912435,0.9901788024110656,1.0,3/11,29.04%,GNRH1;VIP;CCK
prerank,enoyl-CoA hydratase activity (GO:0004300),0.24177755460708006,0.5883914546197383,0.9457013574660633,1.0,1.0,10/10,75.84%,EHHADH;HSD17B4;AUH;ECHDC1;HADHA;HADHB;ECI1;ECHS1;ECHDC2;ECHDC3
prerank,DNA polymerase activity (GO:0034061),-0.20506897513272615,-0.5854899888720065,0.9710884353741497,0.9896098129937729,1.0,5/22,24.38%,POLE2;PRIMPOL;POLN;POLB;POLD4
prerank,nucleotide diphosphatase activity (GO:0004551),0.2281971901143429,0.5834832158869857,0.9569160997732427,1.0,1.0,3/14,17.63%,NUDT11;ENPP5;NUDT3
prerank,carboxy-lyase activity (GO:0016831),0.19800302182768018,0.5767968128716789,0.9779951100244498,1.0,1.0,8/23,24.86%,PISD;DDC;GGCX;MLYCD;ACOD1;ODC1;MVD;AMD1
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.2057307427394886,-0.5766525585467879,0.967741935483871,0.9906841901915661,1.0,1/20,1.88%,SLC30A5
prerank,Notch binding (GO:0005112),0.19597848688218608,0.5761318942859994,0.9675925925925926,0.9977161051652137,1.0,6/22,21.26%,CCN3;DNER;SNED1;ADAM17;SNW1;DLL4
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.18424428957993072,0.5719742050653546,0.981859410430839,0.9953005849616318,1.0,9/28,22.16%,POP7;RPP25;RNASEH1;RPP14;POP4;APEX1;RPP21;RPP38;MRPL44
prerank,nucleotidase activity (GO:0008252),-0.21435608934648048,-0.5538369502895506,0.9765886287625418,0.9956618524213785,1.0,3/15,30.62%,NT5C2;NT5DC1;ACP3
prerank,leucine zipper domain binding (GO:0043522),-0.2426248203906044,-0.5474344958908415,0.9530434782608695,0.9951142357095237,1.0,2/10,15.24%,DAPK3;AATF
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.17624152977418894,-0.5459912686623088,0.9901315789473685,0.9931966357560286,1.0,7/35,21.60%,ALKBH1;FTO;QTRT1;TARS2;AARS1;BCDIN3D;ELAC2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.22984585338020289,0.5426108517337531,0.9542168674698795,0.996122590575503,1.0,4/10,21.46%,DUSP4;DUSP10;DUSP8;DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.22984585338020289,0.5426108517337531,0.9542168674698795,0.996122590575503,1.0,4/10,21.46%,DUSP4;DUSP10;DUSP8;DUSP7
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.22526479064916996,-0.5348872804223995,0.9737302977232924,0.9936082103582148,1.0,2/11,25.27%,SLC25A45;SLC22A3
prerank,ribosomal large subunit binding (GO:0043023),0.21266712698512336,0.53288627675867,0.9671361502347418,0.9943935699223565,1.0,11/11,78.75%,NPM1;CPSF6;MRRF;NMD3;LTN1;DHX33;CPEB2;MALSU1;NEMF;EIF6;RBM3
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.19097298830007767,-0.5125570301826874,0.9911971830985915,0.9955928222838134,1.0,6/18,30.39%,TGFBR1;TGFBR2;SMAD7;TGFB1;ENG;SMAD2
prerank,single-stranded telomeric DNA binding (GO:0043047),0.20971379448096833,0.5103398970030806,0.9883720930232558,0.9948434503490619,1.0,10/11,57.53%,NABP2;TERF1;RPA2;CTC1;TERF2IP;HNRNPA2B1;RAD50;RPA1;STN1;TERF2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.1991503096135522,-0.4925422414069539,0.9899159663865547,0.9961631529123689,1.0,1/13,5.08%,METTL1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.19639890754190417,0.4813983867145043,0.9928571428571429,0.9948849818741343,1.0,2/13,13.98%,EBP;EHHADH
prerank,N-acetyltransferase activity (GO:0008080),-0.17230816185646475,-0.4689560430373566,0.9931153184165232,0.996327829611294,1.0,7/19,38.17%,SAT1;NAA50;SAT2;EP300;GNPNAT1;ATAT1;SATL1
